Awards layout for magazine publishing - Healthcare and Pharmaceutical Awards 2019 - AI Global Media

www.ghp-news.com • 2019 Healthcare & Pharmaceutical Awards

Healthcare & Pharmaceutical Awards 2019

Best Health & Pharma Sales Organisation - Australia We offer a fascinating insight into the secrets behind their success. - Page 4

“At FarmaForce we continue to drive affordable solutions with unique service offerings and to act as a trusted launch partner for international companies looking to enter the Australian market.”

Editor’s Note

,

Welcome to the Healthcare and Pharmaceutical Awards 2019 The responsibility for maintaining and improving the health of millions of individuals worldwide cannot be taken lightly as it is a duty fraught with many challenges and obstacles. In their bid to remain at the forefront in fight against disease and illness while providing cutting edge solutions for the surgery and rehabilitation of patients worldwide, businesses are faced with a myriad of practical and theoretical obstacles.

The Healthcare & Pharmaceutical Awards returns to honour those who provide the highest quality of care and medical products available. We will also pay homage to those whose innovative work within the pharmaceutical industry contributes towards furthering the advancement of patient care in an ever-expanding and demanding sector.

Hannah Stevenson, Awards Editorial Manager Phone: (+44) 0203 970 0082 Email: h.stevenson@aiglobalmedialtd.com Website: www.ghp-news.com AI Global Media, Ltd. (AI) takes reasonable measures to ensure the quality of the information on this web site. However, AI will not assume any legal liability or responsibility for the accuracy, correctness or completeness of any information that is available through this web site. If errors are brought to our attention, we will try to correct them.

The information available through the website and our partner publications is for your general information and use and is not intended to address any particular finance or investment requirements. In particular, the information does not constitute any form of advice or recommendation by us or any of our partner publications and is not intended to be relied upon by users in making or refraining from making any investment or financial decisions.

Appropriate independent advice should be obtained before making any such decision. Any arrangement made between you and any third party named in the site is at your sole risk and responsibility.

Contents

Contents 6. FarmaForce: Best Health & Pharma Sales Organisation - Australia 10. Rehasense Deutschland GmbH: Most Innovative Mobility Products Manufacturer 2019 12. ANCON Medical: Most Innovative Disease Screening Technology Developers 2019 & Best Cancer Detection Technology: Nanoparticle Biomarker Tagging 15. Chapter Care (North Devon) Ltd Best Domiciliary Care Provider 2019 - Devon 16. Neuro-Sys: Best International Drug Development & Discovery Development Company 2019 - France 18. Swiss Biostadt Limited: Best Medical Equipment Supply & Installation Company - Nigeria 20. Phycinity PLLC: Best Pediatric Centre – North Carolina 22. Innovapharma: Most Innovative Rejuvenation & Aesthetics Products Producer - South America 24. Hyalual: Best Aesthetic Medicine Solutions Manufacturer 2019 & Most Outstanding in Skin Rejuvenation 2019 26. Seacross Pharmaceuticals: Best Injectable Oncology Therapeutics Manufacturer 2019 28. STILLE AB: Best Medical Device Company 2019 – Sweden & Best Surgical Imaging Table: STILLE imagiQ2™ 30. Health Economics and Outcomes Research Ltd.: Best Independent Health Economic Modelling Experts 2019 32. Medovate Limited: Most Innovative Medical Device Development Company 2019 - Eastern England 34. Medi-Immune Ltd.: Most Innovative Pathogen Prevention Research Company 2019 - Europe 36. EQUITAS Life Sciences: Most Innovative Life Sciences Consultancy 2019 - North America 38. ISPINE: Most Innovative Cervical Plate System: Combat Anterior Cervical Plate System 40. Shawlands Dental Care: Dental Practice of the Year 2019 – Glasgow & GHP Excellence Award for Outstanding Patient Welfare 2019 41. Greenpower Healthcare Ltd: Best Natural Wellness Products Manufacturer 2019 – Nigeria 42. Instant Consult: Most Innovative Online Medical Consultancy App: Instant Consult® & Leading Healthcare App Development Company - Australia 44. HealthItalyNet: Best Health Services Consultants 2019 - Italy 45. Zaheda Skincare: Best Skin Care Products 2019 - London

Contents

,

46. NeuroTransData GmbH: Best Neurology & Psychiatry Network 2019 – Germany & Leading Provider of Digital Health Solutions - Germany 49. WALKEMORE, S.A.: Best Hospital Footwear Specialist 2019 50. YouMed Ltd: Best Medical Technology Sales & Marketing Company - UK 51. RXLive Pharmacy: Most Innovative Prescription Delivery Service - UK 52. Pace Analytical: Best Pharmaceuticals & Medical Device Testing Experts 2019 53. Aris Pharmaceuticals Inc: Best R&D Services Laboratory - Pennsylvania 54. Practice Partners: Best Healthcare Business Consultancy - Australia 55. Premier Dentalcenter, Clínica Dentária: Dental Clinic of the Year 2019 - Porto Metropolitan Area & Award for Excellence for Paediatric Dentistry Services 2019 - Porto Metropolitan Area 56. The Hear Clinic Ltd: Best Independent Audiology Clinic 2019 57. Clareblend Inc.: Best Beauty Therapy Technology Marketplace 2019 - Nevada 58. inMotion VR B.V.: Best Healthcare Virtual Reality Solutions Provider 2019 & Best Virtual Reality Therapy Platform: Corpus VR 59. Institut Marquès: Best International Gynaecology, Obstetrics & Assisted Reproduction Reference Centre 60. m.Doc GmbH: Best Digital Health Platform 2019 61. DigiPol Technologies: Best Digital Polarimeters Manufacturer 2019 62. CareLineLive: Best Home Care Management Solutions Provider - UK 63. PT Insan Medika Persada: Best Digital Home Care Provider 2019 - Indonesia 64. Kurmis Orthopaedics: Best Orthopaedic Surgical Practice - South Australia & Award for Excellence in Patient- Centric Care - South Australia 65. Iceberg Medical Ltd: Medical Communications Agency of the Year 2019 66. Axis Medicare Limited: Pharmaceutical Products Supplier of the Year 2019 - UK 67. Ozop Surgical, Corp (OTCQB:OZSC): Most Innovative Surgical Implants & Instrumentation Manufacturer - USA 68. Bluefish Pharmaceuticals AB: Most Progressive Generic Pharmaceuticals Company - Scandinavia 69. SureMed Technologies Inc.: Leading Innovators in Medication Safety & Efficacy - USA 70. Psicologia Y Sexologia En Madrid: Psychotherapist of the Year 2019 - Spain 4 GHP / 2019 Healthcare & Pharmaceutical Awards

Contents

,

71. Nutralab Canada Corp.: Best Custom Natural Health Supplements Manufacturer - Canada 72. JSS Medical Research Inc.: Best for Clinical Trials Management Services - Quebec 73. Xeal Pharma: Best Specialist Pharmaceuticals Manufacturer 2019 - Midlands 74. Emphascience Inc.: Best Pharmaceutical R&D Company - New York 76. Mayfair Diagnostics: Best Medical Imaging Company - Western Canada 77. Building Blocks Occupational Therapy: Outstanding Service Award in Multi-Disciplinary Paediatric Healthcare 2019 78. Wheel of Health Limited: Best for Posture Management Analysis Reports - UK & Ireland 79. Liva Healthcare: Most Innovative Digital HealthTech Company 2019 Lifestyle & Disease Management Platform of the Year: LIVA 80. Westwood Care and Support Services (Yorkshire) Ltd: Domiciliary Care Provider of the Year 2019 - Yorkshire & the Humber 81. Audiology Associates Ltd: Best Audiology Company 2019 - Wales 82. Staywell Occupational Health Ltd: Best Occupational Health Services Provider – UK & GHP Client Service Excellence Award 2019 83. Dennison Psychology: Most Trusted Private Psychology Practice 2019 - Melbourne 84. CareRooms: Best Private Healthcare & Rehabilitation Centre - London & South East England 85. DArcy Consulting: Best SME Life Sciences Compliance Consultancy - North East USA 86. MediComb A/S: Most Innovative Drug Information System - Nordic Region & Leaders in Patient Safety 2019 - Nordic Region 87. Accel-Rx: Best Health Sciences Accelerator 2019 – Canada & Seed Investment Experts of the Year - Canada 88. NetCheckIn: Best Medical Services Queue Management Solution: NetCheckIn™ 89. INNOTIO GmbH: Best Specialist Healthcare Communications Agency - Central Europe 90. Vital10: Best National Health Promotion & Support Company – Netherlands & GHP Innovation Award for Medical Monitoring Solutions 91. DrDoctor: Best Healthcare Transformation Specialists - UK 92. International Travel and Healthcare Limited: Best Medical Travel Insurance Provider - UK 93. MedPlan Communications: Best Continuing Medical Communications Agency 2019 - Canada 94. Al-Faraby Medical Group: Healthcare Consultancy of the Year 2019 - South Asia 95. PlantForm Corporation: Best Specialty Protein Drug Biopharmaceutical Company 2019 96. CBD Becomes A Hot Topic In UK Alternative Medicine Market GHP / 2019 Healthcare & Pharmaceutical Awards 5

,

FarmaForce: Best Health & Pharma Sales Organisation - Australia FarmaForce is an award-winning contract sales organisation (CSO) renowned for providing high performing sales teams and solutions to the healthcare and pharmaceutical industries. In celebration of the firm’s recognition in this year’s Healthcare and Pharmaceutical Awards, we offer a fascinating insight into the secrets behind their success.

FarmaForce was established in 2014 with a clear purpose – to provide an unprecedented level of sales force excellence through strategic partnerships with pharmaceutical companies in the ever-changing healthcare industry.

“Based on experience and research, we knew that the healthcare CSO market is littered with transactional engagements that short-changed the customers’ best interest and those of the healthcare space itself,” said

Ghay Haidar, Sales Director of FarmaForce.

“We saw this as an opportunity to focus on establishing a mindset of building long-term, rewarding partnerships founded on shared success.”

Ghay is part of a leadership team that boasts more than 100 years’ collective experience in building successful sales teams and delivering results for clients, a key factor in FarmaForce’s growth to become Australia’s premier healthcare CSO. Over the past 12 months, the company has built and launched

6 GHP / 2019 Healthcare & Pharmaceutical Awards

“...We saw this as an opportunity to focus on establishing a mindset of building long-term, rewarding partnerships founded on shared success.”

g

FarmaForce

GHP / 2019 Healthcare & Pharmaceutical Awards 7

,

three new national sales teams, as well as advancing their Salesforce Effectiveness Analytics resourcing to enhance their data analytics and reporting services.

Through its strategic and consultative approach, FarmaForce offers bespoke and agile solutions for companies looking to increase their sales performance, test new territories or fields, launch new products, or to help meet commercial objectives when there are pressures on headcount.

“We’re constantly building our capability and we see ourselves as the ideal partner for local stakeholders as well as international companies wanting to have a full spectrum presence in the Australian healthcare market” said Mr Haidar. “We invest heavily in our people, processes and infrastructure in order to drive success for our partners and to fuel our continued growth.”

It is this culture of continuous improvement and long-term commitment to staff training and development that FarmaForce attribute as the key driver for their success.

“At FarmaForce, people are at the core of everything we do – they are our DNA” said Mr Haidar. “We focus a significant amount time on our coaching culture that empowers our employees, helping them to achieve and deliver on commercial objectives.”

“The cost of sales continues to increase which is putting huge pressures on margins,” said Mr Haidar. “At FarmaForce we continue to drive affordable solutions with unique service offerings and to act as a trusted launch partner for international companies looking to enter the Australian market.”

Company: FarmaForce Address: Level 9, 85 Castlereagh Street, Sydney NSW 2000, Australia Telephone Number: +61 2 8239 5400 Web Address: farmaforce.com.au

“...At FarmaForce we continue to drive affordable solutions with unique service offerings and to act as a trusted launch partner for international companies looking to enter the Australian market.”

As well as their people, FarmaForce continues to invest in its operations and analytics functions, leveraging digital solutions to drive productivity. Data science is used to develop sales strategies, whilst data and analytics reporting provides their clients with real-time information that can be used to enhance commercial outcomes.

The result of this supportive internal culture and commitment to quality is an exceptional service offering for all clients.

FarmaForce is also a proud member of The iQ Group Global, a consortium of companies that find, fund and develop bioscience discoveries into real life-changing medical innovations and take them to the people who need them most. Being part of such a dynamic group of companies is another key differentiator for FarmaForce, as they are able to draw on the collective expertise and experience of their colleagues from across The Group.

Moving forward, FarmaForce see the demand for CSOs increasing as clients look for ways to maximise their coverage and share of voice within the primary, secondary and pharmacy healthcare sectors.

8 GHP / 2019 Healthcare & Pharmaceutical Awards

g

FarmaForce

Company: FarmaForce Address: Level 9, 85 Castlereagh Street, Sydney NSW 2000, Australia Telephone Number: +61 2 8239 5400 Web Address: farmaforce.com.au

GHP / 2019 Healthcare & Pharmaceutical Awards 9

,

Rehasense Deutschland GmbH: Most Innovative Mobility Products Manufacturer 2019 An international thought-leader and key innovator in the mobility products market, Rehasense Deutschland GmbH manufactures a wide range of selected, high quality mobility products for those with mobility challenges, helping them to overcome the issues they face. In celebration of the firm’s win in this year’s Healthcare and Pharmaceutical Awards we share a unique insight into the secrets behind its success.

Internationally renowned and boasting wide-reaching roots, Rehasense is able to provide award-winning mobility solutions to a myriad of clients.

Led by CEO Roger Dutton, former managing director of Ottobock in Beijing, Asia, the group draws on his expertise to ensure it meets the needs of its varied clients and offers them cutting-edge mobility solutions that will suit modern requirements.

A pioneer in the mobility market, Rehasense was one of the first companies in the world that launched a Carbon rollator named ATHLON in 2014. It was a new technology for a medical device product and with over 500 Euros one of the most expensive rollators within the rollator business.

and as part of this focus, they realise that design and colours are playing an essential role. As such, they have created the ATHLON SL (Super Light), which is available in the colours Carbonblack, Racing Red, Yacht White, and Mat Grey. The SERVER the classic amongst rollators, is available in six colours depending on its size.

Working with a range of clients, including medical supply stores, Rehasense has achieved global renown thanks to these innovative solutions. Germany is one of the firm’s strongest market’s in Europe, but the company is making headway around the world thanks to its revolutionary solutions and commitment to inclusion.

Going even further to ensure users feel comfortable and supported, the firm also released ATHLON for the XL segment, naming it the name ATHLON HD (Heavy Duty). The ATHLON HD only weighs 5.8 kg (without shopping bag) with a high load capacity of 200 kg and a seat width of 55 cm.

As such, it is designed specifically with larger users in mind, and allows more people to make the most out of this ingenious creation.

Dedicated to creating this range of unique solutions is Rehasense’s interdisciplinary team, which consists of specialists in the engineering, design and luxury industries.

Together they have over 20 years’ experience in the market, and as such they are all able to drive the industry forward and offer clients innovative solutions that cannot be found elsewhere.

Weighing only 5kg and with up to eight years warranty, the ATHLON is one of the most desirable carbon rollators, and today ATHLON stands for the premium segment in the firm’s rollator portfolio.

Following this success, competitors quickly followed suit, and as such Rehasense is now working to enhance the success of this unique products and others. The firm is still working on overcoming stigmas to avoid fear of medical products like the rollator and ensure that the user and their family feel better because of better support in the user’s life.

The team at Rehasense believe that clients should not be ashamed to walk with a rollator,

10 GHP / 2019 Healthcare & Pharmaceutical Awards

Ultimately, Rehasense aim is to bring back freedom, independence and recreation to users around the world, and over the years ahead the group will remain driven towards this ambitious goal. As demand continues to rise around the world, moving forward Rehasense will stay focused in the existing markets, strengthening its presence with sales and marketing support and new product developments, which will extend its existing product range and help the group cement its place as a true revolutionary in the growing global mobility space.

Company: Rehasense Deutschland GmbH Contact: Rebecca Graber Email: rebecca.graber@rehasense.com Address: Briener Str. 25, 47533 Kleve Telephone Number: +49 176 344 332 76 Web Address: www.rehasense.com

g

Rehasense Deutschland GmbH:

“A pioneer in the mobility market, Rehasense was one of the first companies in the world that launched a Carbon rollator named ATHLON in 2014. It was a new technology for a medical device product and with over 500 Euros one of the most expensive rollators within the rollator business.

GHP / 2019 Healthcare & Pharmaceutical Awards 11

,

ANCON Medical: Most Innovative Disease Screening Technology Developers 2019 & Best Cancer Detection Technology: Nanoparticle Biomarker Tagging ANCON Medical’s long-term mission is to deliver an innovative, non-invasive technology that can detect a wide range of diseases in their earliest stages. Breath analysis is the “Holy Grail” of medical diagnosis technology, providing a simple, inexpensive way to identify minute traces of molecular biomarkers within a point of care situation, as the firm explores in this unique article.

Why diagnose early?

The first thing to consider is perhaps why early diagnosis is so important? For many this question may seem blindingly obvious, there are myriad stories and accounts of patients who have been told it’s ‘too late’ by doctors upon receiving their diagnosis. What is not immediately obvious is the non-discreet stages of “too late” that exist when dealing with serious, life-changing illnesses.

In between catching a disease at the earliest possible stage and it eventually reaching incurable status, each step affects the treatment options available and the efficacy of these treatments. The earlier a disease such as lung cancer or bowel cancer is diagnosed, the more treatment options are available to doctors, surgeons and healthcare professionals. For advanced stage cancers, surgery is often not a viable treatment option, especially if the disease has spread to other parts of the body.

For instance, lung cancer – which is our main focus at this moment – has a net survival rate of just 15.3% according to statistics released recently by the Office of National Statistics.

However, when diagnosed at Stage 1 this figure almost quadruples to 56%. This could mean that of the 47,000 or so cases each year almost 20,000 (26,000 vs 7,000) more people could potentially survive the disease if all cases were caught at Stage 1. This may seem far-fetched, but this is the potential that diagnosis technology has to change the face of the medical industry.

Why isn’t this already happening?

Current methods rely heavily on patients’ judgement, accuracy of symptom description and the decisions that GPs and consultants make. And once through this first stage, on expensive and relatively inaccurate technologies such as X-rays, CT scans and MRIs. Every day, many thousands of people ignore symptoms for a wide variety of reasons, from busy work and family lives, to a fear of what the diagnosis might be. Research conducted

by ANCON in the UK found that over half of respondents have not visited a doctor in over five years, while over 5 million people have previously ignored serious symptoms due to a lack of time to visit a doctor. This is not a problem that is limited to the UK either, across the world putting off the visit to the doctor’s surgery undoubtedly costs thousands of lives.

12 GHP / 2019 Healthcare & Pharmaceutical Awards

Once an individual has seen a doctor and a serious disease is suspected it comes to the actual diagnosis which can often be expensive, time consuming and, worst of all, inaccurate. Coming back to lung cancer once again as a prime example; it is a notoriously difficult disease to diagnose accurately. When using a CT scan the rate of false positive diagnosis is 36%. Over a third of diagnoses turn out to not to be cancer at all. While when using X-rays early detection is not always possible due to a lack of sensitivity. While MRIs are far more sensitive, this comes with a huge price tag, both in terms of equipment and staffing costs.

For these reasons, effective screening, faster diagnosis and non-invasive options are of paramount importance.

How can this be achieved?

An effective screening strategy could help alleviate some of the anxiety around diagnosis and fast results could free up resources for doctors and allow more people to fit a consultation into busy work schedules.

ANCON Medical’s revolutionary Nanoparticle Biomarker Tagging (NBT) technology potentially offers just that. The NBT device analyses a patient’s breath to provide a fast, point of care and non-invasive diagnosis methods for the world’s most serious diseases.

,

Neither is it just lung diseases that have this give-away: each disease releases their individual biomarkers into the bloodstream of each person which through normal blood flow and blood oxygenation in the lungs is transferred to our breath. Opening up the scope of diagnosis to almost every kind of disease, malady or abnormality that you can think of.

The device operates at a level of accuracy far higher than anything currently on the market or in development, by detecting and analysing individual particles contained in an individual’s breath, known as biomarkers.

Biomarkers are characteristic chemicals, volatile organic compounds or particles produced by the human body and all the individual organisms within it. Each bodily function, process or microorganism produces these biomarkers through everyday activities and survival. This also applies to the functions of deadly diseases, tumours and bacteria.

A lung cancer tumour produces a profile of novel biomarkers that can be detected, leading to an effective way of diagnosis. This characteristic biomarker profile is exhaled through the lungs and into the outside world in each one of our breaths each and every day.

The NBT device is able to analyse a breath sample from just one minute of normal breathing and, through the use of AI, give a diagnosis within 10 minutes at the point of care. This eliminates not only a huge amount of anxiety around results but gives the most possible time to begin treatments.

What is the scope of the technology?

Due to the accuracy and sensitivity of the device, diseases can be detected at a stage even before symptoms develop. A crucial point not only for cancer but perhaps more so for infectious and epidemic illnesses such as Ebola.

In fighting Ebola, researchers have found that early screening is the key to preventing the spread of the disease, but it’s a hard disease to diagnose based on the symptoms, which can be common to other diseases like malaria, typhoid fever and meningitis.

This screening is made more difficult by the logistics of transporting a laboratory setting to rural communities where outbreaks often occur.

Once someone has the symptoms of Ebola, it’s already too late and that person can spread the disease. It’s crucial to find diseases like Ebola at its earliest point of infection, before they are showing the signs.

However, once the body is infected, it will begin giving off the chemical ‘fingerprints’ of the disease, and an NBT device can find these chemical signals, even at their faintest concentrations.

The incubation period for Ebola in humans is between two and 21 days, which is the time elapsed from infection until when symptoms begin to show. Ebola can’t be spread until symptoms are shown, so discovering it early is vital for prevention efforts. Other early detection methods for Ebola require a blood sample, which takes specialised medical training, a laboratory environment and can expose health care workers to some risks.

A portable NBT device can give public health officials an easy-to-use screening device that can be brought into a wide range of places, including airports, train stations, rural clinics and other vital locations where it is crucial to find potentially infected individuals before they can spread the disease.

GHP / 2019 Healthcare & Pharmaceutical Awards 13

Screening for Ebola would be possible with the correct VOC Biomarkers in place, and coupled with the ability to carry out this screening in the field, which is one of the aims of our technology, Ebola could be tackled in a much more effective way. Mobility is crucial.

When might this technology be available?

ANCON Medical is currently developing this technology for human trials in two sites; the facility in Minnesota (USA) is part of the state’s Medical Alley medical device manufacturing community, and the same facilities in Kent (UK) operate within the Innovation Centre located within the grounds of the University of Kent at Canterbury. The collaboration between the two sites will allow human trials to take place both in the US and UK in the coming months.

The company is currently in the process of raising investment for these trials before a further raise to fund clinical trials later in the year. The technology could be on the market as early as 2021 or 2022 which would truly revolutionise what is a sometimes oldfashioned facet of medicine. Treatments for cancer are advancing at an ever-increasing rate, with innovation coming in the forms of new drugs, surgical equipment and techniques of radio and chemotherapy. But treatment is just one side of the coin when it comes to making cancer survivable in the long term with diagnosis at the earliest stage being the other.

NBT technology and the natural world As with the vast majority of medical advances, ANCON Medical’s NBT technology has taken inspiration from the natural world and hopes to bring the ability to quite literally ‘sniff out’ diseases to the clinical arena, to the benefit of thousands.

Sniffer dogs have been used for years to detect drugs, explosives and blood in a variety of situations. The dogs are trained to respond to the compounds given off by whatever the target substance is, whether that be in suitcases, on the street or in homes.

A dog’s sense of smell is around 40 times more sensitive than that of a human’s which gives them this ability to detect smells – or volatile organic compounds as they often are – so much more effectively.

It is not just dogs that can smell certain medical conditions, a common symptom of hyperglycaemia is the smell of acetone on the breath of a person, caused by ketoacidosis, an acute complication of diabetes. This telltale smell – the chemical used in nail polish – is an extreme example to show the power of illness to affect our breath.

Recently, dogs have been used to indicate the presence of certain types of cancer from the compounds emitted by a person’s skin, blood and in some cases breath. And in one case a woman in the UK named Joy Milne was able to smell Parkinson’s disease on a person’s clothes and detected successfully each case of Parkinson’s.

14 GHP / 2019 Healthcare & Pharmaceutical Awards

It is from this basis that the NBT technology has developed to its current state. The technology is in its current state over 1000 times more sensitive than the most effective sniffer dogs. Creating an even more accurate way to diagnose through ‘smell’ at a far lower cost than that of training and handling dogs.

Ultimately, ANCON Medical presents unique solutions for the healthcare industry, providing a pathway to early detection capabilities that can be critical for treating deadly illnesses like lung cancer, tuberculosis and others. In future the firm’s creative technology could be used to detect, diagnose and keep track of over 400 serious diseases and illnesses. The scope to revolutionise the industry cannot be overstated, with daily screening, personalised medicine combined with AI and machine learning potentially coming together to create a future where diseases are treated before symptoms manifest.

Contact Details: Company: ANCON Medical Contact: Wesley Baker Email: medtech@anconmedical.com Website: anconmedical.com

,, Chapter Care Ltd:

Chapter Care (North Devon) Ltd:

Chapter Care Ltd: Best Domiciliary Care Provider 2019 - Devon Chapter Care (North Devon) Ltd is a family owned domiciliary care company based in North Devon, providing care and support to service users across the county. As part of our overview of a selection of some of this year’s Healthcare and Pharmaceutical Awards winners we offer an insight into the services the firm has to offer and how these benefit patients and their families.

With teams of trained care workers providing a range of care services, supporting service users in Barnstaple, Bideford, South Molton, Ilfracombe and surrounding locations, Chapter Care is able to meet the needs of its varied patients and ensure that they and their families are secure in the knowledge that they are properly supported.

As part of its dedication to supporting its team members, Chapter Care have scrapped zero hours contracts for everyone except people who specifically ask for them, and instead pay by a shift worked, which is practically unheard of in the care sector. This gives carers the security of knowing that their role is secure and this helps them to work more effectively for the benefit of their service users.

Working predominantly with elderly patients, the firm is deeply dedicated to providing a professional service. As part of this focus, the firm looks not only to its service users, but also to its staff, providing them with the support, training and guidance needed to provide quality service and support to everyone they help throughout their role.

“Chapter Care have scrapped zero hours contracts for everyone except people who specifically ask for them, and instead pay by a shift worked.”

22 GHP / 2019 Healthcare & Pharmaceutical Awards

Looking ahead, with Brexit looming on the horizon and fewer workers moving to the UK from across Europe, the care industry is facing a shortage of staff. This combined with the constantly rising life expectancies of residents throughout the UK is presenting challenges.

Seeking to change the care industry macro economically and help it to overcome its staff shortage issues, moving forward Chapter Care will be opening a charity to support care workers and showcase the hard work they undertake. Working closely with local business, this latest venture will help to provide every opportunity possible to make caring as attractive a career prospect as possible, helping bring even more new talent into the industry and helping secure the future of the ever-growing care market.

Company: Chapter Care (North Devon) Ltd Name: Jeffrey Wilton-Love Address: B4 Strand House, Fishleigh Court, Fishleigh Road, Roundswell Business Park, Barnstaple, Devon. Ex31 3UD Telephone Number: 01271378842 Web Address: chaptercare.com

GHP / 2019 Healthcare & Pharmaceutical Awards 15

,

Neuro-Sys: Best International Drug Development & Discovery Development Company 2019 - France With more than 20 years of experience, Neuro-Sys develops specific preclinical models of neurological diseases to accurately determine the pharmacological profiling of lead compounds and explore their underlying mechanism of action. In celebration of the firm’s win of not just one but two of this year’s highly coveted Healthcare and Pharmaceutical Awards we profile the firm and share an overview of how far it has come since it first began.

Founded in France in 2013, Neuro-Sys is a research-intensive innovative CRO company specialized in preclinical in vitro models of neurodegenerative diseases and drug development.

16 GHP / 2019 Healthcare & Pharmaceutical Awards

To this very day Neuro-Sys offers advanced disease models and analytical services in the CNS and PNS field. In addition, thanks to its team of developers, Neuro-Sys helps and advises companies in their pharmaceutical development (regulatory and non-regulatory) through its CMC, tox and pharmaco experts.

g

Neuro-Sys:

Recently, in order to build upon its already impressive success, Neuro-Sys, in association with Gain Therapeutics and the Institute for Research in Biomedicine were awarded a €1.4M grant support from Eurostars-2, after having scored 2nd among 325 eligible applications.

Thanks to the expertise of its team and its commitment to excellence, Neuro-Sys has become over the years the preferred partner of the pharmaceutical industry and biotechnology companies internationally that carry out pre-clinical trials dedicated to Alzheimer’s, Parkinson’s, Charcot’s and Huntington’s diseases. Moreover, the company has established strong worldwide strategic partnerships with the pharmaceutical industry and biotechnology companies. With such a dedicated team, the company successfully offers a global service including drug development consulting up to the clinical stage.

As a result, Neuro-Sys has established itself as a worldwide expert for the development of compounds in the field of neurodegenerative diseases. The firm’s expert team implements significant continuous R&D that ensures models to be more efficient and always ahead of the competition.

Name: Dr Noelle Callizot Address: 410 Chemin Départemental 600 - 13120 Gardanne - France Telephone Number: +33413415171 Web Address: www.neuro-sys.com

As part of this focus on continuous improvement, Neuro-Sys is also very close to its customers with a collaborative approach, whether on a technical, scientific or strategic level. Therefore, the firm is able to remain ahead of emerging industry developments and offers patients and healthcare professionals the solutions they need. The firm holds a scientific board on a monthly basis with leading scientists to support the development of its scientific expertise so that it is constantly ahead of emerging market developments.

Dedicated to giving back to the healthcare industry and supporting professionals throughout, Neuro-Sys publishes scientific articles and regularly presents the results of its research on the international pharmacological scene during conferences and congresses. In 2018, it presented no less than eight scientific posters at seven events.

This ongoing research makes it possible to optimize existing models and develop new ones, but also to understand each other’s mechanisms in order to better drive the development of new molecules.

This grant will further strengthen a novel therapeutic approach for targeting rare diseases in the CNS, where lysosomal misfolded enzymes lead to sever clinical phenotypes, where no treatment is available and/or high unmet medical needs still do afflict patients, families and carers. This funding will support the development of the drugs portfolio of Gain Therapeutics for the treatment of Gaucher Disease, GM1 Gangliosidosis and Parkinson’s Disease.

Such a development will help Neuro-Sys to grow and flourish over the coming years, and this is its primary goal. With this in mind, Neuro-Sys has just opened its American branch in Boston, MA to respond more effectively to its customers. The firm has also doubled its automatic test capacity (500 m²) and increased its R&D department to support this growth and ensure that its quality and innovation remains unchanged.

Ultimately, with 11 scientists out of 14 employees and up to 20 years of experience in the field of neuroscience and pharmaceutical development, few CROs are able to provide such a high level of scientific expertise as Neuro-Sys can, and as such clients know that they are in safe hands when they work with this dynamic company and use its innovative solutions. Supporting even more healthcare professionals and patients will remain NeuroSys core focus as it grows into new territories and markets.

GHP / 2019 Healthcare & Pharmaceutical Awards 17

, Swiss Biostadt Limited:

Swiss Biostadt Limited: Best Medical Equipment Supply & Installation Company - Nigeria Part of the renowned African Group, Swiss Biostadt Limited is an innovative Medical Engineering outfit specialist. To celebrate the company’s win in this year’s Healthcare and Pharmaceutical Awards we explore the secrets behind the success of the company and the group.

Founded in 1964, Biostadt Group is a life sciences company formed out of the need to contribute to the fight against hunger, malnutrition and disease burdens in Nigeria in particular and the entire Africa Continent as the nation and continent continue to witness high mortality and morbidity coupled with negative impacts on human capital from above factors.

The incidences of hunger and disease have equally been at the high end of development inhibitions.

To this end the Biostadt Group is continually striving to carry out its activities in an environmentally compatible manner. The group firmly believes that environmental friendliness issues are congruent with economic objectives. The company is dedicated to professional issues that directly and indirectly touch our business.

Under the group’s umbrella are a number of brands including CG Biostadt Nigeria Limited, CG Biostadt Ghana Limited, CG Engineering Limited and award-winning Swiss Biostadt Ltd.

While undergoing several ‘morphological’ changes, over the years the group has also gone through a number of distinct operational and business re-engineering processes with each change bringing it out better and stronger.

Its business forms since inception have included Pharmaceuticals, Agrochemicals, Pigments, Paints, Araldite and Textile Dyestuffs.

Supporting clients throughout Africa, each of these companies works together to drive real change for communities across the continent.

In Nigeria, which is the group’s major hub, it is headquartered in Lagos on a sprawling 2.83 acres of land built into state-of-the art offices and laboratories. It has Business offices in Abuja, the Federal Capital and in each of the geo-political zone of the Nigeria federation.

The group carries its businesses through three strategic business unit areas: Agrocare, Healthcare and Pharmacare. Each area is specifically designed to meet the needs of the African nation and provide communities with the support they need to reduce poverty, hunger and illness.

The group’s trading and medical equipment specialist Swiss Biostadt operates from its headquarters in Lagos and provides a wide range of medical Engineering solutions across the country. The firm is customer focused and aims to offer every service user the exceptional standard medical equipment.

As a social enterprise, the group prides itself on meeting these vital needs and driving local communities forward. After all, the issues of environmental degradation and climate change are quite topical that they have become entrenched in national discourse. This is very well understandable, as Nigeria is an oil producing nation where pollution and oil spillages are prominent.

Currently, the group carries out businesses in Nigeria, Ghana, Liberia and Sierra Leone.

Seeking to extend its reach over the coming years, it has plans to expand to other West and Central Africa Countries.

The business ethics are driven by its core corporate values of Team Spirit, Open Communication, Passion and Determination, Integrity and Ethics and Customer Focus.

18 GHP / 2019 Healthcare & Pharmaceutical Awards

Ultimately, the Biostadt Group’s mission is to support the fight against diseases, hunger and malnutrition in Nigeria and Africa in general and to contribute to the sustainable development of the nation and continent. This ambitious aim will remain central to every aspect of the group’s work moving forward, and Swiss Biostadt will be working tirelessly to help the group to achieve its mission.

Location Address- 387, Agege Motor Road,

by Ilupeju RailwayCrossing, Cappa B/Stop, Lagos Nigeria, P.O.Box 4310 Land line-08094655555 Mobile: 08033341399, 07033438056 Enquiries: info@biostadtgroup.com Website: www.biostadtgroup.com

“The business ethics are driven by its core corporate values of Team Spirit, Open Communication, Passion and Determination, Integrity and Ethics and Customer Focus.”

,

Phycinity PLLC: Best Pediatric Centre – North Carolina Operating out of North Carolina, pediatric clinic, and urgent care facility Phycinity PLLC is dedicated to ensuring the very best healthcare for infants, children, and adolescents in every possible way. Find out how they are leading the way in our profile of the practice.

Focused on delivering highquality patient care to those who need it most, Phycinity is a pediatric clinic and urgent care facility based in North Carolina who work to ensure every family receives the treatment they need as quickly as possible.

The practice offers a variety of services, including regular well-child health visits, vision and hearing screening, developmental assessments, immunizations, and counseling to address obesity, helping children maintain a healthy weight.

At the heart of this medical facility is Dr. Omar Caban. A passionate and knowledgeable doctor, he always seeks to put concerns and worries to rest quickly with compassionate care when it comes to the children. Recently selected as Provider of the Year 2019 by Azalea Health, and Preceptor of the Year 2019 by Campbell University School of Osteopathic Medicine, Caban’s leadership and knowledge proves invaluable to the team at Phycinity in delivering quality service to their patients.

In the busy world of today, families need an affordable healthcare service and carefully designed plan that can accommodate their hectic schedules and lifestyles. At Phycinity, an experienced, board-certified pediatrician is responsible for designing a personalized healthcare plan which works for families, and not the other way around. Not only that, but this pediatric practice strives to offer sameday, sick appointments as another way of accommodating the families that need care the most.

With a carefully designed and personalized healthcare plan, Phycinity is dedicated to ensuring that each family receives the highest quality care through individual attention.

Working hard to identify and treat healthcare problems before they arise, the team at the center is staffed by a certified pediatrician, a team of physician assistants, nurses, and ancillary staff; all focused on delivering that same levels of high-quality healthcare. Boardcertified pediatricians will take the time to know their patients and ensure that they are receiving the care best suited to them and their busy lives.

Not content to simply practice medicine, Phycinity also plays their part in teaching it.

Collaborating with and serving as a training center for Campbell University School of Medicine, this pediatric practice is committed to training the next generation of doctors determined to deliver the highest quality care to patients of all ages. Practicing medicine as a team, all staff provide excellent medical care and service to patients, which sets a perfect example for students to learn from.

What makes this pediatric practice unique is the removal of the waiting room hassle.

Accomplishing this high standard through staff collaboration and active use of technology, Phycinity is setting the bar high for standards of pediatric waiting rooms not just across the state of North Carolina, but the United States as a whole. Through careful use of data analytics technology, the practice can predict and provide care without families waiting days to see their healthcare provider.

20 GHP / 2019 Healthcare & Pharmaceutical Awards

The healthcare industry does come with challenges; however, and Phycinity is prepared to meet them head-on. Ensuring the same level of quality is provided at all times for all patients, the staff is constantly provided training with outstanding educational experiences in the field of medicine.

Consistently delivering the same level of care across all patients of varying issues is just one way that this pediatric practice is further cementing themselves as the first choice for families across the state of North Carolina.

Priding themselves on delivering the best quality healthcare to infants, children, and adolescents, Phycinity is also aware of their successes in providing for rural families and families of those serving in the armed forces.

Continually listening to the needs of their patients and families, this medical practice is at the forefront of providing the highest quality healthcare for those who need it most.

Remaining at the forefront of medicinal and technological developments is important for this industry to continue providing the best patient care possible, and Phycinity is doing just that. Maintaining the high standards and forefront status means being aware of updates to analytical technology, and the latest medicines, techniques, and services practiced and developed across the country.

Yet, with all their success thus far, this pediatric practice is continuing to push the limits of what they can do for their patients.

Looking forward, Phycinity is modernizing their practice, providing a contemporary and minimalistic space for families to enjoy during their visit. As ever, the most important aspect

,

Phycinity PLLC

of the medical industry moving forward is the continued quality of care and high levels of patient satisfaction. The practice is prepared to ensure that their patients continue to be provided with the utmost attention to detail by their board-certified pediatrician, and all members of the team across the center.

Ultimately, the phenomenal success of Phycinity as a pediatric practice is down to their excellent patient care, and keenly attentive to detail, which helps to create personalized healthcare plans for their busy patient families. Being at the forefront of technological and medicinal developments helps to make this healthcare provider one of the most trusted pediatric clinic and urgent care facilities in the state of North Carolina.

Company: Phycinity PLLC Contact: Omar Caban Website: www.phycinity.com

GHP / 2019 Healthcare & Pharmaceutical Awards 21

,

Innovapharma: Most Innovative Rejuvenation & Aesthetics Products Producer - South America With more than a decade of existence, Innovapharma, today, is leading the market for high quality facial and body aesthetics treatments. In celebration of the company’s success in the 2019 Healthcare and Pharmaceutical Awards we profile it and share an insight into how far it has come since it first began to achieve the market leading position it enjoys today.

Originally founded in 2008 in England, in 2012 Innovapharma was acquired by an investment company that has interests in 21 other companies in various business segments.

Since the merger Innovapharma has enjoyed constant investment in new technologies, which has allowed the firm to offer the best products to its clients around the world.

Today, the company offers award-winning aesthetic solutions that comply with the regulations of more than 23 countries around the world. It is now the largest importer of Hyaluronic Acid in Latin America, and a renowned name in the constantly growing facial aesthetic solutions marketplace.

The company’s flagship brand, Rennova® is among the leading brands in hyaluronic acidbased facial fillers and is sold in to clients internationally. The brand’s unique range of products come from leading technology and innovation centres such as Austria and Israel.

Offered to doctors and healthcare professionals around the world, Rennova® products range from facial fillers and biostimulators through to cannulas and cutting-edge RFQ wires PDO and PLLA threads. All of these solutions are produced to the highest possible standard and designed with patient safety and satisfaction in mind.

Created to stimulate, volumize and firm aging skin and rejuvenate facial features, these solutions are increasingly popular in today’s market, where consumers are constantly searching for non-invasive solutions that will help to them look and feel great. Many of the brand’s products offer unique functions that help to stimulate natural benefits as well as offering rejuvenating properties The aging process, as well as the measures against it, has been increasingly studied, due to the constant and current concern about a better and healthier aspect. Facial aging affects not only the skin, but also the subcutaneous tissue and bones. The fat distribution is altered, promoting a facial volume loss. With the natural process of aging, the endogenous hyaluronic acid is reduced, making the skin less hydrated and, consequently, less elastic. All these factors, as well as the photodamage, lead to wrinkles and folds on the face.

For example, one of the brand’s unique products, Rennova Diamond®, is a Calcium Hydroxyapatite-based biostimulator ideal for volumizing, sustaining and firming the skin.

What sets this innovative product apart is that it stimulates the natural production of collagen, presenting an immediate and much longer lasting result. It has two versions, with and without lidocaine, as do many of the brand’s offerings, ensuring the ultimate choice for clients and patients.

22 GHP / 2019 Healthcare & Pharmaceutical Awards

Working to ensure that clients understand the quality of its products, the brand offers a range of innovative motives of communication besides traditional channels, including WhatsApp and a popular Instagram account where users can see photos of Rennova® products in action.

Looking to the future, one of the key drivers of growth for this dynamic brand is increased access to minimally invasive aesthetic procedures and the growth of the aesthetic market worldwide. With distribution centres in Europe and Latin America, Innovapharma is ready to meet the ever-growing demand it is seeing and become one of the world’s leading brands.

Ultimately, driving the rejuvenation and aesthetic market to even greater success and becoming the leading supplier of these products will remain Innovapharma ongoing focus as it looks towards a bright future filled with exciting opportunities to grow and enhance its solution offering and customer base.

Company: Innovapharma Contact: Marcelo Morais Website: www.innovapharma.com

,

Innovapharma

GHP / 2019 Healthcare & Pharmaceutical Awards 23

,

Hyalual: Best Aesthetic Medicine Solutions Manufacturer 2019 & Most Outstanding in Skin Rejuvenation 2019 Multi-award-winning Institute Hyalual is an innovative foundation specialized on R&D, manufacturing and service providing in field of anti-age therapy, skin rejuvenation, correction and restoration. We profile the organisation to learn more about the unique solutions it offers and how it is driving the anti-aging and skin rejuvenation spaces to even greater success through its provision of quality products.

In 2008, Yuria-Pharm, a specialized pharmaceutical corporation, created a new company that merged decades of science with their passion for helping people attain youth and beauty by preserving skin health. Drawing on years of pharmaceutical research, Hyalual was born. The brand has succeeded in its mission for more than ten years, becoming internationally recognized as a trusted leader in aesthetic medicine. The GHP recently nominated Hyalual for two awards: Best Aesthetic Medicine Solutions and Manufacturer 2019 and Most Outstanding in Skin Rejuvenation 2019.

Thanks to its innovative solutions, Hyalual is now trusted by more than 35,000 dermatologists and cosmetologists worldwide who successfully use Hyalual solutions for their clients’ skin quality improvement Today, Hyalual is a global developer of innovative solutions in the field of aesthetic medicine. The corporate headquarters are located in Switzerland. The company oversees representative offices in ten countries and has official partners in more than 20 countries. Hyalual’s manufacturing facilities are located in Italy and Ukraine, with additional partner factories in Switzerland, Spain and the USA. The company also owns

a network of certified research and practical centers in Ukraine, Russia and the United Kingdom.

More than 300.000 medical devices and 90.000 cosmetic products are produced annually. The core values of Hyalual are Science and Results. The firm’s team combine their passion for science and love of beauty to achieve outstanding and naturallooking results.

At Hyalual, Science stands, first and foremost, for the quality, safety and effectiveness of their products, which conform to international quality standards (GMP, ISO). It also stands for continuous in-depth research that allows for ongoing improvement, development of new formulations and implementation of innovative solutions. Another aspect of Science at Hyalual is working to educate doctors and cosmetologists worldwide. This comprehensive scientific approach never fails to bear fruit. Meanwhile, everyone knows that Results are the most important aspect in aesthetic medicine. Hyalual products demonstrate proven skin quality improvement, a harmonized appearance and, naturally, satisfied clients. To date, the brand counts more than 500,000 happy customers worldwide.

24 GHP / 2019 Healthcare & Pharmaceutical Awards

The best skincare solutions demonstrate high quality, proven effectiveness and absolute safety. Returning to development for a moment, it is important to note that Hyalual’s main manufacturing facilities are located in Italy. The Diaco Biofarmaceutici factory acts as Hyalual’s primary manufacturing platform, as well as its main official distributor and logistics partner.

All Diaco factory processes are automated, allowing for precise conformance to quality norms for each product they make. These tightly-regulated manufacturing practices further underscore the trustworthiness of the Hyalual brand. The company also owns manufacturing facilities in Ukraine with partner factories in Switzerland, Spain and the USA, which provide both the necessary manufacturing output and also the flexibility to develop new products and formulations.

It is worth mentioning that Hyalual’s involvement does not stop at the moment of sale. Understanding the importance of investing in their own, Hyalual specialists provide continuous support and education to doctors, share research and expertise and offer the world cutting-edge solutions that address various aesthetic issues.

,

Hyalual

Further cementing Hyalual’s worthiness to compete for the GHP awards (Best Aesthetic Medicine Solutions and Manufacturer 2019 and Most Outstanding in Skin Rejuvenation 2019) is their work in Redermalization. This patented procedure improves skin quality by increasing its regenerative potential.

Redermalization is unlike other skin rejuvenation procedures because it works in three ways simultaneously 1) It helps regulate intracellular biochemical processes; 2) It optimizes skin’s water balance; and 3) It aids in blocking free radicals.

Thanks to Double Synergic Effect Technology, it achieves maximum synergy between the two main components in Hyalual’s line of Redermalization products: hyaluronic acid and amber acid (in the form of sodium succinate). This formula has been a true breakthrough for skin rejuvenation with remarkable skin quality improvement. This is the most powerful surgery-free rejuvenation method available today.

Redermalization restores and supports the skin’s water balance, stimulates the synthesis of key structural proteins and provides mechanical tissue support. The procedure also contributes to the normalization of microcirculation and tissue energy exchange, as well as activation of lymph efflux.

Together, this unique combination of effects produces outstanding results. The results include an even skin micro-relief, decreased pigmentation and a reduction in both the number and depth of skin folds due to dermal consolidation. It erases visible signs of fatigue and lightens dark circles under the eyes by 1-2 shades. Skin radiance also improves since Redermalization supports skin health in general.

To learn more about Redermalization and other Hyalual innovations, please visit the company’s official website at hyalual.com.

Company: Hyalual Contact: Oksana Borysenko Website: hyalual.com

GHP / 2019 Healthcare & Pharmaceutical Awards 25

,

Seacross Pharmaceuticals: Best Injectable Oncology Therapeutics Manufacturer 2019 A UK-based company specialising in injectable oncology products, Seacross Pharmaceuticals are focused on the development and manufacturing of high-quality and effective drugs for worldwide healthcare markets. Seacross is responsible for international sales and registration, establishing business partnerships in more than eighty countries with ongoing product registrations. Discover why they are 2019’s best injectable oncology therapeutics manufacturer as part of our awards season.

Focused on providing the worldwide healthcare market with high-quality and effective drugs, Seacross are determined to help extend the patients’ life span and improve the quality of the patient’s life. Achieving this through continuous development of high-quality innovative drugs, the firm’s products are rigorously tested and approved by the European Union, US Food and Drug Agency, and China’s GMP. Seacross was established by a group of Chinese and European veterans to bring high-quality, regulatory-compliant and costeffective products to meet the demands of the global healthcare industry. An efficient executive team across all functions including manufacture, logistics, engineering, R&D, regulatory, finance and marketing operations work collaboratively to help deliver on the promise of better global healthcare.

Having received MHRA GMP approval and Chinese GMP approval in 2014, Seacross UK also passed the re-audit of MHRA GMP in 2017. The company’s own brand products have been launched in multiple European Union countries, like the United Kingdom, Germany, and France, supplying more than one thousand hospitals across Europe.

With the aim of being a global company that is dedicated to injectable drugs, Seacross’ London subsidiary is responsible for establishing key international links, making sales and forming business partnerships.

With ongoing product registration happening in eighty countries worldwide, this company is ensuring that patients who require oncology treatment across the globe are getting the very best available.

At the heart of Seacross’ mission is their determination to care and respect of life, striving for the best quality products. This care is extended to all aspects of the products life cycle, from development and manufacturing, to storage and delivery, and finally usage. With a firmly-established and rigorous quality management system in place, the firm ensure that their practices exceed the requirements of EU, FDA and Chinese pharmaceutical standards.

The research and development teams of biologics and chemistry both boast an extensive wealth of bio-pharmaceutical experience in working with antibodies.

The in-house product development team ensure that each injectable formula uses the latest and best knowledge from across the healthcare industry, complying with international standards.

26 GHP / 2019 Healthcare & Pharmaceutical Awards

Recently launching strong relationships and co-development projects alongside the National Institutes of Health, National Cancer Institute and Cambridge University, Seacross is at the forefront of researching innovative oncology treatments. Also expanding their oncology injectable production lines, the firm are working to build new non-oncology injectable workshops aimed at delivering pre-filled syringes and sterile powdering dispensing.

As an MHRA-approved and EU releaser, Seacross’ own brand drug supplies over a thousand EU hospitals, sometimes occupying approximately 70% of EU market shares. Not content to rest on their laurels however, the firm understand the need to continuously develop and research highquality innovative drugs. With over a hundred research and development engineers, the company aim to keep the spirit of innovation high, always improving products’ quality and effectiveness.

Company: Seacross Pharmaceuticals Contact: Arshad Ahmedi Website: http://www.seacrosspharma.com/

,

Seacross Pharmaceuticals

GHP / 2019 Healthcare & Pharmaceutical Awards 27

,

STILLE AB: Best Medical Device Company 2019 – Sweden & Best Surgical Imaging Table: STILLE imagiQ2™ STILLE AB is one of the oldest medical device companies in the world, providing high quality products for almost 180 years. As we offer an overview of a selection of this year’s Healthcare and Pharmaceutical Awards winners, we felt it was important to showcase the success this dynamic company has achieved since it began more than a century ago.

Originally founded as a spin-off from Karolinska Institute in 1841, STILLE is now one of the oldest medical device companies in the world with a legacy of excellence behind it that has made it a key player in this competitive market.

The firm’s Founder Albert Stille learned his craft from instrument maker C.F. Ponsbach.

The Ponsbach family had a tradition of cutlery forging extending back to the 1700s, and from there, had taken the step to becoming skilled surgical instrument makers.

Since the firm was founded at Karolinska hospital, it gained rapid recognition and interest from surgeons to collaborate in making better surgical instruments.

In 1887 STILLE launched its first surgical table, with the first battery operated table was launched in the 1960s. The firm was a pioneer in the floating technology for mobile surgical tables, with its first true free float mobile table launched in the year 2000.

Today, STILLE’s offering consists of a strong brand and products renowned for their superior quality. The firm manages its business in two distinct business areas: Surgical Instruments and Patient Positioning.

In its Surgical Instruments business area, STILLE boast a complete offering of handcrafted, forged instrumentation for all fields of open surgery, with a special emphasis on cardiovascular surgery, reconstructive and aesthetic plastic surgery.

These quality instruments feature delicate design, industry leading durability and a unique feel, which has made STILLE a well-known and highly respected supplier by surgeons throughout the world.

Through its Patient positioning business area, the firm offers specialty tables for minimally invasive procedures, with pricing, safety and features optimized for both in and outpatient settings. The STILLE imagiQ2 surgical imaging table with its low-dose capabilities, is optimized for advanced mobile Hybrid OR settings as well as peripheral and interventional procedures. The Medstone line of surgical imaging tables, offer reliability and efficiency at affordable prices.

The STILLE surgical scissors boast blades can be separated and serviced, which guarantees the perfect cut that only STILLE provides, as opposed to other scissors that cannot be separated, which gather blood and other fluids in between the blades, affecting the quality of the cut. Since STILLE invented the first SuperCut-scissors back in 1982, many have attempted to imitate the design.

But after three decades no other brand can measure up to the handmade craftsmanship of the SuperCut. One of the main features is the specially designed cutting surfaces.

With one scissor blade and one knife blade the scissors cut smoothly and efficiently through soft tissue. A perfect cut. Every time.

These solutions are designed to be used for decades, with many scissors sold in the 1990s still in use today, as testimony to their quality.

In this area the STILLE imagiQ2 is the firm’s flagship product and premium table which has become the golden standard for endovascular and other interventional procedures due to its capabilities of optimizing dose while enhancing image quality and efficiency in the OR. This solution impressed the Healthcare and Pharmaceutical Awards judges thanks to its ingenuity and focus on providing exceptional care for both patients and healthcare providers.

28 GHP / 2019 Healthcare & Pharmaceutical Awards

The STILLE imagiQ2 surgical imaging table was launched in 2012, with sales starting in 2013. The table set new low-dose standards and started a trend within the mobile surgery business where the focus went from only a mobile C-arm business, to a mobile / flexible “solution” that included a table with better

,

radiolucency. More hospitals started realizing of the potential of having low-dose friendly (yet powerful systems) with low-dose enabler tables like the STILLE imagiQ2.

The surgical imaging table (or fluoroscopy table) was seen as an important part of the solution to achieve shorter and more efficient interventional procedures. Since the launch, many companies have tried copying or surpassing this unique solution, but despite this STILLE remains to this very day as the state-of-the-art surgical imaging table for the mobile vascular and interventional OR. Such a solution helps STILLE to remain focused on increasing efficiency in the OR while providing safety not only to the patient, but for the entire surgical team. The firm achieves this by keeping close collaboration with experienced surgeons worldwide, that are part of its advisory board called the STILLE Ambassadors program. The STILLE ambassadors are part of the firm’s advisory board. With their clinical expertise, they bring to life projects that they feel passionate about that contribute to surgical perfection and safety and have helped STILLE creating a product road map for the future.

STILLE AB

This collaborative approach allows healthcare professionals around the world the chance to offer their expert opinions on the solutions they use and how these can be better tailored to meet their needs.

Collaborating with clinicians within specific medical procedures to develop and market solutions that contribute to increased patient safety and surgical perfection has helped STILLE to achieve the market leading position it enjoys today.

When it comes to surgical imaging tables, STILLE has gained the reputation of being a “low-dose company” thanks to the dose optimisation properties of the imagiQ2 surgical imaging table and its capabilities to help shortening procedure times, which also minimizes radiation exposure.

Overall, the future looks bright and exciting for STILLE. The company has a strong brand with respected reputation and appreciation from thousands of surgeons and physicians around the world. STILLE is preferred partner to the major imaging companies in the industry and the golden standard when high quality, reliability and efficiency is needed, and its focus over the coming years remains on enhancing this and growing as a company to better support even more healthcare providers and their patients.

Company: STILLE AB Name: Hanna Ernestam Wilkman - CEO Address: Ekbacken 11, 644 30 Torshälla, Sweden Telephone: +46 8588 58000 Web Address: www.stille.se

This reputation has helped the firm to set itself apart from its competitors and mark itself out as the best possible option for a variety of clients throughout the healthcare market and around the world.

GHP / 2019 Healthcare & Pharmaceutical Awards 29

,

Health Economics and Outcomes Research Ltd.: Best Independent Health Economic Modelling Experts 2019 With a large, multidisciplinary team, Health Economics and Outcomes Research Ltd. (HEOR) is a full service, independent, health economics consultancy capable of delivering the complete range of strategically focused services and advice. As we celebrate some of this year’s Healthcare and Pharmaceutical Awards winners, we felt it was important to showcase the vital work this innovative organisation undertakes.

Established in 2011, HEOR is an independent consultancy specialising in health economic modelling, outcomes research and statistical analysis.

Institute for Health and Care Excellence (NICE).

This requires co-ordination across a number of research teams who are involved in either systematically summarising research evidence, analysing clinical trial data or combining this information into mathematical models.

Led by Phil McEwan and Jason Gordon and supported by an experienced team of senior managers and principals, HEOR focuses on research to support healthcare decision makers understand the future costs and health outcomes associated with a specific disease as well as the implications of alternative approaches to disease management. This typically requires evaluating the cost-effectiveness of new health technologies to understand whether they represent good value for money.

Although HEOR’s focus is very much health economics, the firm’s approach to research is built upon mathematics, statistics and operational research (OR). OR is a scientific approach to solving problems designed to enable decision makers to make better decisions. OR utilises advanced analytics, modelling, simulation, optimisation and data science to determine the best solution to the problem and the best practical course of action - this is at the core of what the firm does.

To achieve this, HEOR works hard preparing dossiers for submission to health technology assessment agencies such as the National

Currently the firm boasts a team of 60 researchers based in the UK and Germany who specialise in the development of

Jason Gordon

Phil McEwan

30 GHP / 2019 Healthcare & Pharmaceutical Awards

mathematical disease models, the statistical analysis of clinical trial and real-world data and who perform systematic literature reviews and meta-analysis.

These talented experts support international pharmaceutical companies, and HEOR has worked on projects covering all major disease areas. As a result, the firm has the expertise to support any client and meet their specific needs.

This experience and the unique perspectives of its staff is what sets HEOR apart from its competitors in navigating the complex interactions between healthcare payers, the pharmaceutical sector, patients and clinicians. Evidence of the firm’s unique contributions can be seen in its extensive research track record; membership of esteemed societies, invitations to be expert speakers, senior academic positions at leading UK universities, and the willingness for key opinion leaders to partner with them on studies and publications.

Among the firm’s recent developments is its work to change the shape of the disease research space. At the moment, economic evaluations of new health technologies typically focus on establishing whether the new product represents good value for money when used at a particular stage of disease. For many diseases, particularly chronic conditions, it may make more sense to evaluate strategies that maximise health outcomes and minimise total costs of the whole disease (from

,

Health Economics and Outcomes Research Ltd.

diagnosis to death). For example, the majority of costs associated with diabetes relate to managing the costs of diabetes-related complications – therapy costs are a relatively small component of the whole disease costs.

Seeking to disrupt this model, HEOR are developing whole-disease models that capture lifetime costs and health outcomes.

This will enable healthcare decision makers to better understand the lifetime burden of diseases and fully appreciate the potential benefits associated with optimal disease management strategies.

Looking to the future, this will remain the organisation’s ongoing focus, and there are a number of approaches to datavisualisation that represent real opportunities to communicate the value of whole disease management to a broad range of stakeholders. Whether it relates to the analysis of real-world data, clinical trials or the output from economic models, HEOR is currently working on providing interactive tools that enable complex patterns within data and disease model output to be interrogated in real-time. This will help to bring the firm’s analysis to life and ensure its research output is as impactful and insightful as possible.

Ultimately, this will help HEOR to achieve its mission: to provide globally relevant insight into the value associated with optimal disease management strategies. Importantly, value means different things to different stakeholders, and therefore the firm’s research needs to reflect this. For example, national policy makers are interested in strategies that maximise population level health; local decision makers are often focused on managing demand within fixed healthcare budgets; while clinicians and patients seek improved health outcomes with minimal side effects.

Consequently, it is important that HEOR continues to present its research output in a way that is meaningful to stakeholders to help ensure the implications of health economic decision making is understood across the continuum of a disease and its management. Every future development for the firm will be focused on achieving this to ensure the company remains a key player in this vital sector moving forward.

Company: Health Economics and Outcomes Research Ltd. Contact: Phil McEwan Website: https://heor.co.uk/ Twitter: @HEOR_Ltd

GHP / 2019 Healthcare & Pharmaceutical Awards 31

,

Medovate Limited: Most Innovative Medical Device Development Company 2019 - Eastern England Based in Cambridge, Medovate Limited is a new, dynamic medical device company that is dedicated to developing and commercialising innovative medical technologies created within the NHS. Bringing together the essential finance, technical and management resources required, the team successfully manage medical technology innovations from conception, through to market launch, and on to global implementation. Discover the firm’s success as they win most innovative medical device development company across Eastern England in 2019.

With all the skills and knowledge required for all the key stages of medical device development, the team at Medovate are experts in their industry. The company boasts a core team of nine people providing a wealth of experience in the technical and management areas required for medical technology development and commercialisation. From prototyping, preclinical and clinical testing, regulatory affairs, and final product launch, this firm are wellequipped to support the NHS and technology development throughout the world.

Medovate works with and supports inventors from within the NHS and their respective NHS Trusts, through one of their partners, Health Enterprise East, a leading NHS Innovation Hub. Inventors are helped to turn their ideas for innovative medical devices into manufactured devices, and the firm then also brings them to market. The company also works with a number of other partners, including the Academic Health Science Network and commercial companies with required experience to help support development, testing, commercialisation and uptake of new devices.

The company aim to provide key funding and expert advice at a crucial point in development. Medovate will ensure that medical tech innovations with high potential, identified within the NHS, are supported through the development, manufacture, clinical trial and regulatory approval phases.

That way, those innovations become products that are ready for markets around the world as quickly as possible.

Devices currently in the development pipeline have a focus relating to anaesthesia, airway management, critical care and surgery.

These areas collectively present a number of unmet needs and challenges with significant implications for patient safety. With Medovate’s help, successful new innovations can have a real and valuable impact on the safety and positive outcomes of healthcare delivery for both clinicians and their patients.

Through their NHS innovation hub partner, a number of viable innovations in these aforementioned areas were identified.

Coupled with the Medovate teams collective experience working to develop devices in these clinical speciality areas, the technologies were the obvious choice to initially focus resources on and mature.

32 GHP / 2019 Healthcare & Pharmaceutical Awards

In 2019, Medovate will showcase two new technologies for the critical care and anaesthesia markets, Humidicare and SAFIRA, at leading international trade fairs and events. Humidicare is an innovative safety heat and moisture exchanger (HME) which can help prevent critical airway obstruction. SAFIRA stands for Safer Injection for Regional Anaesthesia, and is designed to provide end-to-end safety solutions when administering regional anaesthetic.

Medovate is unique in its focus on developing medical tech solutions that have arisen from within the NHS, and in doing so creates a virtuous circle. Successful NHS innovation supports further innovation, which then benefits the healthcare system as a whole.

The company also ensure that a portion of all commercial benefits from successful tech commercialisation make their way back to supporting the NHS. One of the most significant breakthroughs for the team at Medovate is the speed at which they have been able to get new medical technologies ready for market launch. Having only been in operation for a couple of years, this company have quickly established themselves as a trusted

,

Medovate Limited

and innovative partner in developing and delivering potentially life-saving new pieces of technology throughout the NHS.

had a thorough commercial, market, IP, and technical review to help ensure the firm are leading developers in the medical arena.

Facilitating this capability was the successful achievement of quality management certification following completion of rigorous independent audits in accordance with specific requirements. Being awarded the ISO 13485:2016 certification confirms that Medovate operates an internationally recognised quality management system for the control of design, development, manufacture, installation and servicing medical devices within speciality areas.

By participating at international industry leading medical tech events this year, Medovate will quickly become a key player in the market. Showcasing their capability to develop quality and innovative devices, the company’s momentum will continue to grow as they raise their tech profile. Throughout 2020, the firm are looking to launch products in both the US and EU for the first time, whilst also always being on the lookout for more technologies to develop in their core medical speciality areas.

The certification has proven to be an important milestone for Medovate, establishing the company as a credible player in the medical tech innovation world.

It assures clinical innovators, healthcare deliverers, and patients that the company’s portfolio is being designed, developed and manufactured in compliance with the highest quality and regulatory standards.

aforementioned SAFIRA incorporate smart technology, gathering regional anaesthesia data to ensure procedures are carried out safely, at correct pressures.

Only in their second year of operation, the great success of Medovate is a fitting testament to the wealth of experience that is driving the company forward. By supporting the NHS Trusts and their clinicians, the company help realise the potential of innovation to create benefits for the NHS and healthcare systems across the world.

Company: Medovate Limited Contact: Stuart Thomson, Managing Director Website: https://www.medovate.co.uk/

What is increasingly common in the healthcare and pharmaceutical industry is the use of smart technology, a key area in which Medovate believe they can make a positive impact. With patient safety also always being at the forefront of the industry, all of the NHS invented products the firm are developing can help to improve patient safety. Newly generated medical tech such as the

Each department lead at Medovate is provided time for continuous professional development so that the company can achieve the most up-to-date knowledge in all areas of work. Additionally, every technology taken into the development pipeline has

GHP / 2019 Healthcare & Pharmaceutical Awards 33

,

Most Innovative Pathogen Prevention Research Company 2019 - Europe A small, UK-based research and development company, Medi-Immune Ltd. is at the forefront of creating ground-breaking technology to combat respiratory problems.

Having invented, developed and tested a new approach to combatting airborne pathogens, the firm are focused solely on respiratory protection and conferring immunity through their new device, ProtectivAir®. Find out why this research company are one of Europe’s most innovative pathogen preventers of 2019 as part of our Healthcare and Pharmaceutical Awards 2019.

Founded in 2008, immunology company Medi-Immune is responsible for developing new and innovative technology that seeks to address the everimpending threat of new pathogens. Aiming to deliver protection from airborne pathogens regardless of mutation, Medi-Immune are offering a unique solution to a dangerous possibility.

Scientists across the world and the World Health Organisation have predicted that society can expect another airborne pandemic, despite not knowing where it will originate from, or when. Current scientific knowledge estimates it will emerge from a mutation of avian influenza, with likely mutations being one or two steps away from human infection and transmission.

When the pathogen does arrive, there will be an immediate need to identify the disease, before developing and producing a vaccine in suitable numbers. Respiratory diseases can be extremely costly to deal with, including high mortality rates, such as the 2009 swine flu epidemic which ended up costing the UK more than one billion pounds, purely in preparatory and response costs. Adding hospitalisation and loss-of-income costs pushed the figure much higher.

Providing immediate protection solutions against all airborne pathogens to save lives and money is the primary goal of Medi-Immune, a small UK-based research and development company specialising in immunisation and pathogens. Whilst respiratory protection has remained unchanged for a number of years, this company has developed ground-breaking technology, ProtectivAir®.

34 GHP / 2019 Healthcare & Pharmaceutical Awards

ProtectivAir® is a new and improved approach that provides non-infective air that can be delivered via a personal wearable device or integrated into existing close environments to protect multiple people.

Developed by three of Medi-Immune’s inventive directors, James Love, John Maudsley, and John James, this new protective device is representing a clear shift in the existing field of immunology and pathogen protection.

With technology at the forefront of the immunology industry, Medi-Immune have created the device to eliminate the threat of any airborne pathogens. ProtectivAir® uses ultraviolet C, shortwave germicidal radiation, to sterilise any inhaled airborne pathogens.

The air passes through a compact, wearable sterilising chamber where the UVc photons pass through the pathogens and disable their ability to reproduce.

Used with a filter-free face mask, a ten-billion times reduction in viable influenza viral particles is achieved at normal breathing rates. Because the method does not use a filtration system, it allows disabled airborne pathogens to be delivered directly to the respiratory tract of the wearer. Then, the disabled pathogens allow the body to initiate

,

an immune response, delivering long-term protection alongside that of immediate protection.

Throughout the last four years, Medi-Immune has developed prototypes into lightweight, battery-powered, wearable examples. In vitro performance testing, carried out at Public Health England in Porton Down, confirmed performance which matched with predicted results, and the company were able to move on to in vivo trials.

The in vivo trials were designed to demonstrate the device’s ability to deliver superior protection from airborne pathogens against existing filtered systems. These trials also confirmed that an immune response was initiated. The use of the device prevents infection from known pathogens and will prove uniquely effective in an environment with an infectious level of currently unknown pathogens.

Medi-Immune Ltd.

These test results represent a massive and radical shift in the field immunology and protection from as-yet unknown airborne pathogens. Medi-Immune and ProtectivAir® promise to be useful tools in supplementing and complementing existing vaccine developments for years to come, especially with the potential development of a new airborne pathogen.

In addition to the instant protection that the device offers against new mutations, the underlying technology can also be utilised in existing stable environments. Where patients with compromised immune systems require protection, ProtectivAir® will also prove an invaluable and important tool.

Recently, there has been exciting development, testing and modelling to allow ProtectivAir® to be installed and used within a cabin environment during transportation, initially in automobiles, to enhance

existing air handling systems to protect and help prevent transmission of airborne infections amongst those travelling. Future development could help protect against diseases that can travel internationally aboard aircraft, Medi-Immune is always developing the potential for this groundbreaking new technology Ultimately, what makes Medi-Immune a success is their unwavering ability to create new and innovative technology that can protect everyone from an unseen threat. By creating wearable technology that offers both immediate and long-term protection against new and old airborne pathogens alike, this company are changing the way science looks at immunisation and viral protection for good.

Company: Medi-Immune Ltd. Contact: John Willcocks Email: johnwillcocks@medi-immune.com Website: www.medi-immune.com

GHP / 2019 Healthcare & Pharmaceutical Awards 35

,

EQUITAS Life Sciences: Most Innovative Life Sciences Consultancy 2019 - North America Expertly combining classic strategy consulting with data science and software engineering, EQUITAS Life Sciences creates custom solutions for healthcare’s most pressing challenges.

Following their win as North America’s most innovative life sciences consultancy for 2019, we put the firm under a microscope to examine the reasons behind their success.

Drawing on decades of experience within life sciences, EQUITAS provides tailored solutions to support client partner needs on topics such as launch excellence, global market access, pricing, and reimbursement, commercial learning and development and medical education. Believing that working together is the only way to enact meaningful change, the company cultivates partnerships with patients, providers, payers and manufacturers on a global scale. Given the constantly evolving dynamics in the healthcare industry, EQUITAS prides itself on its collaboration, responsiveness, and flexibility demonstrated everyday with their client partners.

Founded on the values of kindness, empowerment and fearlessness, everyone at EQUITAS endeavours to engage with curiosity, empathy and genuineness. In living out these core values through every interaction, the company has created an environment where it acts and operates as an extension of its partners. Through seamless communication and shared goals for success, trust is built thanks to careful listening, thoughtful responsiveness and agile engagement.

Comprised of a remarkable group of highly talented individuals with similar beliefs and values, yet diverse and unique experiences, EQUITASers are open-minded, solutionoriented, dedicated to improving healthcare, and passionate about building sustainable relationships across the healthcare continuum.

Applying its SUPER™ model approach to all they do, EQUITAS marries classic strategy consulting with software development and data science. The first step is using the SUPER model to identify opportunities to drive greater Self-awareness, Understanding, Preparation, Engagement and Reflection (SUPER), to enhance existing approaches – whether it’s engaging more meaningfully with customers or delivering a more impactful value story.

The second step involves incorporating classic software development to bring each component of the SUPER model to life through enabling, cloud-based platforms. The model is comprised of five components; AIQ, LEEP™, SPACE™, VCP™, and CLC™.

Artificial Intelligence Questioning, or AIQ, drives self-awareness and connects customer-facing teams across the globe to home office-based teams. LEEP, or Learning Engagement & Empowerment Platform, aims to bring understanding to life sciences by applying evidence-based, adult learning principles, gamification and micro-training to create customised learning experiences.

36 GHP / 2019 Healthcare & Pharmaceutical Awards

Strategic Planning And Collaborative Ecosystem, SPACE, helps put the strategy back into key business processes by enabling true cross-functional, transparent, and measurable call-, account-, brand, or operations-planning. VCP, Value Communication Platform, integrates field team tools and training to automatically customize value stories and visual aids by customer segment while also reinforcing best practices on positioning and delivery to get the most out of every client interaction.

,

Closed-Loop Coaching, or CLC, drives efficiency and effectiveness by harnessing artificial intelligence to simplify coaching to core elements. Through twelve procedurallygenerated and qualitative questions, both the coach and coachee work together to create a reciprocal and continuous improvement plan.

Through these five innovative components of the SUPER model, EQUITAS has created a truly unique approach of holistically addressing a variety of healthcare challenges faced by its client partners.

The final step in designing healthcare market solutions includes overlaying data science and machine learning technologies to extract insights and enhance performance by leveraging the combined power of the technology components of the SUPER model.

The complete ecosystem is called ETHOS™ - and is at the heart of EQUITAS. Each of the five solutions work collaboratively to deliver a marvellously innovative platform that creates a continuous cycle of performance improvement to support professional development and career pathing in a strength-based manner.

EQUITAS Life Sciences

Through this same lens, the team at EQUITAS is constantly looking for new ways to achieve their mission of improving patient outcomes. As extended members of their client partner teams, they witness first-hand the challenges and opportunities faced each and every day. The EQUITAS team is constantly engaging with classical and emerging healthcare stakeholders through primary research and continuously building out their library of insights. With a worldwide network of experts, EQUITAS seeks to keep its finger on the pulse of the industry across local, regional and national healthcare markets.

These trusted partnerships with patients, providers, payers and manufacturers on a global scale are constant reminders of how healthcare touches all of our lives and of the common goals we share to elevate patient outcomes and advocate for the importance of wellness. Only by working together will the healthcare community effect change.

Company: EQUITAS Life Sciences Contact: info@equitasls.com Website: https://www.equitasls.com

GHP / 2019 Healthcare & Pharmaceutical Awards 37

,

Most Innovative Cervical Plate System: Combat Anterior Cervical Plate System ISPINE is an innovative product development specialist dedicated to creating healthcare solutions to meet the ever-evolving needs of providers around the world and across the market. In celebration of the firm’s win in the 2019 Healthcare and Pharmaceutical Awards we profile it to find out more.

Thanks to several years of input, design and development from leaders in the medical and engineering industries ISPINE has now created industry leading products offering surgeons the best possible package for their patients.

These unique products greatly assist surgeons from all over the world in their quest to improve the quality of life of their patients while keeping in mind the rising costs of medical technology.

From the beginning, ISPINE has been focused on developing products that deliver cost effective, faster and more efficient patient care. With industry leaders in the medical and engineering fields advancing the ISPINE range the firm has come to pride itself on delivering excellent value to clients.

Over the years, the firm has become an industry leader committed to providing only the highest possible quality solutions to healthcare providers from across the market and around the world. Based in South Africa, the firm can provide fully-compliant solutions that are designed to be of the highest possible quality and as innovative as possible.

Among the firm’s portfolio of products is its award-winning Combat Anterior Cervical Plate System, which gives surgeons the flexibility to easily customize them to each patient’s unique anatomy. Flexibility is built-in to every aspect of the systems; from plate design and the innovative Single-Twist anti-migration system to the screw options and the instrumentation set. The result is a cervical plate system that is effective and easy to use.

This creative solution boasts multiple constructs for optimum flexibility and performance. The color-coded fixed and variable angle screws can be used alone or in combination to meet anatomical variations and achieve the surgeon’s desired goal.

Ultimately, ISPINE is on a mission to provide industry leading products and service whilst at the same time not losing sight of rising costs to ensure that healthcare providers receive quality solutions and value for money.

Wayne Roach - ISPINE

38 GHP / 2019 Healthcare & Pharmaceutical Awards

ispine.co.za Contact Details: Company: ISPINE Contact: Wayne Roach Website: ispine.co.za Email: wayne.roach@ispine.co.za / belinda.malan@ispine.co.za

g

ISPINE

ispine.co.za

GHP / 2019 Healthcare & Pharmaceutical Awards 39

, Shawlands Dental Care

Dental Practice of the Year 2019 – Glasgow & GHP Excellence Award for Outstanding Patient Welfare 2019 Based in the heart of Glasgow’s buzzing South Side, Shawlands Dental Care is a multi-awardwinning dental clinic and referral centre. We profile the centre to find out more about how it came to win not one but two of this year’s coveted Healthcare and Pharmaceutical Awards.

Offering Invisalign, dental sedation, cosmetic braces and dental implants, Shawlands Dental Care attracts patients from all over the country. As they are able to provide the highest possible standard of dental care to the local community and beyond, they were a strong contender from the outset.

We loved the idea of welcoming all new patients to the clinic through a care coordinator who was there to alleviate any anxieties and answer any questions they may have before, during and after they saw the dentist.

The clinic itself is state-of-the-art (including an on-site CT Scanner) and the clinicians rarely have to refer patients elsewhere.

Thanks to this focus on providing exceptional standards of care, 99% of the patients have all of the treatment they require and want, in this medically, cuttingedge environment.

Innovative services like these, however, need to be provided by the very best staff and as such, Shawlands Dental Care treats every member of its team incredibly well. Unlike other practices we saw that incentivised staff to sell, the management team here incentivised exceptional customer service. Staff wellness is at the

40 GHP / 2019 Healthcare & Pharmaceutical Awards

forefront of their business model.

The break room is well-stocked with healthy fruit and veg deliveries and there are regular team building days scheduled. Little touches like this, as well as the higher rates of pay, mean that the clinic is able to take its pick of the best talent on the market.

Looking ahead, Shawlands Dental Care has exciting plans for expansion within the dental clinic which will be music to the ears of residents who wish to register and referring dentists.

They also hope to make another charity mission with UNICEF either later this year so it can pay its success forward.

Our judging panel was particularly impressed by the company’s commitment to the environment.

They invested heavily in a paperless administration system because they felt that despite recycling whenever and wherever they could, there was still more that could be done.

Contact Details: Company: Shawlands Dental Care Address: 1149-1153 Pollockshaws Road, Glasgow, G41 3YH Telephone Number: 01416321378 Web Address: www.shawlandsdentalcare.co.uk

, Greenpower Healthcare Limited:

Greenpower Healthcare Ltd: Best Natural Wellness Products Manufacturer 2019 – Nigeria Greenpower Healthcare is a leading manufacturer of quality natural wellness products.

In celebration of the firm’s win in this year’s Healthcare and Pharmaceutical Awards we profile it to show how far it has come since it first began and the direction it is moving in over the years to come.

As consumers increasingly focus on using natural products, companies are increasingly focusing on providing remedies that will enhance their health and are completely natural in order to keep up with demand.

One firm that has been doing this since its inception in 2011 is Greenpower Healthcare. From the beginning the firm has been

dedicated to helping millions of Africans achieve total wellness using 100% natural formulas.

form and to uncover the mystery behind the 5000-year-old system of medicine.

Throughout its history, the firm has worked tirelessly to build trust by working closely with its consumers and developing innovative natural wellness brands that are tailored to meet their exact needs. The firm’s absolute focus has always been on bringing herbal medicines to the world in a contemporary

Together, Greenpower Healthcare’s expert team focuses on selecting indigenous herbs and subjecting the formulations to modern pharmacological, toxicological and safety tests to create new medicines.

Driven by a passion for natural wellness, Greenpower Healthcare has created a wide range of products that are trusted by consumers around the world.

These include a range of capsules that include natural ingredients and can help to combat a range of ailments.

The firm’s products are clinically tested and validated, and as such clients can rest assured that they are completely safe and made using organic ingredients which will offer unique health benefits.

All of these solutions are offered via the firm’s website or its range of partners, who include pharmacies, shops and healthcare professionals across Africa. They are all trained to understand the uses of Greenpower Healthcare’s solutions and recommend the best option for every client, so they know they are in safe hands when they work with this dynamic and knowledgeable company.

Looking to the future, Greenpower Healthcare is working towards becoming Africa’s No. 1 Natural Wellness products manufacturer.

This will drive Green Power to new achievements over the years to come and will help it to flourish in this competitive and ever-evolving market.

Contact details: Company: Greenpower Healthcare Limited Contact: Dr. Jeph Akaehie Website: wearegreenpower.com

“...The firm’s products are clinically tested and validated, and as such clients can rest assured that they are completely safe and made using organic ingredients which will offer unique health benefits.”

GHP / 2019 Healthcare & Pharmaceutical Awards 41

, Instant Consult:

Most Innovative Online Medical Consultancy App: Instant Consult® & Leading Healthcare App Development Company - Australia Seeking to combine traditional healthcare services with modern technology, Instant Consult specialises in providing Medical Certificates, Prescriptions, Referrals, Pathology Requests and Radiology Requests. We explore how this innovative firm is revolutionising the healthcare space and driving it to even greater excellence for patients.

In today’s technology driven healthcare market, where patients are used to having instant access to facilities in other facets of their lives, service providers are increasingly exploring the possibility of providing quality healthcare solutions using innovative digital techniques.

Founded in 2017 to meet this need, Instant Consult provides a cutting-edge online platform connecting doctors with patients for online health consultations via video call instantly.

Open seven days a week, the Instant Consult team of doctors aim to take every call immediately, or at peak demand, as soon as possible. As such, patients know that they will receive expert healthcare support when they need it.

Every aspect of the firm’s service offering is provided online, so that patients know their details are safe and that their medical documents and other information can be securely sent to their Instant Consult inbox in a matter of seconds. The platform uses 256 bit SSL Certificates, which includes digital certificate authentication and 256 bit data encryption so that its communications are entirely secure and every aspect of a patient’s health is kept fully confidential.

To ensure patients receive the highest possible quality of care and service, all of Instant Consult’s healthcare providers are Australian registered, fully qualified, insured and experienced Doctors. As soon as they are finished with their consultation patients can rate their experience out of five to offer the platform feedback and ensure everyone receives the exceptional standard of care and support they need.

As Instant Consult practices to the standards developed by the Royal Australian College of General Practitioners (RACGP) and the Australian College of Rural & Remote Medicine (ACRRM) for medical services, patients can rest assured that they will receive the standard of medical support they expect from a traditional doctor’s office with the added efficiency of the firm’s innovative online platform.

Moving forward, as the healthcare market continues to embrace technology and patient need drives many services online, Instant Consult expects to achieve even greater success and work with even more patients.

Not one to rest on its laurels, the firm will continue to enhance its service offering to ensure that everyone it works with receives the healthcare support they need the moment they need it.

42 GHP / 2019 Healthcare & Pharmaceutical Awards

“...Instant Consult provides a cutting-edge online platform connecting doctors with patients for online health consultations via video call instantly. ”

g

Instant Consult:

Company: Instant Consult | Contact: Bianca Brown Website: instantconsult.com.au

GHP / 2019 Healthcare & Pharmaceutical Awards 43

, HealthItalyNet:

HealthItalyNet: Best Health Services Consultants 2019 - Italy Working to provide an integrated healthcare solution, HealthItalyNet provides patients with access to the facilities and professionals needed to help them to solve any medical issues they may be facing. We profile this unique firm to find out more about the innovative concept it is pioneering.

Created in 2015, HealthItalyNet began with the aim to create an environment in which the convergence between medical specialists, health facilities and professionals, companies in the sector and institutional referents create information and health education in an appropriate language in favour of users and partners.

Four years later and the firm’s ongoing focus remains on building a network capable of creating and informing on new methods and procedures and providing high-level specialized health services, offering an exceptional value to users who may need them. By creating the best team, facilities, medical specialists, procedure and technology, the firm will be able to provide the patient with the support to face and solve any specific issue.

44 GHP / 2019 Healthcare & Pharmaceutical Awards

Over the years HealthItalyNet has cultivated strong relationships with medical professionals and facilities across the country, allowing it to connect its patients with them quickly and efficiently and providing them with the support they need at all times.

HealthItalyNet to give potential partners greater confidence and showcase the benefits of this new and innovative way of communicating their excellence for them and for all the patients who will now benefit from this unique solution.

Looking to the future, HealthItalyNet hopes that its success in the 2019 Healthcare and Pharmaceutical will help to propel it towards even greater achievements over the years to come. It hopes it will help

Contact details: Company: HealthItalyNet Name: Gian Marco Masino Address: Via delle Cappuccine 3/1 Phone: +390108939950 Website: www.healthitalynet.it

The No.1 Choice of Skin Care Professionals Created by Harley Street Skin Expert Zaheda Hafez.

This British brand is the evolution of 20 years skin care expertise. Science-led skin care formulations infused with high-performance anti-ageing marine and botanical actives and essential oils work in synergy to deliver powerful collagen boosting benefits. Nourishes and hydrates the skin from within to deliver smooth, firm, plump more youthful looking skin.

Made in the UK

SHOP NOW WWW.ZAHEDA.COM

Zaheda Skincare from The Laser Treatment Clinic 1 Harley Street London W1 Now available on

GHP / 2019 Healthcare & Pharmaceutical Awards 45

, NeuroTransData GmbH:

Best Neurology & Psychiatry Network 2019 – Germany & Leading Provider of Digital Health Solutions - Germany Supporting fully digitalized sites distributed all over Germany, NeuroTransData (NTD) is a physicians’ network in the fields of neurology and psychiatry. To celebrate the firm’s success in the 2019 Healthcare and Pharmaceutical Awards we offer an overview of the range of services it provides to this diverse network.

As a pioneer in digitalisation and personalized medicine, the NTD network has established a registry database back in 2008, which includes different neurological and psychiatric indications such as depression, dementia, epilepsy, migraine, multiple sclerosis, Parkinson and motor disorders, and schizophrenia. The focus currently is on migraine and multiple sclerosis.

From 2008 to 2016 NTD has extended the registry database to a complete patient management system called DESTINY (database-assisted therapy decision support system) containing several modules to support doctors in the assessment of medical data, improve the interaction between doctor and patient (bidirectional data exchange, electronic patient file, app) and enable continuous therapy control and optimization. This results in enhanced treatment success and a reduction of healthcare costs. The whole concept was developed by doctors, for doctors, based on their practical experience as treating physicians.

The central part of DESTINY, the NTD Registry Database, has been active since 2008 and since then it has been continuously

used for patient documentation by all practices of the NTD network. The therapy optimization module for Multiple Sclerosis, which recommends a review of the current therapy to the doctor when certain thresholds are exceeded (e.g. EDSS, relapse rate, quality of life), was launched in 2013 in the NTD network.

One of the key projects and sophisticated modules within DESTINY is the predictive model PHREND (Predictive Healthcare with Real-world Evidence in Neurological Disorders), an award-winning software developed by PwC and NTD combining artificial intelligence (AI) and analytics technology, medical insight and human-centered design to make the treatment of Multiple Sclerosis more effective and cost-efficient.

PHREND connects different disciplines and resources to provide patients and their physicians with a data-based second opinion in the treatment process. Thanks to its accurate predictions and straightforward integration in the existing hospital environment, the personalised healthcare solution enjoys wide acceptance within the medical community.

46 GHP / 2019 Healthcare & Pharmaceutical Awards

As a result of these innovative digital solutions, NTD physicians have been working in a highly digitalized environment for more than 10 years now and are always looking for new opportunities to improve upon the existing system. In Germany there is no other network that can look back on such a long successful history, and as such NTD is proud of how far it has come, but the network is always exploring new solutions and initiatives that will drive it to even greater success.

Currently the network consists of more than 70 sites and 180 physicians treating about 600,000 patients per year. As a network of doctors, NTD was able to develop its innovative DESTINY solution with doctors in mind. The registry database and the different modules contained in DESTINY have been utilised by doctors in their everyday practice for several years and are continuously updated and improved.

In contrary to other solutions, DESTINY therefore has high usability and practicability and can be easily integrated in the day-today work of doctors. Furthermore, DESTINY offers high-quality medical content due to the knowledge pool and expertise of the medical

g

professionals contributing to the system development.

Within the healthcare market currently, the systems of other providers are limited to single areas of use. A real patient management system taking into account the complete patient journey in an outpatient setting does not exist in the market. As a result of its innovative features, DESTINY enters a free field in the outpatient sector and provides a unique solution that doctors simply cannot find elsewhere.

NeuroTransData GmbH:

Company: NeuroTransData GmbH Name: Fabian RoĂ&#x;nagel Address: BahnhofstraĂ&#x;e 103 B, 86633 Neuburg, Germany Telephone Number: +4984315373225 Web Address: neurotransdata.com

Ultimately, the goal of NTD is high-quality individualized treatment for patients using modern technologies and treatment methods that will ensure it cements its reputation for excellence in the field of neurology and digital healthcare solutions.

GHP / 2019 Healthcare & Pharmaceutical Awards 47

ghp

Research, Translation, Commercialisation

Subscribe to GHP

Subscribe here www.ghp-news.com/subscribe

, WALKEMORE, S.A.:

Best Hospital Footwear Specialist 2019: WALKEMORE, S.A. Through its unique specialist footwear brand WOCK®, WALKEMORE S.A. is able to provide clients around the world with comfortable shoes designed to withstand even in the toughest conditions. In celebration of the firm’s success in the 2019 Healthcare and Pharmaceutical Awards we explore the unique range of products it provides to healthcare workers internationally.

Part of the Procalçado Group, WALKEMORE draws on its parent group’s experience in the shoe manufacturing market, which spans over 46 years, to ensure it provides innovative footwear solutions for its clients.

Thanks to this focus, WOCK® provides innovative shoes that allow their users to express their individuality at work always focused on their specific requirements. Users enjoy technical features combined with safety, comfort and most of all the possibility to wear something at work that fits their personality.

Since it was initially created, WOCK® has strategically defined its target as the professional market and, thereafter, certain target niches were determined, particularly in these segments: Hospitals and other Healthcare institutions, Pharmaceutical industry, Cleanrooms, Orthopaedic stores, HORECA channel, Cosmetics, Beauty and SPAs.

After all, workwear can be bland and purely functional, particularly shoes designed to be heavy-duty. WOCK® aims to offer a unique solution that is both comfortable, safe, longwearing, durable and at the same time stylish and modern. By communicating with clients and using their feedback to enhance its ranges, the brand is able to ensure it continues to meet its user’s needs in the modern world of work.

Working with clients across these areas, the brand provides clogs and shoes that have been specifically designed to meet the needs of these clients and are created for those who stand on their feet all day, offering durability and comfort. Company’s team try to bring innovation and technical characteristics allied with a beautiful design, allowing them to get a good performance with their professional shoes, always with quality background.

Recently, the brand launched some new models that will add more diversity and an extra comfort to its already extensive range.

With these three new models, WOCK®’s product range will reach a larger fringe of professionals that seek unique footwear.

The acceptance of the EVERLITE PLUS and FEEL ranges has already exceeded the brand’s expectations, and it looks forward to growing these ranges even further.

Fundamentally, WOCK®’s main goal is to provide their customers a great experience by buying its clogs or shoes. This will be the core driver for the company as it works to expand into new markets and offer its multiaward-winning footwear products to even more clients around the world and throughout the professional market.

“...The acceptance of the EVERLITE PLUS and FEEL ranges has already exceeded the brand’s expectations, and it looks forward to growing these ranges even further.”

EVERLITE PLUS - © WOCK®

FEEL - © WOCK®

Name: Francisco Teixeira Address: Largo Alminhas das Barrancas, 97, 4415-343 Pedroso Telephone Number: 227470611 Web Address: www.wockshoes.com/pt/

GHP / 2019 Healthcare & Pharmaceutical Awards 49

, YouMed Ltd

YouMed Ltd: Best Medical Technology Sales & Marketing Company - UK YouMed Ltd is a bespoke sales, marketing and distribution of high-quality medical technologies in the UK and Irish healthcare markets. We profile the firm to learn more about the services it has to offer.

Drawing on its immense market expertise, YouMed can assist its valued clients to maximize the commercial potential of their products as part of its managed portfolio.

Thanks to its team of experts, YouMed is able to offer a fully tailored, cost effective and practical solution to launching its clients’ state-of –the-art products. Working hand in hand with healthcare professionals, the firm is able to implement cost-effective solutions, enhancing both product profitability and hospital efficiency.

Such a collaborative approach ensures that every stakeholder receives the support they need to take previously unknown products

to market and make them the successes they were designed to be. As a result of its work, YouMed has helped bring a variety of innovations and revolutionary products to the attention of the healthcare professionals that need to use them, ensuring that patients throughout the healthcare landscape receive the cutting-edge treatments they require.

Headquartered near Windsor, YouMed has the central base it needs to support clients throughout the UK and Ireland. It also boasts innovative facilities designed to drive products forward, including warehousing, pick and pack and logistics solutions.

From niche products with relatively small volumes through to fast moving consumables, this driven company can steer

50 GHP / 2019 Healthcare & Pharmaceutical Awards

any solution towards market renown and prosperity. It is its proven track record of success that has helped YouMed to establish itself as a trusted partner for a wide variety of medical technology creators.

Moving forward, as part of its drive towards bringing pioneering new innovations to the healthcare market, YouMed will continue to work collaboratively with innovators, revolutionaries and pioneers throughout the medical devices space, bringing their creations to the wider market and showcasing their unique potential.

Company: YouMed Ltd Contact: Chris Brain Website: http://youmed.co.uk

, RXLive Pharmacy

RXLive Pharmacy: Most Innovative Prescription Delivery Service - UK A pioneer in the industry, RXLive Pharmacy is the first app in the UK to offer a subscription service on private prescriptions, as well as having NHS prescriptions delivered direct to clients.

In celebration of the firm’s win in this year’s Healthcare and Pharmaceutical Awards we profile it and share an insight into how far it has come over the years.

Founded in 2015, RXLive began life in response to the challenges some patients face with mobility and reaching a physical pharmacy in order to access their monthly prescriptions.

In response to this, RXLive created an app that quickly and easily saves customers time by allowing them to order their subscriptions online and have them delivered directly to their home.

a range of former NHS members, medical experts and technological specialists, RXLive is able to uniquely combine this expertise to create innovative solutions that meet its clients’ requirements and are ahead of emerging technological and healthcare market developments.

By creating a free RXLive account clients can order and receive their NHS prescriptions free of charge. The firm also offers a range of additional services to support clients, Today the firm offers a digital pharmaceutical such as a live chat function for clients to app, online and telephone service, ensuring converse with their pharmacist and receive that clients have easy access to its innovative advise and support. They can also shop for solutions offering. Advised and supported by supplementary products, such as over-the-

counter medicines and treatments, and also order private prescriptions.

Seeking to build upon its already phenomenal solutions offering, RXLive is constantly harnessing knowledge in this new emerging area of online healthcare to efficiently cater to all its clients’ varied needs.

This will remain the firm’s ongoing focus as it looks towards a bright future and aims to grow even further to respond to growing demand for its cutting-edge service offering.

Company: RXLive Pharmacy Contact: Shahil Patel Website: https://rxlive.co.uk/

GHP / 2019 Healthcare & Pharmaceutical Awards 51

, Pace Analytical

Pace Analytical: Best Pharmaceuticals & Medical Device Testing Experts 2019 Drawing on its immense market experience, Pace Analytical Life Sciences is a full-service, contract research organization (CRO) providing formulation development, analytical chemistry and microbiology testing services to the pharmaceutical and biopharmaceutical industries.

We profile the firm to learn more about the services it has to offer in this ever-evolving space.

Founded in 2006, Pace Analytical Life Sciences has since flourished into a key player in today’s pharmaceutical and biopharmaceutical formulation development and testing market.

With expert staff and exceptional facilities, the company is able to offer state of the art, complex problem-solving skills combined with reliable, efficient and cost-effective testing solutions. The firm’s Oakdale, MN facility is ISO/IEC 17025 accredited. All of Pace Analytical’ s facilities have long-established histories of very successful audit outcomes from both regulatory agencies and client auditors. Through these successful audits, clients know that when they work with this dynamic company, they will receive quality services that meet their requirements and exceed all expectations.

Through its award-winning facilities Pace Analytical is able to provide its services

globally, with customers in North America, Europe, and Asia. Thanks to its ability to expand quickly and adapt to the various needs of a diverse clientele, the firm has become a preferred partner for a wide variety of clients seeking quality biopharmacueutical and pharmaceutical testing solutions that are fully compliant with current industry standards.

As part of its drive towards becoming a complete one-stop-shop for all services required by the pharmaceutical and biopharmaceutical industries, Pace Analytical acquired Wolfe Laboratories, Inc., in 2017 to complement Pace’s vast analytical capabilities. Recently rebranded as Pace Analytical Life Sciences, the Boston site is a premier contract research organization (CRO) that provides integrated drug development solutions, including the development of complex formulations, to the pharmaceutical and biopharmaceutical industries.

52 GHP / 2019 Healthcare & Pharmaceutical Awards

This development will help Pace Analytical Life Sciences to expand and offer clients the solutions and services they need in this fast-paced and constantly changing space. Pace Analytical Life Sciences, Boston is recognized by global and virtual pharmaceutical and biopharmaceutical companies as a science-driven organization whose mission is to provide outstanding formulation and development services, and as such the site will complement Pace Analytical’ s work and enhance its already impressive service offering.

Pace Analytical Life Sciences has a bright future ahead as they work to grow and offer an even wider range of services to clients throughout the life sciences and healthcare markets.

Company: Pace Analytical Contact: Jim Wheeler Email: james.wheeler@pacelabs.com Phone: 651-738-2728 Website: www.pacelabs.com/life-sciences

, Aris Pharmaceuticals Inc

Aris Pharmaceuticals Inc: Best R&D Services Laboratory - Pennsylvania Headquartered in a 5,000 GSF chemistry R&D and kilo-capacity scale-up (up to 100 liter) lab in Levittown, PA, with oversea R&D and pilot plant (up to 5000 liter) subsidiaries, Aris Pharmaceuticals Inc has the right people and facilities to support a wide range of clients with all their research and development needs in medicinal and synthetic chemistry, from structural design of hit compounds, focused library synthesis to process development and scaling up. We profile the firm to learn more about how its work came to be recognised in this year’s Healthcare and Pharmaceutical Awards.

Founded in 2011, Aris Pharmaceuticals is a dynamic chemistry service organization that serves and supports the R&D needs of over 100 pharmaceutical, biotechnology firms and institutes worldwide.

Working with a wide range of clients, Aris Pharmaceuticals’ products and services parallel the new product discovery process and provide significant advantages with proven track record in quality-cost-value, at each step from computer aided core-structure design, hit-to-lead discovery and optimization, to scale-up preparation of intermediates and chemical process validation.

As part of this service offering, the firm perform laboratory scale synthesis for pharmaceutical companies, drug discovery and “virtual” companies, biotechnology companies, and academic institutions.

of dependability, and a fully equipped laboratory. As such, they are able to ensure that all of their clients’ projects are delivered on time, cost-effectively and with a high degree of quality.

Specifically, Aris Pharmaceuticals has majorly devoted in novel anti-viral AND immuno-oncology drug research programs, including the first in class small molecular HIV long term inhibitors, small molecule NK system activators and A2A adenosine receptor antagonists.

Looking to the future, Aris Pharmaceuticals will continue to strive towards innovation in the R&D market to drive real growth and expansion throughout the healthcare and pharmaceuticals space.

All these researches are conducted by the firm’s expert team of 140 professionals, who have solid experience, a high degree

Company: Aris Pharmaceuticals Inc Contact: Jason Yue, PhD, Site Manager Website: http://www.arispharma.com/ Email: info@arispharma.com; sales@arispharma.com

GHP / 2019 Healthcare & Pharmaceutical Awards 53

,

Practice Partners: Best Healthcare Business Consultancy - Australia Partnering with a wide range of healthcare business owners, Practice Partners is a healthcare business consultancy offering expertise across all elements of practice and business management.

As we celebrate the firm’s win in the 2019 Healthcare and Pharmaceutical Awards, we profile it and offer an overview of how far this young and vibrant company has come over the past year.

When it was established in 2018 Practice Partners was built to educate practice owners and eliminate the stress of needing a practice manager for smaller businesses.

This unique approach allowed clients to utilise option of having a senior receptionist whilst Practice Partners took the major managerial tasks off their hands. As a result, clients did not have to invest in the expense of a full-time practice manager.

Whilst this remains the firm’s main vision, over the years Practice Partners has grown to cater to a much larger market, including site developments and providing support for medical start-ups. With over 30 years of collective experience, the firm’s team is able to provide innovative advice and support that is invaluable to a wide range of healthcare professionals, developers and practice owners.

Today, Practice Partners is able to offer an expansive range of services including business consulting, virtual practice management and coaching and mentoring for ambitious healthcare professionals.

Supporting a diverse range of clients, the firm’s focus is to be flexible and dynamic, taking all the difference business challenges, small and large, within the healthcare industry. With the use of basic and traditional principles in healthcare and business, combined with both research and their own previous experience, Practice Partners is able to devise solutions to meet all of its clients’ business needs.

After all, whilst many healthcare professionals have longstanding experience and quality training in their specialist area of healthcare, they often lack the business skills and experience to drive their own practice forward. Drawing on its knowledge of the healthcare space and business management in general, Practice Partners is able to offer

54 GHP / 2019 Healthcare & Pharmaceutical Awards

clients a unique range of services to help them to grow their practice.

Currently, with around 15 potential medical centre sites in the pipeline, the team at Practice Partners is working to perform feasibility studies, work with partners on the internal plans/ designs and consult on leasing options with tenants to drive new businesses to success.

Later this year, to provide the wider healthcare community with the benefit of its expertise, Practice Partners will be uploading even more podcasts after launching this new feature this year, sharing insight, information and tips to a variety of listeners. There are 4 podcasts currently online with another 12 produced, and these will offer members of the healthcare market the chance to learn more about the firm’s work and how it can benefit them. The firm has also be involved in creating an online educational platform for healthcare business owners to further share its knowledge and expertise in the business element of this ever changing industry.

Ultimately, these exciting new developments will help Practice Partners to achieve its overall mission: to share the pursuit of success in all its forms with medical practices and healthcare clinics throughout Australia.

Company: Practice Partners Name: Ami Assigal, Director Telephone Number: ‭+61 401 825 105‬‬‬‬ Web: https://practicepartners.com.au Podcast: https://anchor.fm/practicepartners LinkedIn: https://www.linkedin.com/company/ practice-partners-au Instagram: Practice.partners Facebook: @practicepartners

, Premier Dentalcenter, Clínica Dentária: Dental Clinic of the Year 2019 & Award for Excellence for Paediatric Dentistry Services 2019 in Porto Metropolitan Area, Portugal The Premier Dentalcenter, Dental Clinic offers an innovative approach to dental care. In celebration of its win of not one but two of our prestigious Healthcare and Pharmaceutical Awards for 2019 we profile the firm and share an overview of how it is working to drive excellence in the dental care market.

Clinical Director Dr. Adriana Vitória

Originally opened in 2012, Premier Dentalcenter is led by renowned Clinical Director DRA. Adriana Vitória, who draws on a wealth of expertise in the industry to provide patients with the highest possible standards of care.

The clinic also offers a transparent pricing structure and a membership card to ensure that patients understand the price of their treatments and are not shocked by unsuspected fees. As such, they know that they are in safe hands when they seek dental treatment from Premier Dentalcenter.

Providing everything from general dental care and orthodontics through to implantology and dental aesthetic treatments, Premier Dentalcenter is able to meet the needs of a wide variety of patients of all ages.

Fundamentally, Premier Dentalcenter believes that dental hygiene is linked to a patient’s overall health, psychological attitude and selfesteem. As such, it aims to treat not only the physical teeth themselves, but also its client’s attitude to their care to drive them to better care for their teeth in the future. This will remain central to this innovative dental clinic’s approach as it looks towards a bright future.

For these patients the clinic offers awardwinning dental care and expert support provided by a team of talented experts who are on-hand at all times to ensure their patients feel comfortable and informed about the treatment they receive.

Patients can schedule their appointment online, in person or over the phone, making the entire process easy and efficient.

Company: Premier Dentalcenter, Clínica Dentária Contact: Dental Business Manager Carlos Vitória Website: https://premierdentalcenter.pt/

GHP / 2019 Healthcare & Pharmaceutical Awards 55

, The Hear Clinic Ltd.

The Hear Clinic Ltd.: Best Independent Audiology Clinic 2019 Operating from an idyllic clinic on the outskirts of Leicester, The Hear Clinic Ltd. is a private audiology practice delivering the highest quality care tailored to clients individual hearing requirements. By combining the latest state-of-the-art technology with expert audiological clinical skills, founder Mr Neel Raithatha works to provide clients with the ultimate listening experience. Discover why this private clinic is the winner of best independent audiology clinic for 2019.

Specifically focused on providing premium hearing care, The Hear Clinic boasts state-of-the-art audio-diagnostic equipment to help them realise that focus. The firm endeavour to ensure the very highest levels of clinical excellence and expertise are always on offer to each and every one of their clients. Founder Mr Neel Raithatha, who comes from a background in clinical research after being awarded a PhD scholarship in Audiology from the Medical Research Council (MRC), makes sure that he keeps up-to-date with the latest audiological research and best practices to offer to his clients.

Mr Raithatha’s main duties as a Consultant Audiologist is to diagnose, treat and rehabilitate those suffering from hearing and balance disorders, which primarily involves prescribing and fitting the latest digital hearing aids. Mr Raithatha also co-founded Clearwax Ltd. who provide international training in endoscopic ear wax removal, and developed the innovative wireless otoendoscope, called the iCLEARscope®.

Over the last few years, The Hear Clinic and Mr Raithatha have witnessed unprecedented success and global fame for his endoscopic ear wax removal procedures, which are regularly uploaded onto Facebook and YouTube. He has now amassed over 100 million views on his YouTube channel. This international acclaim has led to requests for articles to be written for New York Post, Fox News, and Daily Mail to name a few.

There have also been radio appearances for Talktime and the BBC, as well as his procedures appearing on Emmy awardwinning daytime talk show “The Doctors” in America. This recognition has meant that clients are now willing to travel from all over the world to experience these pioneering procedures performed by Mr Raithatha.

Clients who have received treatment from The Hear Clinic are often compelled to comment on the professionalism, passion, empathy, commitment, dedication, clinical knowledge, experience and expertise shown by Mr Raithatha and The Hear Clinic.

Combining all these factors with a willingness

56 GHP / 2019 Healthcare & Pharmaceutical Awards

to go the extra mile is what makes this company so sought after for truly excellent ear care.

Coming from a clinical research background, Mr Raithatha ensures that he stays up-todate with the latest clinical research and findings, by regularly attending audiology conferences around the world. As well as implementing the latest clinical procedures and techniques into his own practice, Mr Raithatha also performs consultancy work for some of the world’s largest hearing aid manufacturers and is therefore always at the forefront of the latest developments in the industry.

In all, the successes of The Hear Clinic are clear to see as it stands out in a competitive market against some of the major high street chains. With international acclaim and global fame online, clients are coming from across the world to receive first-class audiological treatment. Mr Raithatha’s pioneering techniques and clinical excellence make his firm the best independent audiology clinic of 2019.

Company: The Hear Clinic Ltd. Contact: Mr Neel Raithatha Website: https://thehearclinic.co.uk/

, Clareblend Inc.

Clareblend Inc.: Best Beauty Therapy Technology Marketplace 2019 - Nevada Since its inception Clareblend has been known for providing professionals with the most advanced user-friendly technology that provides faster response, extreme accuracy and precise timing. We profile the firm to find out more.

When one purchases a Clareblend (Jeunesse) they get the best therapy technology machines the industry has to offer.

vision. Clareblend not only has a very diverse and robust product line themselves, they are also a private label manufacturer for other industry leaders. That aspect alone speaks volumes about their reputation, product line, Not only are the machines top shelf, but postknowledge, operations, dedication, and sell purchase and support are both customized overall understanding of the marketplace and specifically for the client’s business operations customers’ needs and wants. and their specific clients’ needs. As a result, the client will receive training where our Today, Richard and Nadia Klukovich are distributor flies out to their desired location and owners and operators of Clareblend, Inc. gives a hands-on training on the machine.

They’ve been married for 32 years and have amazing kids and grandkids. Both are the The customer will receive all the videos, brains of the company, while Nadia handles the pamphlets, and full access to Clareblend’s Business side of Clareblend, Richard handles Master Technician of over 25 years at the engineering, design and development.

Clareblend, Inc, Their Technical Team and Back in the early days of the company, Assembly Department has been building Ms. Clare’s husband was an engineer and these machines, watching the evolution of developed the first solid state electrolysis the industry, technology, the competition. system. Clare’s daughter, Margaret Smith, Clareblend’s technological advancements carried on the business upon retiring from were implemented into these machines over UCLA engineering department after 22 years years while continuously working hand and of service. To sustain leadership in technology, hand with their research and development Margaret Smith reached out to Richard team and the F.D.A. Klukovich, an electronic engineer to develop the first and only multi needle blend electrolysis Even though times have changed system, the Nova 2000. considerably since Clare E. Rosner opened her practice in 1927 in Minneapolis, when she Margaret had many reasons to reach out to charged $2.00 an hour, it took years of hard Richard Klukovich. Richards engineering struggle and dedication to educate the public background is highly technical, diversified about the profession. She had a never-ending and includes development in the aircraft and desire for “Total Patient Comfort” and ease military industry. Utilizing this same level of of operation for the Professional Electrologist quality engineering and discipline that was in equipment. Approaching 100 years later, used when developing fire control systems Clareblend, Inc. is an F.D.A. registered for submarines and missiles, this ensures manufacturer in which all Clareblend Clareblend’s equipment has the utmost in equipment is designed and manufactured in safety features and quality in its design. the U.S.A. at their Reno, Nevada facility.

Richard was born in Paris, France, attended At the forefront of these constant changes, the University of Maryland in Munich, Clareblend stands on a firm foundation Germany then finished up his BSEE from Calallowing them to be nimble in the marketplace, Poly in 1972. Majority of his careers were while staying true to their roots and never spent in the Military and Aircraft industries losing sight of Clare E. Rosner’s legacy and in which his projects focused on missile and

torpedo firing control systems and submarine countermeasures. Richard was the obvious candidate to carry on Clareblend’s legacy when Marge Smith wanted to retire in 2004.

Drawing on this expertise, Richard uses the depth and scope of all of this knowledge and focuses it into Clareblend product line, software, and private label manufacturing. Imagine this type of knowledge, safety measures, and technology going into a machine!

The key attributes that truly make these machines stand above the rest, is the fact that these machines come with established pre-sets as well as the ability for the operator to manually add their own. There is no-trial and error period for the end-user. The training that the customer receives on the machine, can possibly alleviate any fears and showcase how each treatment can be beneficial for any potential customer.

The decades of knowledge within the Clareblend team, and these machines, this company, and the knowledge that has been passed along for nearly 100 years. This has ultimately made Clareblend stand out in the industry. Their commitment within the industry has solidified themselves as a must for any beauty therapy business wishing to invest in the very best equipment with highest of quality and customer service.

Looking ahead, next product that Clareblend will be releasing is the industry’s first of its kind: The Innovation. A retractable 6-Needle, Galvanic Multi-Needle Epilating System for faster epilation while maintaining ultimate comfort.

Company: Clareblend Inc. Contact: Nadia Klukovich, CEO Website: https://clareblend.info/ Email: staff@clareblend.com

GHP / 2019 Healthcare & Pharmaceutical Awards 57

, inMotion VR B.V.

inMotion VR B.V.: Best Healthcare Virtual Reality Solutions Provider 2019 & Best Virtual Reality Therapy Platform: Corpus VR Leading the healthcare market towards adopting revolutionary new technologies, Dutchbased inMotion VR B.V. is an innovative technology company. We celebrate the firm’s win in this year’s competitive Healthcare and Pharmacutical Awards by exploring the success of the company and inviting one of its Founders to tell us more about the work it undertakes and how this is reshaping the physical therapy market.

Established in 2016 by expert Serious Game Developer GertJan Brok and Psychosomatic Physical Therapist Kiki Coppelmans, inMotion VR is working to change the healthcare space using cutting-edge virtual reality technology.

Having great technologies like VR rockets therapy from a mostly boring and repetitive ‘must-do’, into a whole new gamified world of healing. As a platform, accessible through a VR app, Corpus VR holds a variety of therapeutic exercises for neck and head, and in the near future also shoulders and trunk stability training.

Besides running a family together, these two experts have combined forces to tackle the challenges in modern healthcare and rehabilitation through innovation. Their flagship solution, Corpus VR, is designed and developed to change the process of rehabilitation by providing adaptive, precise and personalized exercises in Virtual Reality through games.

Designed specifically with patients in mind, Corpus VR was thoroughly tested by a group of physical therapists in the Netherlands and is currently being researched in multiple innovation programs within innovative hospitals like St. Maartens rehab clinic in Nijmegen in the Netherlands and The University Hospital of Ghent in Belgium, which are both partners of Corpus VR in developing the applied program. Kiki explores how the solution was designed specifically to meet the ever-evolving needs of patients and providers throughout the healthcare space.

Using VR in physical therapy increases focus for the patient, and at the same time enables a physical therapist to get better insight than ever before on the process with objective data. This has a direct and profound effect on the outcome and reduces the associated healthcare costs as well. Also, the solution improves therapy loyalty, with an increase to up to 60% patient loyalty.

As part of this focus on getting patients to actively engage with and enjoy therapy, at inMotion VR there is a strong focus to implement fun, gamified exercises. CoFounder Kiki Coppelmans comments on why this is important for increasing engagement for patients.

“For the patient, the healing process becomes a lot easier and less tiresome when they are more engaged. The specific games and environments that we have developed do just that. So that you, as a physical therapist, also directly benefit.”

“Currently, one of the bigger worldwide trends is to focus on self-managed healthcare.

Essentially, this trend brings a patient’s therapy to their home or at work, instead of them needing to go to a clinic or physio center, and thus saving time and money.

However, in order for this to be successful, patients need a system to give them the right guidance and feedback to be able to perform the exercises correctly and get the best results. They also need an app on their smartphone with exercises and tips is certainly helpful, but also very limited.

“A unique entrant to the market, Corpus VR manages to overcome this by providing a personal version that can be connected to a health care provider or even standalone. When immersed in a VR world, the

58 GHP / 2019 Healthcare & Pharmaceutical Awards

cognitive distraction lowers pain perception, while relaxation gets its part in healing. In the meantime, an integrated very precise Range of Motion measurement tool offers a tailor-made, individual exercise program, with in-game monitoring of user progress.”

Ultimately, thanks to feedback from existing clients and ongoing research, inMotion VR foresees a bright future for Corpus VR and is aiming at the top in this innovative market.

Now is the time for clinics and practices to take the next step, and the firm’s expert team will be there to support them and help them to bring the future of therapy direct to their patients, today.

Company: inMotion VR B.V. Contact: Kiki Coppelmans Email: contact@inmotionvr.com Website: www.inmotionvr.com

, Institut Marquès

Institut Marquès: Best International Gynaecology, Obstetrics & Assisted Reproduction Reference Centre Thanks to almost a century of experience, Institut Marquès (IM) is a centre of international renown in the Gynaecology and Assisted Reproduction sector. In celebration of the clinic’s success in this year’s Healthcare and Pharmaceutical Awards we profile it and offer an overview of how its innovative approach is driving this vital market forward.

Since the beginning IM has been offering innovative solutions in the Gynaecology, Obstetrics and Assisted Reproduction space, and as a result it has become an international reference in its sector, with presence in four European countries (Spain, Italy, Ireland and UK) Led and managed by Dr Marisa López-Teijón and Dr Leonardo Marquès Amorós, IM treats patients from over 50 countries. Many of these patients have previously undergone fertility treatment, without success.

Uniquely capable of providing cutting-edge support, IM now specialises in treating previously impossible cases, and it now boasts a 89% success rate per cycle for IVF with Egg Donation, 72% for IVF with own eggs and 62% for IVF with Preimplantation Genetic Testing in patients with risk of chromosomal abnormality.

The centre has its own Sperm Bank and a broad programme of Egg and Embryo Donation. IM is committed to R&D on male infertility and the benefits of music at the start of life and on foetal stimulation. In this regard, its research has shown that foetuses hear from the 16th week of pregnancy onwards, only if the outside sounds reach them directly from their mother’s vagina. For the discovery of foetal hearing, Dr. López-Teijón’s team created the intravaginal speaker Babypod, which is already used by thousands of women and was awarded with the 2017 Ig Nobel Medicine Prize.

market for the better. Music is a key aspect of the centre’s work, and is always present at the laboratories in IM, with the centre even hosting live concerts.

Artists from all over the world, as for instance Sharon Corr, have performed for the embryos in its centres, where all incubators have music inside them. According to the research carried out in the laboratories of IM, music improves a 5% the fertilisation rates of IVF treatments. Music micro vibrations inside the incubators stir the culture medium where embryos develop, achieving a more homogeneous distribution of the nutrients and scattering impurities.

Alongside this study, IM has also developed an app called Embryomobile, which allows parents a real time follow-up of their embryos while they are in the incubator from any location. It is a commitment to transparency that, furthermore, reduces the stress of the mother before the embryo transfer considerably. IM is the only centre where patients can really see how their embryos are.

According to another of the institute’s studies, women who can follow the development of their embryos live during the In Vitro Fertilisation treatment are more likely to get

pregnant. This way, the positive impact of emotions on the outcome of fertility treatments has been demonstrated for the first time.

Male factor (male infertility) is associated with 50% of infertility cases: 30% as the only factor, and in the remaining 20% of the cases, combined with a female factor. At IM they prioritise the study of the male reproductive health in order to have a full diagnosis of each case. Institut Marquès carried out several studies on sperm quality, which demonstrated, among other factors, the connection between sperm quality and the exposure of the embryo to the so-called endocrine disruptors.

Such discoveries and others, including the importance of sexual stimulation on the sperm sample achieved, and the use of telemedicine, has led to a shift in the fertility market and has helped established IM as a true thought-leader in the market.

Moving forward, IM will continue to innovate and adapt around the latest discoveries it makes to ensure it remains successful in all of its endeavours.

Company: Institut Marquès Email: comitecientifico@institutomarques.com Website: https://institutomarques.com/

As a result of his discovery, IM now uses innovative techniques including music, mobile technology, telemedicine and the use of virtual reality to help to change this crucial

GHP / 2019 Healthcare & Pharmaceutical Awards 59

, m.Doc GmbH

m.Doc GmbH: Best Digital Health Platform 2019 Founded in 2016 by an experienced team based in Cologne, Germany, m.Doc GmbH is a healthcare firm that creates digital innovations access to the health care system, improves communication with patients and injured persons and helps to optimize care processes.

The digital health platform accompanies people in all health issues, including on their way through the various facilities of our health care system. Thus, m.Doc wants to enable patients to enjoy a healthy and save freedom at any time.

Find out why this award-winning health service provider is one of the best digital health platforms of 2019. m.Doc supports people with a variety of health issues, all the way through the various facilities of the healthcare system. Using technology at the forefront of the medical industry, the company has developed an intelligent platform that allows information gathered from a diverse range of technical environments and process landscapes to be presented easily in a patient-centred manner.

The mission at m.Doc is to create a digital health platform that both clinics and patients trust in. Building a trusted network of players in the healthcare industry, the company is helping the clinics move into a digital era of optimised communication. This puts the patient at the centre of his or her medical care so they don’t feel left out when it comes to something as crucial as their own healthcare.

With a core motivation to solve key societal issues, the team’s efforts revolve around the increasing burdens on healthcare systems.

With ageing societies, more and more people are requiring effective and efficient medical attention, but there is a shortage of medical personnel and resources especially in rural areas. m.Doc is seeking to guarantee coordinated, networked, transparent and

reliable healthcare, adding value for both the patient and physician.

At the moment, m.Doc Smart Clinic is the main product offered by the firm. Smart Clinic is an application which specialises in the digital control of hospital and rehabilitation stays, supporting patients before, during and after their stay. With this app, a patient is enabled to prepare his or her stay with personalized checklists, and can get support with indoor navigation, calendars, timetables or even informed consent forms to discuss with a doctor. After the hospital stay, the patient care continues with information such as a medication plan, all delivered in a clear and concise manner.

Recognising that there is a great deal of overlap between analogue and digital information paths, m.Doc seeks to address the main problem of independent operation.

Where data is collected in different systems, the company has sought to create a digital eco-system that allows easy access to information during any treatment process.

In digitalising clinics with a patient-centric approach, communication becomes clearer and more accessible across medical departments which in turn enables better care and more value for all parties involved.

60 GHP / 2019 Healthcare & Pharmaceutical Awards

With a strong focus on having the patient at the centre of the digitalisation process, m.Doc is at the forefront of an increasingly important market that big pharmaceutical industries are taking notice of. As big players continue to enter the digital healthcare industry, regulatory and legal frameworks are changing drastically, but the company ensures that they stay ahead of developments across their market to continue offering the best digitisation service they possibly can.

The remarkable success of m.Doc is down to their unrelenting willingness to help solve one of the biggest challenge the healthcare industry today. With ageing societies and a drastic shortage of medical professionals, the digitisation of the healthcare industry can go a long way towards helping share easilyaccessible information between departments and ensuring the patient knows clearly the information he or she needs to.

Company: m.Doc GmbH Contact: Manuela Stenz/Stefanie Berger Website: https://www.mdoc.one/

, DigiPol Technologies

DigiPol Technologies: Best Digital Polarimeters Manufacturer 2019 DigiPol Technologies draws on a long legacy of excellence in the digital polarimeters market to deliver innovative solutions that are popular with clients across the scientific community.

We profile the firm to learn more about the range of products it provides.

Originally founded in 1948 as Rudolph Instruments, DigiPol Technologies has become a historical and global name in the manufacture of Digital Polarimeters.

What has remained the same despite the name change is the fact that DigiPol Technologies’ instruments offer the perfect balance of high-precision, accuracy, longterm reliability and cost-effectiveness, making them popular with the international scientific community.

Thanks to the innovation of Rudolph Instruments, DigiPol Technologies enjoys a long track record of innovation. For instance, in 1959 the firm introduced the world’s first commercial automatic Polarimeter. The company also developed the world’s first fully automatic Spectro Polarimeter and America’s first microprocessor based automatic Polarimeter and Saccharimeter.

More recent innovations from DigiPol Technologies include the firm’s highly successful DigiPol Nova range of Automatic Polarimeters, such as the Nova M6U, a high precision UV/VIS automatic Polarimeter, which is now accepted as an instrument of choice in Pharmaceutical Laboratories and Research Institutes around the world.

The firm rebranded to create a distinctive identity for its leading-edge brand name technology, the DigiPol series of Automatic Polarimeters. The Rudolph Instruments’ DigiPol brand has long been synonymous with innovative and quality Polarimeter Technology.

All of the firm’s range of analytical instrumentation and accessories are employed by a wide variety of industries from pharmaceutical laboratories, research institutes, food processors to conduct cutting-edge research and analysis. Whilst

many companies in the market discontinue service for older models once a new one is released, DigiPol Technologies is committed to providing support to clients regardless of the age of their machine.

It is this dedication to client service that has led DigiPol Technologies to achieve strong relationships with many of its clients, some of whom have been working with the company for as long as 25 years. The firm enjoys working closely with clients and uses their feedback to enhance its machines and solutions offering.

Looking to the future, DigiPol Technologies will continue to innovate and craft unique solutions that disrupt the scientific market for many years to come.

Company: DigiPol Technologies Contact: Dr. Kumar Utukuri Website: http://digipoltechnologies.com/

GHP / 2019 Healthcare & Pharmaceutical Awards 61

,

CareLineLive: Best Home Care Management Solutions Provider - UK Seeking to integrate cutting-edge technology into the thriving home care market, CareLineLive offers a Care Management System that improves efficiency, saves time and is used in Home Care agencies throughout the UK. In celebration of the firm’s win in this year’s prestigious Healthcare and Pharmaceutical Awards we explore how this innovative system is helping to bring the home care market into the digital age.

Originally established by Josh Hough, CareLineLive was born out of his own personal experience with the care system and his desire to integrate the latest technology into social care in order to improve efficiency and help provide people with the best care in their own homes.

that includes a Carer Companion Mobile App, a Care Management Web Platform, and a Family and Friends Web Portal. The solution improves efficiency, saves time and increases productivity in Home Care agencies. It has multiple features that help with the day-to-day running of a home care business, from quick and easy rostering, to automating processes such as invoicing, and verifiable call monitoring.

Specifically, CareLineLive’s Carer Companion Mobile App provides Carers with more time to care as less time is spent on paper-based administration. With the app, Carers can instantly access rotas, securely check-in and check-out of visits, retrieve upto-date care plans, leave notes for the next carer and access eMAR (Electronic Medical Administration Records) and client tasks to deliver responsive care.

When Josh’s grandfather was taken ill, his family did not receive the information they needed to provide them with peace of mind about his care. As a result, he used his technical expertise and understanding of the care system to create CareLineLive, and today he is the Managing Director of this thriving company.

From the outset, CareLineLive’s focus has been to understand the challenges that Home Care agencies face day-to-day. The company’s team have worked closely with home care agencies and as a result its solution’ development has been insight-led so that their system is fit for purpose.

Thanks to this unique, industry led development, CareLineLive offers a cloudbased end-to-end care management solution

As a pioneer in the home care industry, the company has been at the heart of developments in the market since its inception, and has worked hard to combine the latest legislative changes with the ever-evolving needs of families and carers working in the market. As part of this focus on innovation, CareLineLive was one of the first companies in the care space to offer visibility and engagement to clients’ families with its Family and Friends portal, providing information, dates and times about a relative’s visit schedules and care, 24/7.

Working to continually adapt, the firm is constantly enhancing and developing its technology. Earlier this year, CareLineLive launched its intuitive eMAR solution.

Members of the home care industry were fed up with complicated MAR sheets that replicated the paper-based version with split cells for codes and initials and unnecessary information. In response to this, CareLineLive developed an eMAR solution that is simple

62 GHP / 2019 Healthcare & Pharmaceutical Awards

to use, where recurring medication and tasks can be set up easily and whose interface feels like second nature.

As an integral feature of CareLineLive’s Care Management System, this new eMAR and Carer Tasks solution can help to reduce errors as carers are kept continuously updated about a client’s medication needs so can be responsive to a client’s needs. eMAR can also help with CQC inspections providing an auditable trail, as it records medication given and alerts staff when there is a concern in realtime e.g. medication has been missed, and the reason why. The success of this addition to this already revolutionary solution shows the firm’s ongoing commitment to driving beneficial change in the home care market.

Seeking to build upon the already impressive success of this creative and user-focused solution, moving forward CareLineLive remains focused on exploring new ways to improve their solution. For example, the firm’s roadmap of development over the next 12 months utilises the increasing availability of IOT products (Internet of Things). This will enable family members access to information so they can not only see the carer has been in, but make sure that their relative’s house is warm, safe and that their relative is comfortable.

Ultimately, CareLineLive’s vision is to give Home Care agencies more time to care; for their businesses, their staff and their clients.

The firm’s easy-to-use Care Management System can help home care agencies to improve the day-to-day efficiency of running their business, with access to real-time information that can be updated automatically and manually.

Company: CareLineLive Contact: Josh Hough Website: https://carelinelive.com/

, PT Insan Medika Persada

PT Insan Medika Persada: Best Digital Home Care Provider 2019 - Indonesia PT Insan Medika Persada is the largest digital-based home care nurse agency in Indonesia providing award-winning, 24/7 patient care at home. We profile the firm to learn more about how it has risen to this market-leading position.

Founded in 2013, Insan Medika is a health care company that providing professional home care services at home to a wide range of service users.

Initially, the firm was created by Try Wibowo as a digital pioneer of home care business in Indonesia. Having noticed the need for home care that utilised the latest technology, Try created a company that could provide these services and meet the growing need in the country for quality, innovative home care.

Since the beginning Insan Medika has been providing non-medical and medical care thanks to its dedicated team of nurses and caregivers, all of whom are committed to offering clients the highest possible standards of service.

Today, the firm has recruited more than 2000 people and has provided services to over 6000 patients. It is now a pioneer in digital home care business in Indonesia.

Service users range of children and babies through the elderly and those with special needs. What unites this disparate range of clients is the exceptional standard of care they receive from Insan Medika.

Ultimately, Insan Medika is a company that has a vision to help build jobs and train young people in Indonesia to be able to provide services to others, especially sick people and the elderly. Over the coming years the firm will continue to grow to maximize digital service services, especially home care services so that it can reach more people across Indonesia and provide them with the award-winning care services and support that they need to live happy and healthy lives.

Company: PT Insan Medika Persada Contact: Try Wibowo Website: https://insanmedika.co.id/

GHP / 2019 Healthcare & Pharmaceutical Awards 63

, Kurmis Orthopaedics

Kurmis Orthopaedics: Best Orthopaedic Surgical Practice - South Australia & Award for Excellence in PatientCentric Care - South Australia Based in Adelaide, South Australia, Kurmis Orthopaedics is busy orthopaedic subspecialty surgical clinic dedicated to high quality care. We profile the clinic to learn more about how it came to win not one but two of this year’s Healthcare and Pharmaceutical Awards.

Welcoming privately insured and self-funded patients from across the state, Kurmis Orthopaedics is a diverse specialist practice committed to providing every patient with the superior treatment and support they need and deserve.

The practice’s Principal Surgeon, Professor Andrew Kurmis, is a locally-born and bred Specialist Orthopaedic Surgeon with international training and fellowship experience. He holds a senior academic appointment at the University of Adelaide, and is heavily involved in medical student, intern, pre-vocational doctor, registrar and fellow teaching and is a current AOA

accredited advanced trainee supervisor. He has won numerous teaching awards and remains actively involved in examination setting and basic curriculum development.

He was recently also accepted as a Fellow of the Faculty of Surgical Trainers (Royal of College of Surgeons, Edinburgh) - as only the 8th Australian or New Zealand surgeon to be elevated to this prestigious level of membership.

Professor Kurmis is also heavily involved in clinical research, having published over 50 peer reviewed works and delivered talks at nearly 100 national and international conferences and meetings. His recent receipt of both the Royal Australasian College of Surgeons (RACS) Justin Millar Medal for outstanding clinical research and presentation, and the 2017 Frank Stinchfield Prize from the International Hip Society for outstanding contribution to the field of hip surgery give testament to the international significance of his work.

All of this experience helps Professor Kurmis to drive Kurmis Orthopaedics towards delivering the highest quality of surgical care for patients in need of primary, complex or revision hip and knee replacement. His active and ongoing involvement in clinical research helps drive the clinic’s push to make sure that his practice is always offering advancements in orthopaedic care that are safe and evidence supported. He uses a range of technology-assisted approaches to deliver optimised and patient-specific outcomes

64 GHP / 2019 Healthcare & Pharmaceutical Awards

including image-derived and imageless navigation, robot assisted surgery and advanced three-dimensional pre-operative templating.

Professor Kurmis sees one of the greatest coming challenges in the field of joint replacement surgery to be the need to deliver increasingly high-quality implants that provide even greater function and durability, in a more cost effective and timely manner, utilising the latest evidence-supported delivery technologies. Looking to the future, Kurmis Orthopaedics will be working to overcome these challenges and continue to innovate in the orthopaedic sector in order to enhance its already exceptional care and treatment selection for patients. Professor Kurmis’ 3D pre-operative hip planning project with one of the major leaders in implant design promises to be one of the very exciting advancements ahead, as is his work with international centres of excellence to instigate a global screening tool for genetic susceptibility to adverse reactions to implant-generated metal debris that could offer enduring benefits to joint replacement patients across the planet and contribute to a lasting legacy of innovation for Kurmis Orthopaedics.

Company: Kurmis Orthopaedics Name: Professor Andrew Kurmis Address: Level 1, 151 Hutt Street, Adelaide, South Australia, 5000, Australia.

Telephone Number: +61 08 8232 9999 Web: www.kurmisorthopaedics.com.au

, Iceberg Medical Ltd

Iceberg Medical Ltd: Medical Communications Agency of the Year 2019 Iceberg Medical Ltd is a medical communications agency working with pharmaceutical companies, undertaking all forms of work, including digital, print and meetings programmes in a variety of therapy areas. As we showcase a selection of this year’s Healthcare and Pharmaceutical Awards winners, we profile the company to find out more.

Iceberg Medical is totally committed to helping their healthcare clients engage with their customers, always striving to improve patient outcomes.

They offer a diverse range of services: the company’s strength lies in the highly skilled and qualified team, who keep the customer at the centre of everything they do. The members of this dedicated account team are all degree educated. The group have the skills and industry knowledge to drive the firm forward and offer the innovative services that the company prides itself on.

Each and every member of this team endeavours to rise above and beyond for their clients, ensuring they receive the exceptional standard of service they both want and expect. The healthcare sector is a

vital component of any society, and as such its members need this support to be able to offer patients and stakeholders exceptional service and treatment when they need it most.

Iceberg Medical has the specific industry experience and drive to ensure that companies throughout the healthcare space communicate, market and showcase themselves in the best possible way. As part of this focus, Iceberg Medical has run meetings programmes dedicated to providing education to healthcare professionals, some for more than five years now. The programmes have tailored and comprehensive agendas, allowing delegates to network, share and contribute with ideas to improve everyday clinical practice.

When hosting these programmes, Iceberg Medical manages every single aspect of

the meeting, from a logistical point of view to ensuring speakers and delegates are exceptionally well looked after. They also manage all meeting materials and slide decks, ensuring that they are compliant and informative, but still engaging.

Digital media is now becoming a key focus in all facets of the corporate landscape, including that of healthcare. Iceberg Medical works hard to adapt and ensure that its solutions are always ahead of any emerging developments. As such, the agency offers interactive digital material for both iPads and video leavepieces. These are developed to allow sales teams and healthcare professionals alike to discuss and engage in a way they have not been able to previously.

This focus on providing cutting-edge solutions that meet its clients’ needs has helped the firm to compete against other communications agencies, showcasing its superior skillset and dedication to client satisfaction.

Moving forward, Iceberg Medical is expanding so that it can meet both the everevolving needs of its clients and undertake the growing number of projects it is being offered. This growth will help the company achieve its overall mission: to build strong, long-lasting relationships with clients and to provide exceptional service whilst delivering projects to the highest possible standard.

Company: Iceberg Medical Ltd Address: Unit 12, Chess Business Park, Moor Road, Chesham, Bucks, HP5 1SD Telephone Number: 01494 776289 Web Address: www.icebergmedical.com

GHP / 2019 Healthcare & Pharmaceutical Awards 65

, Axis Medicare Limited

Axis Medicare Limited: Pharmaceutical Products Supplier of the Year 2019 - UK With a longstanding reputation for excellence in the pharmaceutical market, Axis Medicare Limited is able to offer the innovative solutions patients need. We profile the firm to learn more about the solutions it has to offer and how these benefit a variety of healthcare practitioners and those they treat.

Initially established in 2004 as a supplier of Over the counter medicines to the pharmacy market, over the years Axis has developed into a national supplier of generics, injectables, vaccines and medical devices, to pharmacies, doctors, travel clinics, vets, dentists and wholesalers.

Additionally, the firm also manufactures the Early Bird Swift pregnancy test that was recently voted Pharmacy product of the year 2019. The brand holds 30 years of heritage and continues to grow year-on-year, enabling it to continue to flourish.

Offering a bespoke service to clients, the company is able to ensure that they receive the products and support they require. After all, every client is different, and the firm’s

expert team understand and value this. They work with clients to ensure that they achieve real value from their association with Axis.

To ensure this level of customer service is constantly provided, Axis employs a dedicated team of staff who are constantly driven to find new and innovative ways to support clients. The team all enjoy the challenge of building the company together and understanding their role in doing that.

Working collaboratively is a key aspect of Axis’ approach, and as such the team meet daily as a whole company to discuss challenges and good news and this means that issues get addressed quickly and good news can be shared and capitalised on immediately. They also listen to customer feedback and try to ensure that they constantly receive solutions

66 GHP / 2019 Healthcare & Pharmaceutical Awards

that are creative and ahead of emerging market developments.

Over the coming years Axis will be working to build upon its current success and grow even further. Recently the firm completed the expansion of its offices to accommodate further growth, and going forward the firm will remain focused on growing whilst at the same time offering clients the exceptional quality service and products that they have come to expect.

Company: Axis Medicare Limited Name: Darren Collett-Mills Address: Unit 1, Vanguard Industrial Estate, Henwood, Ashford, Kent, TN24 8DH Telephone Number: 01233636662 Web Address: www.axismedicare.co.uk & www.earlybirdswift.co.uk

, Ozop Surgical, Corp (OTCQB:OZSC)

Ozop Surgical, Corp (OTCQB:OZSC): Most Innovative Surgical Implants & Instrumentation Manufacturer - USA Ozop Surgical Corp. invents, designs, develops, manufactures, and distributes innovative endoscopic instruments, surgical implants, instrumentation, devices and related technologies focused on spine, neurosurgical, and pain management procedures and specialties. We profile the firm to gain an insight into how far it has come over the years in this vital sector.

Thanks to the experience of its Senior Team, Ozop Surgical is advancing spinal care through improved spinal implants in conjunction with thoughtleaders and surgeons in this space. Taking a minimally invasive approach the company plans to develop specialized implants which will be implanted through an opening too small for existing technology. This minimizes trauma, can reduce infection and allows patients to return to their normal activities more quickly.

Currently, one of the firm’s core focuses is on creating an innovative balloon interbody device. This solution and others will help the firm to disrupt the surgical implants and instruments space and drive it towards greater creativity, safety and innovation.

Less invasive solutions are vital in today’s cost conscious and outcomes-based healthcare market. Faster operative and recovery time, decreased infection, less blood loss are all potential benefits of MIS surgery. Working to support healthcare professionals across the market, Ozop Surgical is developing devices that address these issues and provide new options to surgeons and patients.

Ozop Surgical is on a mission to economically disrupt the orthopaedic and neurosurgical markets by providing premium quality surgical devices that result in immediate significant savings for providers, payors, and patients; and to continue to design and manufacture cutting-edge surgical solutions, with an emphasis on employing its innovations in the

rapidly growing field of minimally invasive surgery. As a small, nimble company Ozop Surgical is able to focus on its core areas of expertise and develop and bring to market products faster than larger competitors.

This will remain the firm’s core focus as it looks towards a bright future filled with new opportunities for growth and prosperity.

Company: Ozop Surgical, Corp (OTCQB:OZSC) Name: Michael Chermak Address: 319 Clematis Street, Suite 714, West Palm Beach, FL 33401 Telephone Number: 866-286-1055 Web Address: http://ozopsurgical.com/

GHP / 2019 Healthcare & Pharmaceutical Awards 67

, Bluefish Pharmaceuticals AB

Bluefish Pharmaceuticals AB: Most Progressive Generic Pharmaceuticals Company - Scandinavia Bluefish Pharmaceuticals AB is an innovative generic pharmaceuticals specialist dedicated to making quality medicines accessible to even more patients around the world. We profile this internationally respected company to learn more about the work it does to achieve this ambitious mission.

Founded in Sweden, a country renowned for its long tradition of industrial entrepreneurship, Bluefish has risen to become one of the most progressive generics pharmaceuticals companies.

With operations in more than 13 countries in Europe, including its recently opened office in Ireland, Bluefish is able to offer its clients the benefit of its international reach and exceptional knowledge of the pharmaceutical market.

Through its international presence, the firm is able to create value in the full pharmaceutical value chain from developing to manufacturing and successfully marketing generic pharmaceuticals. The firm takes pride in doing this in an innovative, responsible and cost-

efficient way, thanks to its corporate culture and close collaboration with development and manufacturing partners, both of which are integral parts of Bluefish’s effort to deliver quality products at affordable prices.

Each and every one of Bluefish’s quality products originate from a generic substance, and the efficacy and safety of this are well documented. Through the firm’s many collaborating partners it has access to a vast range of products with high availability , enabling the Bluefish team to develop and enhance its product portfolio constantly for the benefit of its clients and patients.

This unique strategy with a virtual and lean organisation based in several countries which develops and market products based

on well-known substances with a broad and somewhat niche product portfolio with a significant market potential. Bluefish achieves this with a lean organisation delivering with relatively short development time, low risk, and limited investment.

By focusing on innovation and simplicity in both thought and action, and by taking responsibility on all markets and cost efficiency in all stages, Bluefish is creating a strong and vibrant brand that offers stable supply of quality pharmaceuticals at prices affordable to all. This creative approach is driving the firm forward and helping it to showcase the benefits of its work to a wider range of clients around the world and throughout the pharmaceutical and healthcare spaces.

Bluefish believes that an empowered organisation that acts smart and strive towards simplicity and continuous improvements will delivers excellent customer service. This young and dynamic company will be working towards enhancing its already impressive global presence and striving towards its focus of supporting more patients around the world and allowing them access to generic medicines that will help them live healthier and happier lives.

Company: Bluefish Pharmaceuticals AB Name: Berit Lindholm Address: Gävlegatan 22, 9 tr, 11330 Stockholm, Sweden Telephone Number: +46 8 519 11600 Web Address: https://bluefishpharma.com/

68 GHP / 2019 Healthcare & Pharmaceutical Awards

, SureMed Technologies Inc.

SureMed Technologies Inc.: Leading Innovators in Medication Safety & Efficacy - USA SureMed Technologies Inc. (SureMed Tech) offers healthcare providers, pharmaceutical and patients the highest quality, and most reliable and useful platforms for tracking usage of parenteral drugs and improving medication outcome using its ePlungers, eCaps and eSleeves.

In celebration of the company’s success in the 2019 Healthcare and Pharmaceutical Awards we profile the firm to explore how its cutting-edge technology is fuelling change in the medical technology and healthcare spaces.

Since it was created in 2017 SureMed Tech has been aiming to improve medication safety and efficacy in new area of healthcare by bringing its digital connectivity solutions to injectable medical devices.

Thanks to the firm’s hard work and dedication, over the past two years SureMed Tech has built a competency through its disruptive technologies and quality management.

The firm’s unique solutions help to overcome worldwide issues in the healthcare space.

The World Health Organization (WHO) states that “Medication Adherence is the most important factor determining Medical Outcomes”. Medication non-adherence is also called “a Silent Killer”.

In the USA, 66.7% prescription are under non-adherence annually and 125,000

premature deaths are caused by nonmedication adherence annually. This results in $300B cost for the healthcare system and $637B cost for pharmaceutical industry annually.

Striving to overcome this challenge, SureMed Tech’s invention will significantly help to overcome these problems. The firm is the only company currently offering solution to digitally connect PFS and manual injectors.

Its innovative eCap and ePlunger technology is designed to be pharma manufacturing and patient friendly, while its eSleeve technology applies to both common three step autoinjectors and push-start (2-step) autoinjectors.

As part of its user-centric approach, the firm’s design philosophy is to create injectable e-Connect solutions that does not interfere nor alter existing injection steps.

This is integrated into every solution that the company develops and has helped it to become a pioneer in the industry.

Ultimately, the overarching goal of SureMed Tech is to be the leader in the digital parenteral injection space by introducing disruptive technologies without requiring significant costs. As part of this ambitious aim, the firm is currently developing a revolutionary digital connectivity solution for the injectable devices market to enable convenient, quick, easy, and most importantly, seamless adoption. This development and others will drive the company to achieve its goal and lead this competitive and flourishing market over the years ahead.

Company: SureMed Technologies Inc. Email: info@SureMedTech.com Web Address: www.SureMedTech.com

GHP / 2019 Healthcare & Pharmaceutical Awards 69

, Raul Padilla

Raúl Padilla: Psychotherapist of the Year 2019 - Spain Raul Padilla is a dedicated professional with extensive clinical experience in psychology, sexology and couples’ therapy who is dedicated to working with clients to enhance their lives.

We profile Raul to find out more.

With psychology an increasing focus as patients come to understand the link between the mind and their wellbeing, there has been a surge in demand for quality support and services in this area from experts.

As such, Raul Padilla works tirelessly to help people deal with and overcome their emotional, emotional, relational, behavioural and learning problems.

As such, Raul works with individual clients to get to the root of their issues and provide them with the support they need to live their lives to the fullest. For over 20 years he has helped clients through Madrid, and he draws on this extensive experience to give every client the best possible level of service and individual support.

He offers a range of services including advice and guidance using new technologies, traditional clinic and sexual and couples’ These problems are sometimes labelled by therapy. As part of his work, he conducts mental health professionals to abbreviate and a large number of press conferences, thus be able to treat people who have similar presentations at sexology conferences, symptoms, but the label marks the person, television and radio interviews and published and each person is unique and irreducible numerous articles in prestigious scientific to a word as simple as “depression” or journals and blogs. These resources are “anxiety”. available to his clients and industry peers

70 GHP / 2019 Healthcare & Pharmaceutical Awards

and allow Raul to give back to the wider community.

Additionally, he is able to also offer a range of group therapy sessions for a variety of issues, including sexual therapy and couples therapy. He also offers training to help aspiring therapists to learn and prosper and provide their clients with the best possible service.

Looking ahead, Raul will remain committed to offering the range of solutions, treatments, workshops and training plans that his patients need to enjoy their best mental health in today’s stressful world.

Contact: Raul Padilla Website: https://www.raulpadilla.es/

, Nutralab Canada Corp.

Nutralab Canada Corp.: Best Custom Natural Health Supplements Manufacturer - Canada A private label contract manufacturer for natural health supplements, NutraLab Canada Corp. is one of the country’s premier, vertically-integrated companies in the natural health sector.

The firm offer all manner of turnkey operations including R&D, formulations, regulatory clearance, ingredients sourcing, label design, full-dosage form manufacturing, and packaging.

As a winner of a coveted Healthcare and Pharmaceutical Award, discover why this company are one of the best manufacturers of custom natural health supplements.

Focused on offering complete manufacturing solutions to national and international clients, NutraLab strive to ensure a seamless launch to market from start to finish. By vertically integrating all upstream processes, the company is able to completely control the cost and speed of every step of production. The client has the peace of mind, knowing that this company are one of the most efficient onestop-shops for health supplement contract manufacturing.

With over fifteen years of experience as one of the leading private label vitamin manufacturers, NutraLab has been serving both Canadian and international clients with great success. Drawing on their expertise, professionalism, and dedication, the company offer better quality and costeffective products and services to their clients.

for solid, powder, and liquid formats.

Achieving full dosage form manufacturing over ten years ago, NutraLab is committed to continuously expanding production capabilities with all the latest innovative changes to the industry. With internal sourcing of ingredients, robust quality assurance and control systems, and thirdparty testing, the company can continually guarantee better product quality.

Having over forty percent of the company’s products being exported worldwide, NutraLab strives to ensure that it stays aware of national and international policy changes.

Despite order fluctuations, the firm always strives to adapt to new policy changes and continue to deliver high-quality natural health supplements to their clients, all over the world.

The continuous investment into the company’s practices also help ensure that they continue to improve across a number of areas. Giving themselves an advantage through scientific research and global technical cooperation, NutraLab’s always put the clients and their needs at the centre of everything achieved.

The successes of NutraLab are down to their unique ability to offer full dosage form manufacturing, whilst maintaining the incredibly high standards of quality that clients expect. Employing a wealth of experience to ensure the continued international delivery of top-quality custom natural health supplements, this Canadian manufacturer are creating their own success.

Company: Nutralab Canada Corp.

Contact: Peter Ou Website: https://nutralab.ca/

The company’s facility is also registered with the US Food and Drug Administration, representing a new stage for NutraLab in meeting international safety and quality requirements. This latest development further highlights the company’s commitment to manufacture and supply private label vitamins of the highest quality standards.

NutraLab is one of the only contract manufacturers in Canada to offer full dosage form manufacturing. While other manufacturers will focus on one or two dosage forms, this company has manufacturing capabilities for softgels, tablets, capsules, powders, liquids, and syrups. Also, the firm boasts packaging capabilities for bottles, cartons, and sachets

GHP / 2019 Healthcare & Pharmaceutical Awards 71

, Best for Clinical Trials Management Services - Quebec

JSS Medical Research Inc.: Best for Clinical Trials Management Services - Quebec Since evolving from a local Canadian contract research organisation (CRO) to an international full-service CRO, JSS Medical Research Inc. now conduct clinical research in over twenty countries worldwide. Under the wise leadership of Dr John Sampalis, this company has developed into an internationally-recognised partner that helps manage multiple, complex clinical trials across a wide range of therapeutic areas. We unearth the secrets behind their success, as they receive a Healthcare and Pharmaceutical Award for being the best in clinical trials management services in Quebec.

Established in 1985, JSS has since gone on to become a full-service contract research organisation, providing clients with a one-stop-shop from study conception to results dissemination. The company’s expertise in clinical development and post-trial marketing helps to serve the needs of leading pharmaceutical companies, as well as medical device, biotech, and nutraceutical clients.

Headquartered in Montreal, Quebec, the company has additional offices across the world in Colombia, India and Poland, granting them a global presence and client base. With over three hundred employees worldwide, the firm are currently engaged in over two hundred ongoing projects. The vision behind the work at JSS is to achieve excellence in health research by linking the industry, academia, regulatory authorities, payers, and patients through one scientific foundation.

The firm have been instrumental in various clinical trials that have produced results which have led to major changes throughout the healthcare and pharmaceutical industry.

Upon evaluating and revising the Quebec trauma care system alongside the Ministry of Health, JSS were key in establishing the Quebec trauma registry, which subsequently caused a reduction of major trauma mortality from 55% to 18%.

Academic affiliations of JSS push the company to the cutting edge of research.

Several staff are undertaking graduate training in clinical research to ensure that they always have innovative ideas and new knowledge integrated into the services offered. New discoveries in science constantly present new opportunities for research to enhance the company’s ability to conduct better clinical research.

Also assessing the impact of waiting times on the outcomes of patients undergoing coronary artery bypass graft surgery in Quebec, JSS conducted the first ever analysis of its kind. The results were critical in the creation of delay thresholds and determination of wait list reduction targets. The company also evaluated scintimammographical technology, before supporting adaptation of it across Canada and worldwide for early detection and treatment of breast cancer.

Having already established themselves with offices in four major continents, JSS are looking to expand their operations into the United States and Europe by partnering with a like-minded strategic investor. The firm are ahead of the curve, understanding that the future of health research lies in realworld evidence. By conducting real-world epidemiological and clinical research for three and a half decades, this company are at the forefront of clinical research developments.

The successes of JSS come from their wealth of understanding regarding the clinical research industry within healthcare, and the vital role it plays. Having already been instrumental in establishing game-changing healthcare developments, this global research firm’s vital work is going to see them grow from strength to strength.

Company: JSS Medical Research Inc. Contact: John Sampalis Website: https://www.jssresearch.com/

72 GHP / 2019 Healthcare & Pharmaceutical Awards

, Xeal Pharma

Xeal Pharma: Best Specialist Pharmaceuticals Manufacturer 2019 - Midlands With a reputation in the industry for quality, reliability and efficiency, since its inception Xeal Pharma has risen to become a trusted specialist pharmaceuticals manufacturer, suppling a wide range of clients throughout the healthcare space. We showcase the solutions this innovative firm creates and how these are helping it to grow and flourish.

Trusted throughout the healthcare space, Xeal Pharma is a MHRA GMP certified pharmaceuticals manufacturer.

Over the years Xeal Pharma has come to specialise in manufacturing unlicensed medicines, referred to as ‘Specials’. The firm now supplies these products to healthcare professionals to provide the necessary pharmaceutical care to their patients.

To ensure quality for every client, the firm strongly believes in building a relationship with customers. This ensures that Xeal Pharma is perfectly suited to meet their needs and to provide a more personal service. Whenever working with a client, the

company strives to create lasting business relationships that surpass its competitors.

healthcare professionals and is of the best possible value for money.

Alongside this exceptional standard of service, the firm also boasts a diverse range of products and services, which are designed to deliver the highest standards to all of its customers and their end users.

Fundamentally, Xeal Pharma takes great pride in manufacturing and supplying pharmaceutical special products at affordable and competitive prices. This will remain the firm’s core driving force as it looks towards a bright future and aims to take over even more of this vast market.

This innovative combination ensures that Xeal Pharma is the perfect partner for healthcare professionals throughout the UK’s healthcare marketplace, including pharmacies, hospitals, private practices and many more. Collaborating closely with leading organisations, including the NHS, the firm is able to continually adapt its service offering to ensure that it meets the needs of

Company: Xeal Pharma Contact: Husam Jafar Website: http://xealpharma.co.uk/

GHP / 2019 Healthcare & Pharmaceutical Awards 73

, Emphascience Inc.

Emphascience Inc.: Best Pharmaceutical R&D Company - New York Award-winning Emphascience, Inc. is a private pharmaceutical company, focused on developing novel formulations of proven drug products to address unmet medical needs in the treatment of pain, cancer, infections, and many fatal and debilitating diseases. We share an insight into the work the firm undertakes in this vital sector and how it aims to drive lifeextending developments throughout the pharmaceutical space.

Thanks to its vast industry expertise in the design and development of complex dosage forms, Emphascience has come to be a respected name in the pharmaceutical research and development market.

Since it first began, the firm has been focused on the reformulation and optimization of drug products, creating innovative solutions to a variety of existing issues.

After all, a pharmaceutical product formulation comprises both, active and inactive ingredients, in the finished product.

More than just being a means to package and deliver the drug to a patient, they become an environment that is meant to protect and promote the preferred characteristics of the active ingredient. In a way, similar to how the environment at a school can help nurture and turn the attention of its pupils to education. Pharmaceutical product formulations can protect the drug from chemical degradation, improve the rate and extent of delivery to its site of action, increase patient acceptance, or improve compliance of a treatment.

Yet, the novelty of the formulations and drug delivery strategies developed by Emphascience offer, in most cases, the possibility of patent-protection, differentiated branding, exclusive market presence and faster market entry than a typical generic product. Bolstered by its emphasis on science, creativity, and energy for limitless exploration, the Emphascience team is passionately committed to offer newer, safer, more exciting therapeutic options to all stakeholders of healthy lives.

Since innovative formulations designed by Emphascience are based on molecular-level interactions of the active with its immediate environment (product composition), the concepts and technologies that work for one drug are often applicable to other drugs with similar structures.

This approach leads to multiple product concepts within a very short period of time. In the last six years, Emphascience has built upon some outstanding technical successes to develop a sizeable pipeline of differentiated products for commercialization.

For example, a strategy developed by Emphascience to slow down deamidation of some peptides and protein-based actives By redesigning the composition of existing has been effectively used for the design of medicines, whose pharmacological and a room-temperature-stable, ready-to-use therapeutic efficacy have already been injectable for a drug used to treat serious, established in the clinic and in practice, acute conditions that would otherwise be the path to market is one of the surest and lyophilized (freeze-dried) or frozen below fastest, and considerably less risky or costly -20°C. For many high potency drugs, in compared to a new chemical entity. In most addition to chemical instability, often the loss cases, this means that no new clinical studies of potency due to selective sorption on the to establish safety and efficacy. container is a challenge. Emphascience has developed a simple solution to prevent loss

74 GHP / 2019 Healthcare & Pharmaceutical Awards

due to adsorption for various large and some small-molecule drugs without changing the container type or the chemical structure of the active.

Other technical successes achieved by Emphascience include antioxidant free, chelator-free formulations for drugs that are susceptible to oxidation; stable, heatsterilized, ready-to-use sterile solutions for injections that require cold-chain, or freezedrying, or cannot be terminally sterilized; product compositions that are safe and suitable for very young children; long-acting drugs that do not require frequent dosing.

Work is in progress to improve products that cause significant injection-site pain, or severe allergic, anaphylactic reactions, and these developments will drive even greater success for the firm.

Emphascience’s current business model is to conceive and design creative new pharmaceutical product concepts and turn them into innovative, scaleable formulations in a research laboratory setting, before licensing the knowhow and technology to pharmaceutical corporations for development and scale-up under good-manufacturingpractices (GMP),, followed by registration, regulatory filing and marketing.

Unlike large pharmaceutical corporations, early explorations of product concepts are not limited by clinical or commercial expectations. Yet, once successfully designed, the products are selected for licensing only if they satisfy both clinical and commercial acceptance-criteria. Such research-focused setting affords flexibility and allows innovation to thrive. In the future,

Emphascience Inc.

integration of in-house research with strategic partnerships for development and marketing is expected to expedite the commercialization of many more high quality and innovative products that improve standard of care and address many unmet needs.

Essentially, Emphascience’s success revolves around its focus on creating unique solutions and taking a completely original approach to drug development. This will remain the firm’s ongoing focus over the years ahead as it seeks to continue to disrupt the pharmaceutical market for the benefit of patients with a wide range of diseases and health concerns.

Company: Emphascience Inc. Contact: Rebanta Bandyopadhyay Website: http://emphascience.com/

GHP / 2019 Healthcare & Pharmaceutical Awards 75

, Mayfair Diagnostics

Mayfair Diagnostics: Best Medical Imaging Company - Western Canada Supporting patients across Western Canada, Mayfair Diagnostics is a medical imaging company offering diverse and specialized services. We showcase these services in more detail and outline how they have helped the company to achieve its success.

Since its inception Mayfair Diagnostics has been leading the way in medical imaging in Canada, driving innovation into this vital aspect of the healthcare sector.

A pioneer in the sector, the company was the first in Western Canada to introduce the region’s newest mammography technology which is ergonomically designed to help make the experience more comfortable for patients. It also includes the option for patient-assisted compression; a remote control that allows patients to adjust the level of compression during the exam, decreasing their anxiety and increasing their willingness to return.

Such innovations have helped the firm to flourish and expand its service offering to meet the changing expectations of referring physicians and their patients. Thanks to this growth and the expertise of Mayfair Diagnostics’ medical teams, they are able to provide comprehensive screening, diagnostic, and interventional medical imaging services across 13 clinics in Calgary, and one in Regina.

Owned and operated by over 60 radiologists, Mayfair Diagnostics uses state-of-the-art technology to serve more than 700,000 patients and interpret images from over 90,000 patients in rural and remote locations.

Together the company’s medical teams provide community-based X-ray, ultrasound, nuclear medicine imaging, image-guided pain

76 GHP / 2019 Healthcare & Pharmaceutical Awards

therapy, mammography, and bone mineral densitometry services, as well as private pay MRI and CT exams.

Working to achieve its vision of world in which every person has clarity about their health, Mayfair Diagnostics plans to continually invest in technology that improves outcomes for its patients, as well as their services to meet the changing needs of patients and referring physicians. This focus will help the company to change the shape of the Canadian healthcare market.

Company: Mayfair Diagnostics Address: 132, 6707 Elbow Drive SW, Calgary, AB T2V 0E3 Telephone Number: 1-403-385-0256 Web Address: www.radiology.ca

, Building Blocks Occupational Therapy

Building Blocks Occupational Therapy: Outstanding Service Award in MultiDisciplinary Paediatric Healthcare 2019 The early years of a child’s life are extremely important in maximising their physical, social, emotional, and learning potential. Building Blocks Occupational Therapy aims to improve development in children, support those with problems that range from handwriting issues to more complex needs. As part of our Healthcare and Pharmaceutical Awards for 2019, we examine the firm and its vital work in more detail.

Established over eighteen years ago in Hornsby, Sydney, BBOT initially began as a home-based Paediatric Occupational Therapy service, founded by Celeste Riach. Since the firm’s inception, it has grown from sole trader to housing eighteen employees across two locations designed to serve the community.

be something for every child. Whether it’s the Holiday Handwriting Happenings club, Ready…Set…School program, or the team sports-based program BB All Stars, the company can offer a wealth of support across all areas of child development.

Relationships and support are the key convictions of BBOT, as defined by founder Celeste’s own personal beliefs. With a tag line of “Build, Develop, Excel”, the staff aim to make meaningful connections with the children, their families, and teachers whilst providing high-quality innovative and goaloriented therapy services.

Over the last few years, BBOT’s practice has expanded to offer a more multidisciplinary service. As recently as June 2019, the company welcomed a Speech and Language Pathologist to join the existing Paediatric Physiotherapist, who both work onsite and in schools allowing BBOT to help children across all areas of their development. By bringing in specialists, the company are further establishing themselves as the go-to firm for paediatric healthcare.

Incorporating honesty, integrity and excellence in all they do, the team has maintained a high profile in their local area, thanks largely to the high level of trust placed in them by clients. BBOT has a presence in many local schools, meets regularly with local healthcare practitioners, and collaborates alongside other complementary health services including paediatric dentists, psychologists, chiropractors, and speech therapists.

With the arrival of the National Disability Insurance Scheme and the subsequent closure of most government services, there has been a much greater demand on private therapy practices across Australia. This increased need has seen BBOT’s client base expand greatly, with the firm at times experiencing challenges keeping up with the high demands for services. Offering more group and in-school programs, expanding

their physical locations to offer more space for therapy, and recruiting more staff have all helped overcome these issues.

To ensure that the firm stay at the forefront of industry developments, all therapy staff undertake regular professional development and attend relevant training courses and conferences to update their skills. Maintaining memberships with certifying organisations means that staff regularly receive the latest scholarly news and ensures they stay abreast of evidence-based practice treatments. In turn, clients can rest assured that their child is getting the best help possible.

Ultimately, it is the vision of BBOT to help those in the community who most need it, and that is the reason for their continued success. Dedicating their time and service to maximising the potential of children, the staff at this Occupational Therapy company are helping pave the way for a new generation of confident and successful children.

Company: Building Blocks Occupational Therapy Contact: Celeste Riach Website: https://bbot.com.au/

Many of the children that BBOT see and work with have issues that range from gross motor skills, fine motor skills and handwriting, through to social skills and sensory processing, as well as a number of conditions, disorders and syndromes. Such conditions can include ASD, cerebral palsy, Down syndrome, hypermobility and other learning difficulties.

Able to offer a multitude of groups, BBOT puts the power in the hands of parents and carers. With a wide variety of tailored groups to suit all manner of needs, there is sure to

GHP / 2019 Healthcare & Pharmaceutical Awards 77

, Wheel of Health Limited

Wheel of Health Limited: Best for Posture Management Analysis Reports - UK & Ireland Since the firm’s inauguration in 2005, Wheel of Health Limited (WoH) has specialised in offering Postural Analysis, management assessment and intervention to adults and children with complex and challenging healthcare needs. As we examine the firm’s vital work, we also reveal their success in winning one our coveted Healthcare and Pharmaceutical Awards for 2019.

An extremely personable company who put clients first, WoH ensure that every service they offer is efficient and meets a client’s individual needs.

Specialising in wheelchair seating and roundthe-clock posture management, the firm provide solutions and resources for patients who need support in maintaining, gaining, or regaining their independence.

With a team of eighteen highly skilled and competent occupational and physiotherapists (plus support staff), every staff member has significant post-graduate experience and training in the specialism of wheelchair seating and posture management. Over the last nearly fifteen years, WoH’s client base has continued to grow, thanks to long-term commitment to ongoing review. Posture management needs continue to progress, irrespective of the clinical presentation or prognosis.

Posture is often seen as static, with wheelchair users’ posture presented at assessment often being considered as their permanent posture. Under the influence of rehabilitation, variable and changeable muscle tone, spasticity patterns and behavioural changes among other factors, postural requirements of wheelchair users change much more. WoH is focused on achieving the best possible results for their clients through being involved at all stages of the postural management process.

From initial postural analysis and assessment, right through to handover and final setup of recommended equipment, WoH’s team of clinical specialists are present to ensure that maximum benefit can be,

and is, achieved. This often includes much necessary positioning training with the client and their carers. It has been recognised in the medical community that regular programmed postural reviews are required to maintain the best possible continued benefit, as well as improved usefulness.

It is vitally important that postural management is used effectively, as more often than not, a wheelchair user’s very independence can hinge on it. WoH’s postural management influences systemic bodily functions, ease of access to driving controls in a powered wheelchair, ease of propulsion in a manual wheelchair, access to and completion of all daily activities, and access to communication and assistive controls.

The first, and perhaps most important aspect of any postural management assessment process, is to carefully examine the patient’s physical condition, taking note of deformities, altered muscle tone, impaired sensations, and effects of trauma. All WoH findings are clinically recorded to give an accurate reference point for future problem solving.

If there is pelvic asymmetry for example, that can be corrected, then any seating solution should seek to do that, but if it is not correctable, any postural management solution should seek to accommodate it, therefore reducing the risk of worsening any existing issues.

Competent clinicians must work with equally competent technical teams as collaboration is a necessity. For wheelchair users who fully depend on their equipment, they require both clinical and technical input to address complex needs. The ethos at WoH is to

78 GHP / 2019 Healthcare & Pharmaceutical Awards

work in direct collaboration with competent equipment suppliers who can provide, maintain and assist in the adjustment of equipment to meet the ongoing clinical changes of all clients.

Rapidly increasing levels of highly sophisticated technology means that more patients can increase their level of independence. WoH’s effective posture management intervention through clinically appropriate solutions, facilitate access to more activities and can be the difference between independent function or not.

The firm work in direct collaboration with specialist equipment partners across the United Kingdom and Ireland, each of whom have the technical skills and abilities to deliver for WoH’s highly complex client base.

At the centre of WoH’s success, is its drive and determination to ensure that every wheelchair user is entitled to potentially life-changing equipment. By carefully making sure that every detail regarding posture management and wheelchair seating needs are met, clients can experience high-level care and input, by a firm that has nothing but their best interests at heart.

Company: Wheel of Health Limited Contact: Lucy Weech Website: https://www.wheelofhealth.co.uk/

, Liva Healthcare

Liva Healthcare: Most Innovative Digital HealthTech Company 2019 Lifestyle & Disease Management Platform of the Year: LIVA Based across Copenhagen and London, Liva Healthcare is an international health tech company that helps improve the lives of people who live with, or are at risk of living, chronic conditions such as type 2 diabetes, obesity and heart diseases. Driving positive change through lasting behavioural changes, join us as we uncover the secrets behind this award-winning firm’s success as part of the 2019 Healthcare and Pharmaceutical Awards.

Used by healthcare, private insurance and pharma companies including NHS England and AXA PPP Healthcare, Liva’s platform offers a program designed to deliver lasting change for those living with chronic conditions. Founded in 2015 by the entrepreneurs behind the successful e-health company NetDoctor.com, this innovative firm continues to make real, tangible difference to people’s lives today.

The statistics don’t lie, either. Where Liva has been used, 85% of clients have seen reduced haemoglobin A1C, with 40% of pre-diabetics reversing their course after six months. Average weight loss over a six-month period for clients is twelve and a half pounds, and on average, over two thousand euros has been saved per diabetic clients. On the Liva platform, each supervisor handles up to five hundred patients per year.

Currently operating in Denmark, United Kingdom, Sweden and Canada, the firm’s growing momentum will allow for expansion into more European countries such as France and Ireland, as well as more international growth in Singapore. Alongside the geographical expansion, the firm are also looking to partner with wearable tech companies in a bid to upgrade their platform with more accurate measurements for patients.

Uniquely, Liva is a hybrid model of technological analysis and human interaction.

Through an app and desktop service, Liva Standing out from other health tech innovations focuses on preventing chronic lifestyle that simply rely on technology alone, this conditions such as type 2 diabetes, obesity company connect patients to their own physical and heart disease. Patients are connected health coach. Working together on a number with health coaches who help implement of aerobic sessions, the relationship between goals to change behaviours, such as setting patient and coach continues throughout the smart goals, self-monitoring, lifestyle tracking, duration of the program for maximum benefit. motivational tools, video communication with the coach, and an online support group with In order for Liva to stay at the forefront of other users. the digital healthcare industry, the company regularly take part in research projects.

It is also used by healthcare providers to drive Often collaborating with universities across patient engagement, clinical outcomes and the world, the firm are able to measure the healthcare delivery efficiency with real-time success of digital tools in treating a wide data insight. Pharmaceutical companies range of conditions. The firm recently won use Liva to help manage patients who have funding to begin a research project looking at been prescribed medication for their chronic digital lifestyle tools to prevent and reverse conditions. The app can help encourage type 2 diabetes for pregnant women. This those patients to take their medication at the will see increased collaboration with other appropriate times, as well as combine that with experts such as University College Dublin exercise to maximise the healthcare potential. and Bristol University.

Fundamentally, the success behind Liva is down to their hard work in improving the lives of those who are living with chronic conditions.

The company’s innovative technology and health programs help facilitate ongoing personalised health coaching through an intuitive app, building strong bonds between the healthcare professional and the client.

Company: Liva Healthcare Contact: Charlie Bush Website: https://livahealthcare.com/

GHP / 2019 Healthcare & Pharmaceutical Awards 79

, Westwood Care and Support Services (Yorkshire) Ltd

Westwood Care and Support Services (Yorkshire) Ltd: Domiciliary Care Provider of the Year 2019 - Yorkshire & the Humber Built on the belief that independent life is about people making their own choices and achieving their aspirations, Westwood Care and Support Services (Yorkshire) Ltd works to offer high-quality, bespoke domiciliary care to residents of the Yorkshire and Humber area. We profile the company to find out more about how it works to ensure clients and their families receive the support they need to live happy, independent lives.

Established in February 2011, Westwood Care and Support provide tailored home care packages that meet the needs of adults and children, and families across Hull and East Yorkshire.

the night, sleeping nights, providing peace of mind that someone is on hand should they be needed, hospital to home support when people are discharged from primary care, this service includes post-operative support. Westwood Care and Support also provides specialist care including dementia, end of life care and Person-centred and tailored to each complex health needs along with respite individual’s needs, the firm’s services can be breaks to enable carers to take a holiday or provided to people of all ages, disabilities and spend some time looking after their own needs. health conditions. Thanks to its experienced team of care givers, the firm can offer a wide The company also manages Dales House, a range of services to suit all needs, such as small residential care home for adults aged companionship, light housekeeping, meal 18 plus who have profound learning and preparation, transport and errands. The firm physical disabilities and complex or multiple also offers personal care including washing, needs. As such, Westwood Care and dressing, continence care and medication Support is able to meet the diverse needs of administration. clients from across Yorkshire, whether they wish to receive support in their own home These services are flexible and designed or relocate to a space where they can enjoy to ensure everyone receives the care they specialist care designed around them. need; with this in mind, the company is able to provide waking nights where a personal As part of its drive to providing individuallyassistant is on duty throughout the course of tailored services, Westwood Care and

Support adapt to peoples changing needs in a positive way, carefully matching service users with staff so that they always feel comfortable.

Such an approach is innovative in today’s under-funded, challenging care market, in which many service users are forced to take whatever support can be provided.

Central to this service offering is staff, and as such Westwood Care and Support is deeply committed to providing its teams with the support they need to ensure excellence for clients. Since it first began the firm has been driven by a passion to support people to lead their best lives possible and to reach their fullest potential. This applies to the people it supports, their families and the firm’s own staff. The company works in partnership with everyone who plays a role in the support pathway ensuring best possible outcomes for all concerned. With employee recognition and other schemes the firm is able to ensure that staff feel safe and comfortable in their work, allowing them to provide the high quality of care and support that their clients and their families have come to rely on.

Moving forward, Westwood Care and Support will remain committed to providing the same exceptional services it has become renowned for, working with even more clients throughout the Hull and East Yorkshire region.

Company: Westwood Care and Support Services (Yorkshire) Ltd Contact: Elaine Jennings Registered Manager Web Address: www.westwoodcareandsupportservices.com

80 GHP / 2019 Healthcare & Pharmaceutical Awards

, Audiology Associates Ltd

Audiology Associates Ltd: Best Audiology Company 2019 - Wales Based throughout South Wales Audiology Associates Ltd are a private & independent hearing care team who stand out from the crowd for all the right reasons. We profile the firm to learn more.

Audiology Associates was founded in 2014 by husband and wife team Rhys Barber and Leah Morris Barber.

Both are experts in their individual fields, and they have drawn on their collective experience of Audiology and Business Management which has allowed the company to grow from strength to strength.

Together this dynamic team lead Audiology Associates and drive their ever-expanding portfolio of clinics to even greater success.

The extended Audiology Team are a group of clinical experts highly revered in their field with extensive Audiology experience amongst them. The team and their patients are also bolstered by Audiology Associates’ dedicated Clerking and Administration Team.

To ensure quality services for all clients, Audiology Associates invest highly in all staff members clinical training. Their Administration Team have also received counselling practice to aid patients in their journey towards better hearing health.

Assisting their patients further Audiology Associates run a ground-breaking and educational YouTube Channel. This channel provides transparency of the techniques used to remove ear wax and patients can be seen mid procedure. It also educates its’ subscribers and viewers on Aural health and when to gain assistance from a Hearing Professional. The channel currently has over 160k subscribers worldwide and is the UK’s most subscribed channel. Audiology Associates regularly gain messages of thanks and support from other Audiologists, Trainers, Universities and Individuals who all use the channel as an educational tool

in best practice or gaining assistance with hearing loss / issues.

The team at Audiology Associates work on an ethical drive, very unusually in this sector none of the team are on a commission structure and there is a non-pressured friendly environment for patients and staff alike. The ethos for this organisation is to educate and improve hearing health in whatever way possible and that is enough. As a result, patients feel supported throughout their journey working with this dedicated and professional company.

Thanks to this team of experts and the firm’s longstanding provision of quality hearing care solutions, over the years Audiology Associates has come to be a key player in the market, and offers a range of digital hearing aids from industry leading manufacturers, as well as a wide range of treatment options.

Each and every member of the firm’s team firmly believes that no client should have to compromise when it comes to the quality of their aural care, and as such they are committed to offering only the highest possible quality of service and treatment.

Looking to the future, Audiology Associates has exciting plans to continue to grow and flourish, working to support an even wider array of clients over the years ahead and offer them the chance to restore their hearing and enjoy a happy, healthy life.

Leah Morris-Barber Director & Co Founder continued that sentiment by stating, “Rhys, myself and our wonderful team are so delighted to be awarded Best Audiology

Company In Wales! It reflects what we are privileged to hear from our patients every single day.

“At Audiology Associates we pride ourselves on being a company that does not offer a cookie cutter approach to gain sales. Our ethos is strong and our morals stronger. We knew that to make a real difference to our patients we needed to build a business from the ground up, creating a truly welcoming and educated experience from the first phone call into the clerking office to our aftercare. We get to know each patient on an individual level, we understand their daily life and struggles. Our team sees the profound impact that our Audiological Service has, not only on our patients lives, but on their family and friends also.

“It’s wonderful to be recognised in this manner and it goes to show that if you stay loyal to your core as an organisation and more importantly to your patients’ needs that it works! Our primary goal is to provide a personalised solution for the individual patients needs in a no obligation local environment, free from sales pressure and high mark-ups. With an overburdened public health care system, we offer primary audiological services with a very small wait time. We would never take for granted what we have here at Audiology Associates, each team member works so hard and offers the highest level of service, Audiological expertise and loyalty to our patient’s needs, thus enabling them to live better lives! It doesn’t get much better than this.”

Company: Audiology Associates Ltd Contact: Leah Morris Website: www.audiologyassociates.co.uk

GHP / 2019 Healthcare & Pharmaceutical Awards 81

, Staywell Occupational Health Ltd

Staywell Occupational Health Ltd: Best Occupational Health Services Provider – UK & GHP Client Service Excellence Award 2019 Family-owned and operated Staywell Occupational Health Ltd is committed to providing the highest possible quality occupational health services to organisations throughout the UK. As we showcase a selection of this year’s Healthcare and Pharmaceutical Awards winners, we offer an insight into the firm and its service offering to see how it came to be awarded one of these prestigious and highly-coveted accolades.

Since it was created in 2015, Staywell has built a first-class reputation as being a flexible, cost effective occupational health provider, delivering first class occupational health services to companies across the UK. Staywell believe that Occupational Health should be accessible for all, regardless of company size and they can provide their services on an ad hoc basis to micro, small and medium sized companies as well as large, multi-site organisations, within both the public and private sectors.

Today the firm’s diverse list of clients operates across a myriad of disparate sectors, including Construction, Rail, Manufacturing, Finance, and Education.

For all of these clients, regardless of size or sector, the team at Staywell aims to offer quality occupational health services that will meet their individual needs and those of the organisation’s staff.

A member of the Commercial Occupational Health Providers Association (COHPA), Staywell is able to assure clients of its quality service and support, leaving them secure in the knowledge that their staff will receive the care, treatment and advice they need to work safely and effectively. Staywell is also working toward the formal accreditation of Safe, Effective, Quality Occupational Health Service (SEQOHS).

Through its network of Occupational Health Advisors, Physicians and Physiotherapists, Staywell provides a personal service,

delivering value through expert insight and high-quality standards, tailoring a complete solution for client’s occupational health needs.

Every team, industry and organisation the firm works with is completely unique, and Staywell understands this, and as such each member of Staywell’s team is committed to working with clients and their staff to ensure they receive a service they can trust and rely on.

Thanks to this experienced workforce and its dedication to providing a quality service, Staywell has become renowned for being customer focused and delivering a reliable service. Clients throughout the UK’s corporate landscape rely on the firm to keep their staff happy and healthy, and this is the core focus of the company’s dedicated healthcare professionals.

Fundamentally, Staywell aims to eliminate and prevent work related causes of ill health, achieve maximum staff productivity and improve the sense of wellbeing and morale within a workforce. This will remain central to the firm’s focus over the years ahead as it continues to collaborate with the best occupational health professionals on the market and work with them to offer quality support and service to organisations throughout the UK. Company: Staywell Occupational Health Ltd Email: enquiries@staywelloh.co.uk Website: https://www.staywelloh.co.uk/

82 GHP / 2019 Healthcare & Pharmaceutical Awards

, Dennison Psychology

Dennison Psychology: Most Trusted Private Psychology Practice 2019 - Melbourne Dennison Psychology is a private psychology practice offering a professional, respectful and confidential service, in a comfortable setting. We profile the firm to learn more about how it provides this vital support to clients in Melbourne.

Established with one psychologist working on a part-time basis out of a single consulting room, over the past six years Dennison Psychology has experienced dramatic organic growth to a team of seven psychologists, operating within independent purpose-built premises.

Today the practice’s team of highly-qualified psychologists (the majority of whom have completed post-registration endorsement programs, which recognise higher-level training/ abilities) offer services to adults,

adolescents, children and couples. Treatment is provided for a wide range of issues, across the spectrum of severity: from clients who wish to improve their relationship or better manage stress, to clients suffering from severe and complex psychiatric disorders.

In terms of service offerings, the practice ensures its team of psychologists are trained in a diverse range of evidence-based treatment approaches, and have an interest in working with particular client populations and their presenting issues. This means individuals who attend Dennison Psychology can be matched to the psychologist(s) who

are best suited to their specific treatment needs. To this effect, the practice provides a free customised matching service to potential new clients. The decision to offer this service was driven by the research in the field, which demonstrates that client treatment gains tend to be greatly affected by the fit between a client and their treating psychologist.

Dennison Psychology’s focus on skill enhancement comes from the top. For the past six years, the practice’s founder and principle psychologist Dr Joanne Dennison has sat on the national executive board of the Australian Psychological Society’s Counselling College and, during this time, has served as Chair of the board’s state committee in Victoria.

Through forecasting emerging market developments, the practice strives to anticipate industry changes and adapt accordingly. The practice assumes that, in the near future, the Australian government will implement the recommendations recently made by the Australian Psychological Society (APS) in their White Paper submission. This will have a knock-on impact on the field of psychology at large. At a private practice level, it is likely to improve how financially accessible treatment is for clients of private psychology practices in Australia. With this in mind, Dennison Psychology is currently in the process of planning changes it will make, should policy changes ensue.

Looking ahead, Dennison Psychology intends to continue utilising a sustainable growth model, that remains adaptive to industry changes, whilst maintaining a culture that fosters respect, quality and authenticity.

Company: Dennison Psychology Name: Dr Joanne Dennison Address: Suite 3, 2 Avoca Street, South Yarra VIC 3141 Telephone Number: 03 9041 8351 Web: www.DennisonPsychology.com.au

GHP / 2019 Healthcare & Pharmaceutical Awards 83

, CareRooms

CareRooms: Best Private Healthcare & Rehabilitation Centre - London & South East England Offering a unique model designed to provide support for the UK’s healthcare system and give patients a relaxing space to recover, CareRooms connects householders with spare rooms with patients in need of somewhere to convalesce. As we share an overview of this year’s deserving Healthcare and Pharmaceutical Awards winners, we felt it was important to showcase this creative company and its innovative network.

With an ageing population and increasing overcrowding in hospitals, many patients are seeking an alternative way to recuperate from operations, long bouts of illness and other health-related events.

Whilst hospitals remain centres of excellence for the treatment of many issues, they are not always the quietest and most tranquil of spaces, making them ill-suited for convalescence.

Established in 2016 with the aim to address this issue, CareRooms arranges safe, welcoming and comfortable places for people to enjoy a better recovery after, or instead of, a hospital stay.

Acting as a unique network, the firm works with hosts, many of whom are retired healthcare professionals, who have spare rooms and turns them into spaces where patients can recover in safety and comfort. These hosts take pressure off the health system and are financially rewarded for their kindness. They have rooms that have been inspected and specially modified by CareRooms to become the ideal recovery environment.

As a result, patients and their families can rest safe in the knowledge that CareRooms has selected the best possible space for recovery. Whilst hosts provide the space, the firm itself offers everything from step up, step down and respite capacity as required, as well as support for delayed transfer of care, reablement and even a ‘front desk’ service for any queries or complaints.

Patients in a CareRoom receive more than just a quiet place to recuperate; they have 24/7 care at their fingertips, with a technology enabled team monitoring their vital signs and wellbeing plus a video GP service that can be accessed around the clock. Everything from mobility aides through to three delicious meals a day is provided as part of a patient’s stay. Indeed, one of the most stand-out aspects of the CareRooms service is “hope” and psychological recovery which comes from feeling safe and knowing that you’re not lonely or vulnerable.

Accredited by a number of independent agencies including Q doctor, CECOPS and the Social Care Institute for Excellence, CareRooms is able to offer a truly unique service that cannot be found elsewhere. It benefits all stakeholders, from healthcare providers through to homeowners and patients themselves.

Ultimately, by bringing together world leading technologies and the ‘sharing economy’ to connect homes and communities, CareRooms aims to drastically reduce common issues such as social isolation for host and patients and an increasing cost of care that far surpasses the majority of people’s retirement incomes. This will remain the firm’s core focus over the coming years as it works with even more hosts and patients from throughout the UK. Company: CareRooms Contact: Elizabeth Gaudin Website: https://carerooms.com/

84 GHP / 2019 Healthcare & Pharmaceutical Awards

, DArcy Consulting

DArcy Consulting: Best SME Life Sciences Compliance Consultancy - North East USA Drawing upon the expertise and industry knowledge of its team, DArcy Consulting is a niche compliance consulting company that helps start-up companies navigate the complex path of regulatory approval. We profiled the firm to find out more about how it came to win one of this year’s coveted Healthcare and Pharmaceutical Awards.

Since it first started in 2014, DArcy Consulting has focused on helping clients, predominantly start-ups, plan and prepare for regulatory approval of their first product.

adequate quality expertise or oversight, whether in planning a clinical trial or preparing for a filing, is often a luxury that few start-ups can afford. This is where DArcy excels. They create great partnerships and work seamlessly with their clients to get the job done.

The firm’s founder Catherine Arthey brings many years of experience working in Pharma as well as the main consulting firms. During this time, she realized that for small companies, specifically start-ups that are planning to file their first IND, there are few vendors that provide the ‘nurturing and supportive environment’ that these fledging companies need. This is the focus of DArcy Consulting and with an impressive suite of offerings to support such emerging life science companies, they are making a name in this space.

Within the life sciences market, recent changes in the industry, particularly ICH E6(R2), have caused a stir in the industry and forced companies to assess where they are at. This, according to Arthey, has been very positive. Clients want to know that they are following the regulations. In addition, the focus on areas such as risk, vendors and quality has forced companies to look at their internal processes, this in the long run will ultimately make companies more efficient and effective.

Thanks to its small size, the firm has been able to establish an intimate working relationship with clients and this has been central to DArcy’s success in the marketplace. DArcy’s approach is very hands on. They have deep expertise, knowledge and experience and this comes across very quickly. They are intimate yet flexible with their clients and can very quickly blend in with client teams. For many start-ups, the focus is on securing funding, developing the science and preparing the market. Having

Incorporating regulatory updates is a critical component of any service that DArcy Consulting provides, and remains its focus moving forward. The firm’s extensive knowledge of the industry and its singular focus on start-ups has given them a unique advantage among their peers. Working across biotech companies, device companies and small CROs, they have been able to identify common themes and typical pith falls for any start-up. In effect, they know exactly what to look for. This focus has been core

to their success and with so many start-ups seeking accelerated approval, this will help drive the company to even greater success over the years to come.

With a team of four full time employees and a network of over eight consultants, DArcy Consulting is growing. The firm’s new clients come in predominantly through referral and they have no problem providing names of very satisfied clients. Indeed, for one client, the FDA Inspector commented on the quality of the client’s quality system, which the firm helped establish. DArcy’s clients are start-ups, many are rare disease companies including gene therapy and stem cell companies. The firm currently works with a range of clients throughout the US, UK and Japan. With a growing list of clients in Philadelphia as well as the life science hubs of San Francisco and Boston, the company is well positioned to grow its expertise and reach.

Company: DArcy Consulting Name: Catherine Arthey Address: Devon, PA 19333, USA Telephone Number: 6102416983 Web Address: www.darcy-consulting.com

GHP / 2019 Healthcare & Pharmaceutical Awards 85

, MediComb A/S

MediComb A/S: Most Innovative Drug Information System - Nordic Region & Leaders in Patient Safety 2019 - Nordic Region A Danish start-up, MediComb A/S have developed a drug information system which provides an instant overview of treatment with many simultaneously-taken drugs, or polypharmacy.

Following their double win in Global Health & Pharma’s Healthcare and Pharmaceutical Awards 2019, we uncover why the firm are the most innovative drug information system and leader is patient safety across the Nordic region.

An increasingly ageing population in Western society has placed immeasurable pressure on the health and care industries. As a result, new and expensive drugs that are emerging to treat difficult diseases are often excluded due to the steeply-rising cost of treating the elderly.

Danish firm MediComb are on a mission to deliver better, safer, healthier lives for the growing number of elderly patients, whilst defusing the demographic time bomb.

Offering a system which holds the best and most comprehensive medicine information, MediComb are ensuring that all parties involved in a medical process have the necessary tools to make the most well-informed decision they can. The firm currently offer two version of the system, one professional and public.

The healthcare professional version is targeted at GP’s, dentists, hospitals, pharmacies, and care providers, each with individual user profiles to simplify matters.

The public version of the system is designed for consumers, whether that be patients or relatives, and empowers them to validate the utility of their medication. With a growing importance on patient empowerment, having

the knowledge to have informed discussions with medical professionals is invaluable for patients when determining what course of medical action is best for them.

The system contains all information in a summary of product characteristics, but also integrates other sources like interactions, direct healthcare professional communication, unintended incidents and medical guidelines.

All information is related to a patient’s drugs and it is possible to filter out information by sex, age, weight and patient type.

Users can also find all the necessary and relevant information or precautions for the elderly or other groups. The system will notify MediComb users of special conditions for lab tests, surgery, and anaesthesia and inform them about relevant monitoring or measuring in relation to those special conditions.

Adverse reactions may be grouped according to ICD10 organ classes.

By reducing inappropriate medication, it is estimated that there would be a 15% reduction in drug expenditure, a 5% reduction in hospital admissions, and the potential for cost of care to be reduced by between 10 and 20%. Improved patient safety and quality of life and care would usually

86 GHP / 2019 Healthcare & Pharmaceutical Awards

result in increased cost, but MediComb’s technological solution enables better welfare for less money.

Most drug information today is digitalised, but remains document-based, meaning that users still have to read lots of information pages for each drug. Searching for many types of additional information and trying to manually establish an overview of multi-drug treatments can be tiresome for users, but MediComb have solved this problem.

In all, the resounding success of this Danish start-up is down to its necessity across the medicinal and pharmaceutical industry. At a time where ageing populations and drugintake are under constant scrutiny, MediComb are paving the way for hospitals and care providers to help mitigate the risk of multidrug prescriptions with a clear and easy-touse system of information regarding drugs.

Company: MediComb A/S Contact: Henrik Reiche Website: www.medicomb.co.uk

, Accel-Rx

Accel-Rx: Best Health Sciences Accelerator 2019 – Canada & Seed Investment Experts of the Year - Canada Supporting health innovation companies developing pharmaceuticals, medical devices and diagnostics, Accel-Rx is Canada’s premier health sciences accelerator. As seed investment specialists, the company focuses on stewarding early-stage companies with smart capital to a level where they can successfully raise a Series A financing. Discover the reasons behind their award-winning success as part of our Healthcare and Pharmaceutical Awards 2019.

In the last decade, venture capital funding has shifted away from early-stage companies to focus on later-stage opportunities in an effort to minimise risk, despite creating a financing gap in the commercialisation continuum. Accel-Rx was formed to bridge this gap and address those specific growth challenges.

Through their own unique growth platform, Accel-Rx provides access to capital, industry connections, mentorship and customized guidance—a formula designed to stimulate Canada’s health sciences sector. In the high-risk field of health science investing, the company aims to reduce the risk for young companies, giving them an increased chance of success. By providing funding and expertise, the firm helps early-stage companies navigate the journey from being a privately funded seed stage company to an investor-ready one that can successfully attract public and venture capital.

Accel-Rx’s support for entrepreneurs goes beyond funding. In 2018, the company launched their Accel-Rx Mentor Program (AMP), a nation-wide mentor program that matches a team of experienced industry executives with early-stage start-ups. The mentors’ primary objective is to help any promising venture through their critical stages of development on an ongoing basis.

There is no time limit to the program, and the composition of the mentor team can change according to the needs of the venture.

Mentors and mentees are screened prior to acceptance into the program in order to ensure optimal fit for success.

The AMP helps take start-up ventures to the next level with wisdom and guidance from global health science leaders. With deep and diverse expertise in commercialisation and business execution, these CEOs provide regular, objective advice and access to their extensive networks in a trusted and conflictfree environment.

Since the firm’s inception in 2014, they have screened over two hundred companies and selected ten for investment. Accel-Rx has invested five million dollars across those ten start-ups, enabling another forty-four and a half million dollars in co-investment. Three of those ten have secured a further fortyfive million in follow-on funding, a significant financial boost for those companies.

and establishing private partnerships that can help build scale and increase impact. AccelRx’s network is made up of over one hundred partners including large academic research institutions, translational centres, multinational pharmaceutical companies, small and large biotech companies, investor groups, provincial governments, and much more.

Ultimately, Accel-Rx’s success comes down to their willingness to invest in earlystage companies that are commercializing innovative technologies. By enabling them to get off the ground and deliver innovative creations that could one day save lives, this firm’s work continues to be vital for Canada’s healthcare industry.

Company: Accel-Rx Contact: Natalie Dakers, President & CEO Website: https://www.accel-rx.com/

The seed stage syndicate landscape has also been changed. Accel-Rx is only able to invest up to half a million per venture, but those companies need a lot more to truly get off the ground. Through their rigorous diligence and relationships with the investment community, the average deal size has grown to $4-5M from $1-2M at the seed level; generating significant positive impacts throughout the community.

Collaboration is key, critical in identifying emerging industry developments, advancing early-stage commercialisation opportunities,

GHP / 2019 Healthcare & Pharmaceutical Awards 87

, Net Check In

Net Check In: Best Medical Services Queue Management Solution Headquartered in Minneapolis, one software solutions developer is transforming the way the world waits. Having developed software solutions for industry-leading companies for more than thirty years, Net Check In has become the go-to provider for transformative technology that connects people with services. Discover their successes as part of our Healthcare and Pharmaceutical Awards 2019.

Serving a range of industries that include government, retail, hospitality, education, financial services, automotive, and healthcare, Net Check In’s focus is on queue management. Particularly within the healthcare industry, the firm is dedicated to enhancing the patient experience by eliminating long queues and the stress of crowded waiting rooms.

By developing a simple and easy-toimplement solution, patients can check-in remotely online and then wait for service anywhere they choose — at home, work, a local park, or a coffee shop. Constantly updated on their position in the queue, patients are then notified when it is time for them to arrive at the medical facility for their service. Mobile technology is being used by Net Check In to remove the doubt as to when patients will be seen, and the frustration of having to wait for long periods in queues and waiting rooms filled with sick people.

The innovative software works in three ways to transform the waiting process: • First, a patented algorithm and artificial intelligence work to estimate an accurate wait-time. Based on actual real-time service intervals and resource levels, Net Check In also posts those estimates on the healthcare provider’s website and in custom apps so that patients can determine which location is most convenient for them.

•

•

Second, Net Check In enables the patient to check in remotely online from their phone, tablet or desktop, increasing mobility and flexibility and allowing patients to wait for their services wherever they want.

Finally, the software updates and notifies the patient on their status within the queue. Continuously updated via the app or browser with real-time status of remaining wait time, patients can use this to gauge when it is time for them to make their way to the facility.

Net Check In’s patented algorithm and AI have proven to be over 90% more accurate than traditional staff estimates on waiting times, and are currently being used by more than ten million users with over four million check ins per month. The unrivaled accuracy, reliability, and flexibility are just some of the reasons this software has experienced massive success. Also, being a web-based solution, there is no need for extra hardware or regular downloads. Service is provided on a monthly subscription (there are no contracts and customers can cancel any time ….but they don’t). Net Check In has excellent 24/7 customer support where there is always a live US-based representative available to answer any questions.

It is not just patients who benefit greatly from this software. Healthcare providers are able to access metrics on wait-times, no-shows, peak loads, staff utilization, service duration,

88 GHP / 2019 Healthcare & Pharmaceutical Awards

patient satisfaction, and much more. On-site wait times have seen a 78% reduction, with most users waiting less than five minutes in the waiting room. With the reduction of crowds and tension in waiting rooms, staff and employees are less stressed and able to deliver better patient care, while resources are more effectively optimized.

The unparalleled success and necessity of Net Check In’s innovative software cannot be overstated. By reducing wait times, ensuring patients get seen quickly and efficiently, and improving the healthcare provider’s ability to deliver quality patient care, this ingenious web-based solution is the easiest and most cost-effective way for a service provider to enhance the patient experience and boost customer satisfaction and retention.

Company: Net Check In Contact: Jim Alviani Website: https://www.netcheckin.com

, INNOTIO GmbH

INNOTIO GmbH: Best Specialist Healthcare Communications Agency - Central Europe Designed with the healthcare market in mind, INNOTIO GmbH is an agency specialized in reimagining scientific, brand and corporate communication solutions to meet evolving medical environments. As such, we felt it was important when showcasing the best of this year’s Healthcare and Pharmaceutical Awards winners to share an overview of this dynamic and creative company.

Since its foundation in 2008, INNOTIO has been working to make healthcare communications live up to expectations, driving efficiency and effectiveness for clients throughout the medical market. INNOTIO has an international team of experts with over 25 years of industry experience. With longstanding clients and partners, the company is now a multi-award-winning agency working at the top of their game without loosing that all-important personal touch.

Clients are important to them: They turn their dreams into reality; and over the last 11 years, INNOTIO has partnered with a range of companies, from large pharma healthcare to specialized biotech teams as well as nonprofit medical associations.

Thanks to its expertise and market knowledge the firm is now able to offer a selection of services tailored to meet the needs of clients across the healthcare space.

The firm’s focus is based on “GREAT”, great because its team support great launches with excellence in the following: • “G”- GRISP: strategic communication platforms, brand guidelines, corporate Identity design, logos and more • “R” READ: Medical writing from abstract to large scale of publication types, management of experts’ panels, symposia, stand alone, disease awareness campaign and MoA: an omnichannel communication system from F2F to virtual and hybrid activities to cover the scope of medical communication • “E” EXCITE: from creative concepts to onsite supervision, INNOTIO is the

•

•

one-stop solutions agency for corporate meetings, live acts, hospitality services, celebrations and VIP events in Healthcare “A” ACT: from concept to build in exhibitions, digital solutions and patient advocacy activities. As such, the firm is a trusted partner of choice “T” TALK: from hybrid and digital to the F2F, large symposia, scientific standalone, preceptorships with renowned centres of excellence, INNOTIO can undertake any aspect of a project and make it perfect.

From strategic thinking to state-of-the-art execution, all of these services are designed with the client in mind and are tailored to meet specific requirements of their therapeutic field and/or business imperatives.

‘Solutions and Execution’ is the firm’s motto, and this is central to its success.

on year. Success in any industry requires a passion for detail. The firm likes to think that its attention to details is one of the defining characteristics that sets INNOTIO apart from its competitors alongside encouraging creativity as one of the best ways to encourage innovation.

Looking to the future, INNOTIO will continue to strive towards greater successes in this space by further enhancing its market knowledge and working on increasingly innovative projects.

Company: INNOTIO GmbH Contact: Florence Manger Website: https://innotio.eu/

The digitalization of the healthcare industry means better connectivity between disparate areas of medicine, which results in improved healthcare outcomes in general. Healthcare as an industry is changing at an increasing rate. New technologies are continually being introduced, creating excitement among medical practitioners, researchers and patients alike.

The future of the healthcare industry will inevitably rely on cutting-edge technology and innovations, which can then be further developed and personalized for each medical sector and use case. While this is fantastic and of high importance, INNOTIO’s priority will be to make sure that the personal touch is not lost.

The team’s entrepreneurial spirit, a key value within INNOTIO, is the reason that the firm has been growing at an increasing rate, year

GHP / 2019 Healthcare & Pharmaceutical Awards 89

, Vital10

Vital10: Best National Health Promotion & Support Company – Netherlands & GHP Innovation Award for Medical Monitoring Solutions Supporting users throughout the Netherlands, Vital 10 is an innovative organization for health promotion, self-management, and remote support and guidance. We profile the firm to learn more and share an insight into how far it has come since it was initially established.

Since it first began in 2007 Vital10 has been striving to encourage people to stay healthy. To achieve this, the firm has been working to offer low threshold healthcare services that will meet their needs in today’s modern market.

Healthcare systems are often complicated, opaque and difficult to navigate, even for the healthiest in society. Whether attempting to speak to a doctor, stick to a medication plan, analyse test results, or monitor recovery progress, patients are having to rely on a slow-moving and uncommunicative network of clinics, hospitals and insurers. Demanding more from providers, Vital10 are encouraging responsiveness, with customised and clear support that enable patients to take on personal health challenges with confidence.

Everyone want to live a healthier and happier life, whether that is recovering from

a heart attack, fighting diabetes, reducing cholesterol, lowering blood pressures or simply working out more often. Vital10 makes it less hard to get healthy, inspiring users to set goals and then working alongside them to see those goals achieved.

face to face, is completely unique to the market. This leads to much lower health care costs both for the members and for society, and as it cannot be found elsewhere it helps the firm to draw new members to experience its quality and creative healthcare services.

Working alongside users every step of the way, Vital10’s digital health coaches monitor progress and help ensure that the path to a healthy life is both effective and efficient. Should users need help along the way, the platform will also connect them to an accredited expert via smartphone or computer, whether that be a physician, physical therapist, trainer, or nutritionist.

More than just a digital platform, Vital10 is an ecosystem for healthy living. Together with network partners outside the healthcare system, the platform allows patients and clients to become members of the company and access discounts on extra services throughout the ecosystem.

Membership of Vital 10 is open to everyone, and members get access to the firm’s innovative and cutting-edge online health care platform. This platform offers special benefits such as discounts on a range of, preferably sustainable, products and services. Not only products that allow people to do self-checks on their health and services that give valuable advise on how to improve their health, but also discounts on hotels, restaurants, clothing, etc.

As it works to provide quality healthcare Vital 10 works closely with the best health care professionals, specialized companies and knowledge institutions. The platform’s remote health care services concept, which offers members 24/7 contact with their doctor or specialist without the necessity of meeting

90 GHP / 2019 Healthcare & Pharmaceutical Awards

For example, where supermarkets are offering healthy products, the platform allows members to access all manner of healthy recipes. The ecosystem operates as a twosided personal health app, saving the needs and preferences of each member, and then connecting them to suppliers who can help.

Fundamentally, Vital10 has been specifically designed to inspire members to set health goals and then work with them to achieve them. This focus helps the firm to drive greater health management among the wider community and reduce the burden on healthcare services. This will remain central to the firm’s focus as it looks towards a bright and exciting future.

Company: Vital10 Contact: Sabine Pinedo Website: https://www.vital10.nl/

, DrDoctor

DrDoctor: Best Healthcare Transformation Specialists - UK Through its creative solutions, DrDoctor is working to radically change the way patients interact with the NHS, allowing patients to receive the best possible care at the lowest possible cost and providing healthcare providers with the tools they need to deliver long term, high quality, care. As we showcase a selection of this year’s Healthcare and Pharmaceutical Awards winners we offer a unique overview of this dynamic and creative company and the cuttingedge solutions it has devised to drive these drastic changes.

Since its creation in 2012 DrDoctor has been putting patients in control of their healthcare, whilst maximising valuable NHS resources.

In today’s digital age, the firm has developed solutions designed with modern users in mind. By harnessing the power of the internet, smartphones and SMS, patients can choose and reschedule their appointment times, feedback on services and learn more about what to expect from clinics.

then implementing these techniques into its solution. For example, the company has established that reminder messages increase the likelihood of attendance. This is particularly important, as 1 in 10 patients do not attend their appointments, which costs the NHS ÂŁ900 million a year.

Thanks to this research and the innovative solutions it offers, the outcome of using DrDoctor is more efficient clinics, a cost saving to hospitals and a much better experience for patients.

catalyses technology led change in hospitals and healthcare systems. The firm has had to work hard to disrupt the current system and drive real, beneficial change, and it still has a long way to go, but its success so far is down to its innovative solutions and dedication towards innovation. These principals will help the company to grow and prosper over the years ahead.

Company: DrDoctor Contact: Netta Nyrhinen Website: https://www.drdoctor.co.uk/

Every aspect of the appointment is dealt Overall, since it first began DrDoctor has with digitally, allowing for efficiency for all been striving towards creating a platform that stakeholders. Cancellations are automatically refilled using a proprietary algorithm presented to the patient. This automation and efficiency improvement also allows for a greater quality of care provided and helps staff to operate at the top of their practice by focusing their efforts where they can have the greatest impact.

As part of its focus on improving efficiency for the NHS, the firm has worked hard to establish how to improve the chances of patients attending and gaining benefit from their appointments and treatments, and

GHP / 2019 Healthcare & Pharmaceutical Awards 91

, International Travel and Healthcare Limited

International Travel and Healthcare Limited: Best Medical Travel Insurance Provider - UK Working to fill a gap in the market, International Travel and Healthcare Limited is dedicated to providing comprehensive travel insurance for consumers who have extensive medical conditions. We profile the firm to find out more about how this service offering has helped drive it to win in this year’s competitive Healthcare and Pharmaceutical Awards.

Created in 2005, International Travel and Healthcare has thrived over the years, and today it encompasses a range of brands including Safe Journey, OneStop4, Fit-4-Travel and more recently InsureMyCruise.

Among these is the pioneering Safe Journey, the UK’s first specialist terrorism travel insurance. Launched in May 2016, Safe Journey has been designed to provide financial protection for the changing world.

Finally, the firm offers Fit-4-Travel, which has been designed specifically for the most medically impaired travellers and their companions. As a result, it enables those who struggle to get other travel insurance to enjoy comprehensive cover, with a range of optional benefits of their choice, including unlimited medical expenses and medical repatriation cover as a standard feature.

As a specialist provider, the firm is able to support many other travel insurance brokers and price comparison websites, who are unable to cater for this extreme amount of health-impairment. Through this collaborative approach International Travel and Healthcare can offer clients the best possible service that is at the very cutting-edge of the latest insurance market developments.

Through these brands International Travel and Healthcare is able to offer specialist cover across a range of niche areas, including cruise cover, terrorism travel insurance as well as specialist insurance for those participating in winter sports and other activities.

With the future stretched ahead of it, International Travel and Healthcare has many further exciting developments in the pipeline to ensure it remains the travel insurance provider of choice to a wide range of clients both now and moving forward.

Alongside this, International Travel and Healthcare has also created OneStop4, a highly respected travel insurance brand, specialising in pre-existing medical conditions and travellers aged 50 and over. OneStop4 These unique schemes cover a range of risks provides International Single Trip and Annual that other policies in the market exclude; for Multi-Trip policies. instance, if a consumer is disinclined to travel after an act of terrorism has happened at their chosen destination, or require insurance for a cruise costing up to ÂŁ100,000 per person. Therefore, International Travel and Healthcare is able to set itself apart from other insurance distributors operating in this highly competitive industry and mark itself out as the best possible option for a variety of travellers including those with terminal, degenerative and congenital medical conditions.

92 GHP / 2019 Healthcare & Pharmaceutical Awards

International Travel and Healthcare Limited is authorised and regulated by the Financial Conduct Authority. FRN 433367.

Company: International Travel and Healthcare Limited.

Registered office: West House, 46 High St, Orpington. Kent. BR6 0JQ. Contact: Kate Huet Phone: 01689 892 228 LinkedIn: https://www.linkedin.com/company/ international-travel-and-healthcare-limited/ about/

, MedPlan Communications

MedPlan Communications: Best Continuing Medical Communications Agency 2019 - Canada Specialised in the development of continuing professional education programs and initiatives for healthcare professionals around the globe, MedPlan has been awarded the distinction of Canada’s Best Continuing Medical Communications Agency for 2019.

Since its inception in 1998, MedPlan Communications has established itself as a market leader and key collaborator in strategic healthcare communication services. With a diverse and ever growing portfolio of partners comprised of physician organizations, universities and pharmaceutical companies, MedPlan is at the forefront of developing impactful, valueadded education for healthcare professionals worldwide.

From scientific meetings to certified continuing medical education programs and practice enhancement initiatives, MedPlan creates learning platforms that fundamentally change the way clinicians care for their patients. Their programs bridge the gap between theory and practice, bring together networks of physicians, challenge clinical decision-making and drive the adoption of evolving healthcare approaches.

OPTIMED is an online practice assessment platform developed by MedPlan as a result of significant efforts to develop strategic approaches to clinical practice assessment.

The platform allows clinicians to evaluate their clinical decision-making behaviours and benchmark them against guidelines, expert recommendations and their peers. This is just one example of the agency’s potential for innovation.

The consistent success of MedPlan as leader in strategic healthcare communications for more than two decades is down to their commitment in staying at the forefront of medical and technical developments. Helping healthcare professionals deliver the best possible care to patients is a vital practice, and with new ventures on the horizon, the innovative work of this Canadian healthcare firm will continue to evolve to meet the needs of clinicians.

Keeping a keen eye on innovative developments, MedPlan is pushing the limits of what OPTIMED can do, exploring how machine learning and artificial intelligence (AI) can aid in the clinical decision making process. Working alongside a team of data scientists and AI specialists, the team is launching an integrated, multi-channel, personalised learning journey coupled to the OPTIMED platform in 2020.

Company: MedPlan Communications Inc. Contact: Emy Behmoaram – Director, Client Services Website: http://www.medplan.ca/

MedPlan is an interdisciplinary team of 30+ strategists, medical content creators, designers, developers, project managers and other specialists, constantly challenging themselves to find new and innovative ways of sharing relevant medical information. At the heart of their company mission is an educational methodology that effortlessly combines established adult learning principles, gamification concepts, and a deep, meaningful reflection of practice. Welcoming digital change is imperative for all industries, including the medical and pharmaceutical industries.

The team is continuously on the lookout for platforms and ideas in other fields that can be applied to the medical field to connect emerging technology to everyday physician needs.

GHP / 2019 Healthcare & Pharmaceutical Awards 93

, Al-Faraby Medical Group

Al-Faraby Medical Group: Healthcare Consultancy of the Year 2019 - South Asia Established over twenty-five years ago, Al-Faraby Medical Group is focused on providing high quality healthcare solutions and services that are compassionate, culturally sensitive, and respectful. Following their win as Healthcare Consultancy of the Year across South Asia in our Healthcare and Pharmaceutical Awards 2019, we explore the firm’s work and continued success.

Offering advanced, effective and competitive medical care solutions for individuals and corporations from a wide variety of business fields, Al-Faraby are South Asia’s leading healthcare service provider and consultant. Complying with the highest quality medical standards, the firm has concentrated its resources on providing state-of-the-art occupational healthcare services that match both local and international industry standards.

their industrial partners occupational health screening programs, project management services, healthcare consulting services, and health education courses, to help maintain quality healthcare standards.

Alongside their dedicated healthcare facilities, Al-Faraby also offer a Pharmacies Division, Medical Supplies Division, and Faraby Training Centres. The pharmaceutical division focuses on managing the operation of external and internal pharmacies within the company’s own medical centres, and other company’s individual pharmacies. Medical supplies division work alongside clients to make sure that they have access to necessary medical equipment and consumables, whilst the Faraby training centres work to provide continuous professional development, life support and certified courses.

Understanding the complex risks faced by employers, the experienced team at AlFaraby work tirelessly to match their bespoke services to the needs of each individual client or business. Ensuring that their offerings are cost-effective and tailored, each client can rest assured of efficiency, confidentiality, and minimal disruption to the daily workings of the business.

Pioneering the acquisition of approval from the largest oil and gas company in the world in With three separate professional healthcare Saudi Aramco, Al-Faraby were swiftly listed in facilities, Al-Faraby offers comprehensive their Approved Healthcare Providers for Onsite healthcare solutions to the needs of clients, and Remote Area clinic operations. Their whatever industry they are working in. The ambition is matched only by the level of their Healthcare Solutions Division of the firm offer healthcare consultation services, delivered by the best qualified medical and support staff.

That ambition will see the group continue to plan and work on winning more mega projects in oil and gas, as well as expanding their market spectrum beyond their current borders.

By maintaining their focus on increasing HR capabilities and resources, Al-Faraby are continuing to attract and acquire the very best talents in the market to join their family. Alongside this, the group is keen to keep enhancing the aforementioned training centres and their capabilities to develop the

94 GHP / 2019 Healthcare & Pharmaceutical Awards

skills and knowledge of the team. Despite the stringent internal audit and quality control programs to ensure compliance with policies and procedures, the firm is also dedicated to promoting their development programs in order to enhance the patient experience at all levels of service.

Looking to the future, the team at Al-Faraby are acutely aware of developments in the field of healthcare, especially its focus on new technologies such as IOT and artificial intelligence to help provide more convenient services. Ensuring that they adapt to any new changes and new technologies, the group will continue to utilise them in offering that same convenience and patient-centric services for all their clients.

Ultimately, the success of Al-Faraby is down to their dedication to form constructive, long-term and professional relationships with clients across the whole of South Asia. Committed to achieving the highest possible satisfaction rates with clients and the best healthcare services possible, the group are continuing to ensure their success will rise for years to come.

Company: Al-Faraby Medical Group Contact: Sami Abutteen, Executive Director Email: info@faraby.net Website: www.faraby.net/index.php/en/

, PlantForm Corporation

PlantForm Corporation: Best Specialty Protein Drug Biopharmaceutical Company 2019 Rapidly developing and producing specialty antibodies and protein drugs, PlantForm Corporation is a biopharmaceutical company focused on making life-saving biologic drugs more affordable and accessible around the world for patients with critical illnesses. Discover why this company, using its proprietary technology platform vivoXPRESS®, is the best in specialty protein drug in 2019’s biopharming industry.

A privately-held Canadian biopharmaceutical company, PlantForm is focused on developing and marketing therapeutic drugs, whilst also advancing projects of interest to other parties that use its vivoXPRESS® platform. The plant-based system makes it easier, faster and less expensive to produce approved biologic drugs for novel indications and new markets.

Co-founded by Chief Scientific Officer Dr. J. Christopher Hall, PlantForm is developing a wide range of biologic drugs, including monoclonal antibodies and therapeutic proteins. Many of these products are biosimilars, which patients, physicians, and healthcare funding agencies are beginning to accept over established drugs.

Through pre-clinical and clinical testing, PlantForm is ensuring its biosimilars demonstrate the highest standards of safety and efficacy. Marketing partners of the firm are aiming to bring these drugs to the world market at significantly reduced cost than both originators and other biosimilar competitors.

Using the technology of vivoXPRESS® to genetically engineer tobacco plants to produce biopharmaceuticals in less than six weeks, goods can be produced at a significantly lower cost compared to industry

standard fermentation systems. The system has many advantages on top of costeffectiveness, including rapid development and production timelines, high levels of drug expression, lower risk of unwanted immune reactions, and unlimited scale-up capability.

PlantForm has significantly increased production rates from the vivoXPRESS® platform using specialist knowledge of genetics, molecular biology, plant physiology and process engineering. With production rates increased a hundred-fold over five years, the company can now produce biosimilar products at a tenth of the cost that equivalent name brands can.

Research and development groups at PlantForm have attracted scientists to lead in-house laboratory studies, and manage a number of collaborations with universities, government institutes and companies to develop and evaluate new technologies. Through a strong scientific advisory committee, the company gains insights on industry direction, and support for collaboration on emerging technologies. Staff are also regular contributors and reviewers of scientific journals, and sit on advisory panels to associations, ensuring that the firm develops and uses the latest cutting-edge technology.

Looking to the future, the company is developing its business internationally.

Expanding upon an existing partnership in Brazil, PlantForm will also be advancing a new biosimilar program in the region and aim to develop a suite of drugs for the Brazilian and world markets. There is also potential for more international partnership with a leading South African biopharmaceutical company, with the potential for establishing the vivoXPRESS® technology in a manufacturing facility in Africa.

AntoXa Corporation, a subsidiary of PlantForm, is also developing specialty drugs to help protect military and civilian personnel from biological and chemical agents. With an exclusive license to the vivoXPRESS® platform, AntoXa is producing defencerelated therapeutics and countermeasures against agents such as ricin and sarin.

Ultimately, the success of PlantForm is coming from the application of specialist knowledge to create cost-effective, biosimilar drugs at a fraction of the cost. With industries seeking high-value product opportunities from plant-based production systems, this firm intends to pursue and evaluate potential collaboration across the world.

Company: PlantForm Corporation Contact: Don Stewart Email: don.stewart@plantformcorp.com Website: https://www.plantformcorp.com/

GHP / 2019 Healthcare & Pharmaceutical Awards 95

, CBD Becomes a Hot Topic In UK..

CBD Becomes A Hot Topic In UK Alternative Medicine Market Whilst CBD products have been popular in America for many years, they have been slower to catch on in the UK. However, a new wave of companies is now moving into the provision of CBD products which could reshape the country’s alternative medicine industry, as Staff Writer Hannah Stevenson highlights.

CBD, a cannabinoid derived from cannabis, has long been a healing product around the world, with healers from China, America and Mexico, among others, all reported to use it to treat a variety of conditions.

Today, there are many brands that incorporate CBD oil into everyday products such as coffee, biscuits and energy bars.

Around the world CBD oil is becoming increasingly prevalent, and with many US states legalising cannabis itself, the oil is now used more prevalently across the country.

In the UK, cannabis is still illegal, however CBD oil is allowed as long as it does not contain THC, the actual substance in cannabis that makes the substance illegal.

The country’s drug laws are complicated and whilst police can issue a warning or an on-the-spot fine of £90 if a person is found with cannabis, any oils such as CBD which do not contain THC are legal. As the Drug Licensing Factsheet-Cannabis, CBD and other cannabinoids states:

“CBD as an isolated substance, in its pure form, would not be controlled under the MDA 1971 / MDR 2001.”

The report also elaborates on the concentration needed to be rendered legal:

“There needs to be a defined commercial end use and the Home Office only issues licences for cultivation of plants from approved seed types with a THC content not exceeding 0.2%. The ‘0.2%’ reference is used solely to identify varieties which may potentially be cultivated, within the scope of this policy, and to differentiate between the fee level is applicable under the Misuse of Drugs (Fees) Regulations 2010. The Hemp (Third Country Imports) Regulations 2002 also require, except in specified circumstances, that hemp from ‘third countries’ be imported under a licence and, in the case of hemp seeds other than for sowing, under an authorisation.”

Many UK based companies are now moving into CBD services and products, including fourfiveCBD, which was founded by professional rugby players George Kruis (Saracens and England) and Dominic Day (Saracens and Wales) and has recently announced the availability and launch of its 0% THC, CBD product aimed at professional athletes. fourfiveCBD 0% THC is the first and only cannibis product in the world to also be third-party tested and certified for cross contamination of banned substances. These services have been provided by a leading international third-party provider of testing and certification, BSCG (Banned Substances Control Group).

96 GHP / 2019 Healthcare & Pharmaceutical Awards

The launch of fourfiveCBD 0% THC comes as a direct response to demand from fellow professional athletes, coaches and medical teams who have seen the benefits of taking CBD, but have, until now had concerns about the provenance of products currently available on the market.

Now professional athletes, who are subject to testing, can enjoy the benefits that CBD can offer, safe in the knowledge that fourfiveCBD contains 0% THC and has been thoroughly tested for any cross contamination of banned substances. fourfiveCBD was founded by two professional rugby players Dominic Day and George Kruis.

The two have developed a line of natural CBD products to help aid recovery and help with the rigours of contact sport. The new product was developed after the pair realised there was a need for a CBD product that was tested to the highest standards. With the new 0% THC product, anyone that is drug tested can use CBD in confidence. fourfiveCBD 0% THC oil is available today from the fourfiveCBD.co.uk webstore priced at £74.99 including delivery. Each 30ml bottle contains around 240 sprays of 100% natural CBD. There are 1000mg of CBD in each bottle.

All the fourfiveCBD products are guaranteed to be free from pesticides and herbicides and are also vegan and vegetarian friendly.

g

“fourfiveCBD is delighted to be the world’s first CBD product to be approved by BSCG. As a BSCG Certified Hemp® product, fourfiveCBD’s 0% THC ensures that professional athletes can now take CBD with total peace of mind that our product is free from cross contamination of banned substances, synthetic chemicals and problematic ingredients,” said Dominic Day, co-founder and director, fourfiveCBD. “As professional athletes ourselves, we have responded to the market demand for a 0% THC and cross contamination checked product which has guaranteed provenance.

Now, any athlete who wants to try CBD can do so with complete confidence. We’ve also created this new product with coaches and medical teams in mind who can now recommend a product to athletes that has been comprehensively tested. If you’re an athlete or part of a team around an athlete and you’re considering the use of a CBD product that hasn’t been tested for 0% THC and cross contamination of banned substances, we’d strongly advise against it.”

BSCG offers a complete suite of product testing and certification programs that protect against drugs or other harmful agents, and recently introduced BSCG Certified Hemp™, the first broad-spectrum international thirdparty hemp certification program.

CBD Becomes a Hot Topic In UK..

“We’re pleased that fourfiveCDB 0% THC, a professional athlete-driven product developed for other professional athletes, happens to be our first official BSCG Certified Hemp™ product,” said Oliver Catlin, BSCG President. “Smart athletes who want to protect their health, their reputations and their sports are always better off choosing supplements and other products that have been rigorously tested by a top third-party certification provider like BSCG.” Seeking to enter into the UK’s burgeoning cannabis markets is Cura Partners, Inc., one of the largest cannabis and hemp-based CBD consumer products companies in the world, which has moved to officially enter the European market (EU) through a distribution agreement with Plata Wellness.

The agreement allows Cura’s Select CBD products to be available direct to consumers in legal markets across Europe via the website www.selectcbd.eu. Cura has appointed Plata Wellness Limited (Plata) to assist with its entry into the EU. In addition to Plata’s role as Cura’s inaugural overseas distributor, Plata is also providing a number of other services including order fulfilment, payment processing, and in the future, licensing and manufacturing.

This partnership begins with the introductions of Select’s CBD disposable vaporizer cartridges but will, over time, add other legal consumer products including tinctures, gel caps and muscle rubs.

“Cura’s decision to move into Europe is in direct alignment with the company’s mission to be the leading provider of cannabis oil to consumers and brands in legal U.S. and international markets,” said President and Chief Executive Officer Cameron Forni. “I’m proud of the team that made this possible, and look forward to partnering with Plata Wellness to get the Select CBD brand into the hands of consumers across Europe.”

Europe is home to more than 741 million people, more than double the combined population of the United States and Canada.

When trying to extrapolate these numbers to account for the potential demand in Europe’s much larger population, there is a crystal-clear reason why established cannabis companies in the United States are now turning their attention to Europe.

“We are very delighted to have partnered with Cura, the market leading company in this sector. We are excited to work together to bring the Select brand to prominence in Europe and to supply consumers with these award-winning products,” said Jon Robson, Managing Director at Plata Wellness Limited.

Such a move showcases a new trend in the UK’s alternative medicine market and could provide many opportunities for other firms over the coming years.

GHP / 2019 Healthcare & Pharmaceutical Awards 97

ghp

Research, Translation, Commercialisation